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ABSTRACT 
The core antigen (HBcAg) of hepatitis B Virus (HBV) can be expressed in 
Escherichia coli where it assembles into icosahedral particles of two sizes 
containing 240 or 180 subunits. These particles could be fractionated by sucrose 
gradient centrifugation and light scattering showed their size distribution to be 
essentially monodisperse. HBcAg is 183 amino acids long and highly enriched in 
arginine residues in the C-terminal region. Around 50% of these residues are 
encoded by the rare triplet AGA in E.coli. Supplementation of the level of AGA 
tRNA in the cell with plasmids expressing the T4 AGA tRNA gene significantly 
enhanced the yield of HBcAg. SDS polyacrylamide gel electrophoresis of the two 
kinds of particles showed that around half of their subunits were smaller than the full 
length HBcAg and varied in size. N-terminal sequence analysis revealed that these 
smaller species were heterogeneous at the extremely basic C-terminal end. 
In the virus the icosahedral nucleocapsids are surrounded by an envelope 
consisting of cellular lipids and three related surface antigens (L-, M-, and 5-
HBsAg) which result from alternative translation initiation of a common reading 
frame. The L-J4BsAg is believed to mediate the contact between the envelope and 
nucleocapsid. The N- and C-termini of this protein were shortened in order to define 
the minimum stretch of amino acids that contains the exact contact residues. To 
determine which residues are directly involved in the interaction, single and 
multiple mutations were generated by site-directed mutagenesis. The resulting 
mutated proteins were expressed in rabbit reticulocyte lysates and their ability to 
interact with HBcAg was examined with an immunoprecipitation assay and a newly 
established equilibrium binding assay in solution which allows the determination of 
relative dissociation constants with Scatchard and non-linear regression analyses. 
Binding of each type of HBcAg particles by L-HBsAg displayed two widely 
differing dissociation constants, suggesting the existence of two binding sites 
between the molecules. It appears that amino acids 24 to 191 of the L-HBsAg N-
terminus form one intact binding domain and a second binding domain between 
residues 191 and 322 is required for the protein to bind with high affinity to HBcAg. 
Disruption of either one of these domains resulted in a weak interaction showing 
xv 
only one dissociation constant. Mutation analysis revealed that Arg-92 was very 
important for the interaction. A synthetic peptide carrying the epitope for a 
monoclonal antibody to the PreS 1 region competed with L-HB sAg for HIBcAg, but 
peptides corresponding to a linear sequence at the tip of the nucleocapsid spike did 




Chapter 1: Introduction 
1.1 Hepatitis B virus 
Human hepatitis B virus (HBV) is the prototype of the family of 
hepadnaviridae. Other family members have been found in Pekin ducks (DHBV), 
ground squirrels (GSHV), herons (HHBV), and woodchucks (WHY) (Seeger et al., 
1991). HBV has a narrow host range, infecting only human and other higher 
primates such as chimpanzees, but does not infect baboons, lower primates or other 
mammals. Until recently, this virus could not be propagated in cell culture systems. 
HBV is transmitted in the same way as HIV, through direct contact with 
infected blood or body fluids, through perinatal transmission from an infected 
mother to her offspring. After an initial acute infection, a proportion of patients who 
fail to eliminate the virus become chronic carriers. The risk of becoming a carrier is 
strongly depends upon the age at which a person is infected. Infants who are 
infected at or shortly after birth have a greater than 85% chance of becoming carrier 
(Stevens et al., 1985); however, this incidence declines to below 19% after the age 
of five. Currently, there are estimated to be more than 300 million carriers of HBV 
world-wide, particularly in the Southeast Asia and Africa. They have an increased 
risk of developing chronic liver disease such as cirrhosis and hepatocellular 
carcinoma (Dudley et al., 1972; Redeker, 1975). The exact role of this virus in the 
development of hepatocellular carcinoma cells is not known, but these cells 
frequently contain integrated HBV DNA sequences. This suggests that integration 
of the HBY genome might alter the transcription of a cellular gene regulating cell 
division which culminates in the development of liver cancer (Dimmock and 
Primrose, 1994). 
The infection can now be prevented through immunization with vaccines 
based on surface antigens (HBsAg) derived from human plasma (Szmuness et al., 
1984) or produced in yeast resulting from genetic engeneering approaches (McAleer 
et al., 1984; Murray et al., 1984). For those who had already acquired a chronic 
infection, a-interferon appears to hold the best hope to clear the virus (Thomas and 
Scully, 1985). This protein acts by enhancing the expression of major 
histocompatibility (MHC) class I by infected liver cells and not through an antiviral 
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activity. HBV-specific peptides are then presented in sufficient amount by MHC 
class I to allow CD8 cytotoxic T lymphocytes (CTLs) to lyse the infected cells 
(Dimmock and Primrose, 1994). The successful rate of this treatment is about 50% 
(Thomas and Scully, 1985). 
1.2 Virion and genome structure 
With the electron microscope, three morphological distinct forms of particle 
are observed in infectious sera: spheres and filaments of 22 nm diameter (Bayer et 
al., 1968; Gerin et al., 1969) and 42 nm double-shelled particles or known as Dane 
particles (Dane et al., 1970). 
The Dane particle (Fig. 1) is now known to be the infectious agent (Robinson 
and Luttwick, 1976). It consists of an outer envelope derived from the host cell 
membrane. Embedded in the envelope are three distinct but related forms of surface 
protein (HBsAg): 5- (small), M- (middle) and L- (large) HBsAg. Internal to the 
envelope is the viral nucleocapsid or core (HIBcAg). Within the core is the genome 
and the polymerase protein (P) which is covalently attached to the negative strand 
DNA (Ganem, 1991; Nassal and Schaller, 1993). 
Nucleocapsid  




(PreS2 + S regions) 
DNA 	
) 	 L-HBsAg 
DNA 	




Fig. 1: A schematic representation of virion structure of HBV 
The representation of the L, M, and S forms of HBsAg have no quantitative 
or positional significance. (modified from Nassal and Schaller, 1993). 
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The genome appears in the form of partially double-stranded circular DNA 
about 3.2 kb (Fig.2), the smallest of any animal DNA virus yet encountered. The 
DNA strands differ in size. The negative strand is about 3.2 kb long and serves as a 
template for transcription of all viral mRNAs. The positive DNA strand is of 
varying length, from 1.7 to 2.8 kb long. Neither of these DNA strands is covalently 
closed, but the circular configuration of the double-stranded DNA is maintained by 
hybridisation of complementary sequences at the ends of the long and short DNA 
strands which results in a molecule with a single-stranded gap. Near to the 5'-end 
of the two DNA strands is a pair of directly repeated 11-base-long sequences (DR 1 








Fig. 2: The Stuctural and Functional Features of HBV DNA 
The minus and plus strands of HBV DNA are shown in the innermost portion of the 
figure. The viral direct repeat (DR) sequences are boxed and the P protein is 
indicated by (.). Dashed line indicates the presence of the single-stranded gap. 
The viral open reading frames (ORFs) are indicated by arrow bars, with 
arrowheads indicating direction of transcription and translation. Major viral 
transcripts are indicated as bold lines in the outermost portion of the figure. 
(modified from Ganem and Varmus, 1987; Schaller and Fischer, 1991). 
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The 22 nm particles, which are enormously abundant in the blood stream of 
infected carriers, are composed of HBsAg and host-derived lipid which consists 
mainly of phospholipids, free and esterfied cholesterol and small quantities of 
triglycerides. No viral genetic information is found in these particles and therefore 
they are noninfectious. Also, these particles lack the nucleocapsid component and 
have no detectable cellular polypeptides (Ganem, 1991). The biological function of 
these noninfectious particles is unclear but they may weaken the efficacy of the 
immune response by acting as decoys that trap antivirus antibodies. They are highly 
immunogenic and therefore have been exploited as a subunit vaccine against HBV 
infection (Szmuness et at., 1980). 
1.3 Genome organisation and viral transcripts 
The HBV genome carries four major open reading frames (ORFs) which 
overlap each other extensively and are encoded by minus-stranded DNA: ORFs S, 
C, P and X (Fig. 2). The nucleotide numbering system used in this study is that of 
Pasek et al. (1979) which select the first nucleotide of the coding sequence for 
HBcAg as number 1. Upstream of ORF S which encodes for HiBsAg, is an in-phase 
reading frame (ORF PreS) with two conserved in-phase ATG codons which 
subdivide the PreS regions into two functional subregions, termed PreS 1 and PreS2, 
whose products are known as L- and M-HIBsAg. Similarly, the coding region for 
HBcAg (ORF C) is also preceded by a short upstream in-phase ORF, termed PreC, 
which produces an amino-terminally extended protein that is processed and secreted 
as HBeAg; this is believed to be involved in the virus-host interaction by influencing 
the immune response. ORF X encodes a product that is believed to be important for 
the establishment of infection by an unknown mechanism. Overlapping these coding 
regions, ORF P, encodes protein P which has polymerase, reverse transcriptase and 
RNAse activities (Ganem and Varmus, 1987; Ganem 1991; Nassal and Schaller, 
1993). 
Four species of mRNA transcripts (Fig. 2) are produced from a 
corresponding set of promoters on a covalently closed circular DNA (cccDNA) 
utilising the transcription machinery of a host cell. The RNA species can be divided 
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into two classes: genomic and subgenomic. The genomic RNAs are approximately 
3.5 kb in length and their synthesis is controlled by the core (C) promoter (Yaginuma 
and Koike, 1989). These RNAs are bifuntional, serving not only as the mRNA for 
the precore, core and P proteins, but also as the template for reverse transcription 
into the DNA genome. The subgenomic mRNAs consist of three species with 2.4, 
2.1 and 0.9 kb in length. The PreS 1 promoter regulates the transcription of the 2.4 kb 
mRNAs which serve as a template for the L-HIBsAg (Will et al., 1987). The M- and 
S-HBsAg are encoded by the 2.1 kb mRNAs which are the most abundant in acutely 
infected livers. Synthesis of the 2.1 kb mRNAs is controlled by the PreS2/S 
promoter (Raney et al., 1989). The smallest transcript, 0.9 kb, gives rise to the X 
protein, HBxAg. All these transcripts are capped, unspliced and terminate at a 
common polyadenylation site, about 20 nucleotides downstream of the conserved 
hexanucleotide TATAAA (Ganem and Varmus, 1987; Schaller and Fischer, 1991; 
Nassal and Schaller, 1993). 
1.4 Viral proteins 
1.4.1 Core antigen (HBcAg) 
The nucleocapsid or core particle of HBV is a protective container for the 
viral genome and polymerase. Its interior provides a suitable environment for the 
process of reverse transcription during replication. Furthermore, its exterior 
interacts with the viral envelope proteins in an unknown manner leading to 
maturation of the virus. The capsid is made up from many copies of core proteins; 
serologically known as core antigen (HIBcAg) which is translated from the second 
in-frame initiation codon (AUG) of the C ORF and comprises 183 amino acids with 
a molecular mass of approximately 22 kDa. It is organised in two distinct domains: 
the first 144 amino acids are required for self-assembly; the C-terminal portion of 
the molecule (residues 145-183) is extremely basic, displaying non-specific nucleic 
acid binding and represent a motif required for packaging of the pregenomic RNA 
(Ganem, 1991). 
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Several groups have demonstrated that nucleocapsids isolated from infected 
liver (Petit and Pillot, 1995; Machida et al., 1991), and produced in E. coli 
(Matsuda et al., 1988; Gallina et al., 1989; Hatton et al., 1992) have non-specific 
nucleic acid binding activity. A detail dissection of the protamine-like region has 
revealed four repeated sequence motifs (Hatton et al., 1992). The first motif, 
spanning amino acids 150-157 (RRRDRGRS) is the minimal region required for 
RNA binding and packaging, but does not bind DNA, while the three other repeats 
bind DNA much more efficiently than RNA. Nassal (1992) showed that only half of 
the C-terminal region spanning to amino acid 164 was sufficient for pregenomic 
RNA encapsidation with an efficiency similar to that of the full-length HBcAg. In 
addition, amino acids 165-173 of the C-terminus were required for proper genome 
replication. This suggest an extensive role of the protamine-like domain, not only in 
pregenomic RNA encapsidation, but also in genome replication. 
HBcAg can be expressed in a variety of heterologous systems, including E. 
coli (Pasek et al., 1979; Burrell et al., 1979; Edman et al., 1981; Stahl et al., 1982), 
tissue culture cell lines (Gough and Murray, 1982; Rossinck et al., 1986), yeast 
(Kniskern et al., 1986), baculovirus (Hilditch et al., 1990), Acetobacter 
methanolicus (Schroder et al., 1991) and Xenopus oocytes (Zhou and Standring, 
1991). In these systems, core proteins are able to self-assemble into nucleocapsids 
in the absence of other viral proteins. When observed in an electron microscope, 
such particles are morphologically similar to authentic nucleocapsids isolated from 
infected liver (Cohen and Richmond, 1982; Uy et al., 1986; Miyanohara et al., 1986; 
Ou et al., 1986). Deletion mutagenesis of HBcAg indicates that the first 140 amino 
acids are sufficient for self assembly (Zlotnick et al., 1996). 
To date, the three dimensional structure of HBcAg particle or its subunits at 
atomic resolution has not been solved. Perhaps, purified HBcAg particles with 
heterogeneous populations, as shown by electron microscopy (Cohen and Richmond, 
1982; Onodera et al., 1982) do not allow the particles to crystalhise easily. Usually, 
most viral capsid proteins assemble into particles of a fixed, predetermined size, but 
HBcAg particles are dimorphic. Using electron cryomicroscopy and image 
reconstruction Crowther et al. (1994) showed that HBcAg expressed in E. coli 
assemble into two sizes of particles: small and large, approximately 30 and 34 nm in 
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diameter, respectively (Fig 3). The large particle corresponds to a triangulation 
number T=4 containing 240 protein subunits. The minority species (less than 15% 
of the total population), comprising the smaller size of particle, corresponds to a T=3 
shell of 180 monomers. 
Fig. 3: Three-dimensional maps of hepatitis core particles 
Large empty (a and b) and small empty (c and d) core particles determined by 
electron cryomicroscopy and image processing. a and c show the view along a two-
fold axis of symmetry, b and d show the view along a five-fold axis (Source: 
Crowther et al., 1994). 
Nucleocapsids isolated from human liver show a ratio of 13:1 of large to 
small particles (Kenney et al., 1995). Recently, Zlotnick et al. (1996) showed that 
the proportions of small particles isolated from E. coli increased systematically with 
larger deletions from the protamine-like region; a mutant comprising 149 residues 
formed approximately 5% of small particles, while a shorter mutant containing 140 
residues produced approximately 80% of small particles. However, a C-terminally 
truncated mutant at residue 144 with several additional amino acids extending its N -
and C-termini also produced predominantly (approximately 85%) small particles. In 
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addition, when cysteine 61 of the 149-residue mutant was mutated to alanine, the 
amount of small particles increased to around 30% (Ziotnick et al., 1996). This 
observation indicates that the C-terminus is not the only factor to affect the 
dimorphism. The factors which control the dimorphic distribution are not 
understood. Furthermore, the physiological implications of the two different species 
of core particles in vivo remain an enigma. 
FIBcAg particles produced in E. coli can be dissociated into dimers without 
unfolding the protein and reassembled under appropriate conditions (Wingfield et 
al., 1995; Zlotnick etal., 1996). This shows that the fundamental building block is a 
dimer, and the residues involved in dimer linkage are Cys-48 and Cys-61 (Zheng et 
al., 1992). Each dimer consists of a protruding spike that stick out from the 
underlying shell domain. The large and small particles show 120 and 90 spikes, 
respectively (Crowther et al., 1994). The spikes are similar in structure for the two 
types of particles which are shaped like an inverted capital 'T' (Zlotnick et al., 
1996). The stem of the T's form the external spikes and from the calculated volume, 
the authors estimated that the spikes received a contribution of about 35 amino acids 
from each monomer. Most recently, using electron cryomicroscopy, Böttcher et al. 
(1997) solved the structure of the large particle to 7.4 A resolution, and at the same 
time Conway and colleagues (1997) published a 9 A-resolution map. Both groups 
showed that each dimer consists of a 4-helix bundle, formed by the pairing of a-
helical hairpins from both subunits. A diagram of the polypeptide fold of the 
monomer subunit as proposed by Böttcher et al. (1997) is shown in Fig. 4. It 
appears that the immunodominant loop of amino acids 74-89 in the core protein 
(Argos and Fuller, 1988; Salfeld et al., 1989; Borisova et al., 1993) is exposed near 
the tip of these protruding domains. Since this region is nearest to the viral 
envelope, it is very likely to be involved in the interaction with the envelope 
proteins. In principle, this could be established by biopaning the HBsAg with a 
bacteriophage display library (Scott and Smith, 1990) and the peptide sequences 
obtained should reflect the docking site on the core protein. 
With three dimensional image reconstruction, it is clear that the assembled 
particles have holes penetrating the protein shell (Crowther et al., 1994; Kenney et 
al., 1995; Zlotnick et al., 1996). At 17 A resolution, the largest holes on T=4 
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particles are measured to be around 500 A2 . Since the HIBV capsid serves as a 
compartment for reverse transcription of pregenomic RNA to double-stranded DNA, 
it is important for the inside of the core to be accessible to the small molecules 
necessary for DNA synthesis (Crowther et al., 1994). 
W. 
48 	 112 
Fig. 4: Polyp eptide fold of the HBcAg monomer 
Each monomer consists of 4 a-helices (indicated as cylinders). The a-helix near to 
the N-terminus is —15 A long. The two longest a-helices are —42 A long and joined 
by a loop corresponding to amino acids 78-82. The first long helix is roughly 
straight, whereas the second long helix has a kink in the middle. The C-terminal 
helix corresponds to residues 112-128 is —23 A long. The numbers indicate 
approximate amino asid positions in HBcAg and putative amino and carboxy ends 
are indicated by N and C respectively. (modified from Böttcher et al., 1997). 
A striking feature of HBcAg is that the extremely basic C-terminal region 
can be replaced by foreign sequences of varying length, without disruption of the 
ability to form particles (Borisowa et al, 1989; Stahl and Murray, 1989; Schoedel et 
al., 1992). Those fused foreign peptides, in some cases, can be detected by specific 
antibodies on the outside of the assembled particles. Since the arginine-rich C-
terminus has been shown to bind nucleic acids and play a role in genome replication, 
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therefore, it is likely that the inserted foreign sequences emerge through or located 
near the edge of the holes in the assembled particles, and are thus accessible to 
antibodies (Crowther et al., 1994; Kenney et al., 1995). Another explaination is 
that these particles could be less stable, disrupted in the reaction conditions used 
and exposed to antibodies. Image reconstruction from cryoelectron micrographs of 
those assembled particles could be a straightforward technique to prove those 
suggestions. 
The assembly of core-like particles is also unimpeded by the addition of 
heterologous sequence to the N-terminus of HBcAg (Clarke et al., 1987; Stahl and 
Murray, 1989). However, certain amino acids in this region are important for the 
formation of correct determinants. Deletion of the first eleven amino acids of 
HBcAg resulted in a drastic loss of antigenicity (Salfeld et al., 1989). Similarly 
Stahl et al. (1982) demonstrated that particles, produced in E. coli, which have 
eleven foreign amino acids fused to residues 3-183 of HBcAg reacted well with 
polyclonal anti-HBcAg while a protein which differed only in the deletion of amino 
acids 3 and 4 of HBcAg failed to react significantly with antibody. Further 
investigation by Stewart (1993) showed that protein lacking amino acid 3 reacted 
less well with polyclonal anti-HBcAg, relative to wild-type. 
1.4.2 HBeAg 
Upstream of the ORF C lies another in-frame initiation codon of the pre-C 
region. Translation of the complete pre-C/C gene produces a 25 kDa precore 
protein, p25, which has an additional of 29 amino acids at the N-terminus of HBcAg. 
The first 19 amino acids act as a signal sequence which targets p25 into membranous 
organelles, probably endoplasmic reticulum and Golgi (Ou et al., 1986). The protein 
is then proteolytically processed at both ends and eventually secreted in the sera of 
infected individuals as a soluble 17 kDa protein, pl7e, which known as hepatitis B e 
antigen (HIBeAg). It consists of the first 149 amino acids of core polypeptide, 
preceded by 10 amino acids remaining from the pre-C sequence (Takahashi et at., 
1983; 1991). 
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Although HBeAg and HBcAg share a long fragment of identical primary 
sequence, these proteins show several distinct properties: HBeAg is nonparticulate, 
whereas HBcAg self-assembles into core particles; HBcAg particles induce a rapid, 
strong and long lasting humoral immune response in almost all infected individuals. 
In contrast, HBeAg induces a distinct, weaker, and delayed response giving anti-HBe 
antibodies, which usually correlate with viral clearance (Hoofnagle et al., 1981). 
The biophysical and serological distinctions between l{BeAg and HBcAg indicate 
that these antigens adopt different conformations. Nassal and Rieger (1993) 
demonstrated that Cys-7, located in the 10-amino acid N-terminal extension, forms 
an intramolecular disuiphide bond with Cys-6 1. This intramolecular disulphide 
bridge keeps HBeAg in a specific conformation that prevents dimerisation and 
consequently particle formation, explaining the nonparticulate nature of HBeAg. 
Mutation of Cys-7 to Ala or Ser produces dimeric HBeAg exhibiting both HBe and 
HBc antigenicity. 
1.4.3 Surface antigen (HBsAg) 
HBV encodes three related surface antigens (HBsAg) within one single ORF 
by using three different in-frame start codons and a common stop codon (Fig. 5). 
Hence, the proteins differ at their N-termini, but have a large sequence in common. 
Initiation at the 5'-most AUG results in the production of the largest of the three 
proteins, the L-HBsAg (39 kDa), which contains 108 or 119 residues (depending on 
serotype) encoded in the PreS 1 region as well as the 55 PreS2 amino acids added to 
the N-terminus of the S region which comprises 226 amino acids (Heermann et al., 
1984). The second largest protein, the M-HBsAg (31 kDa), arises from translation 
beginning at the middle initiation codon and gives N-terminal extension of 55 amino 
acids termed PreS2 (Machida et al., 1984). The smallest of these polypeptides, 5-
HBsAg (24 kDa), begins at the innermost initiation codon and is the most 
abundantly expressed of the HBV surface glycoproteins. All these proteins exist in 
two isomeric forms, either glycosylated at Asn-146 of the S region or unglycosylated 
at this site. The M-HB5Ag is additionally glycosylated at Asn-4 of the PreS2 region. 
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A myristic acid group is amide-linked to the N-terminal glycine residue of L-HB sAg 
(Persing et al., 1987). 
PreSi 	PreS2 	 S 
* 	 * 	* 	
HBVp01yA 





Fig. 5: Envelope Proteins of HBV 
The translation products of the HBsAg gene are shown as lines of different tickness. 
S-, M- and L-HBsAg are translated from a common open reading frame of the 
HBsAg gene by the use of three in-frame initiation codons (*) at the N-tennini of 
PreSi, PreS2 and S. Glycosylation is indicated by G. MYR represents the myristic 
acid. 
The S-HBsAg is unique among viral envelope proteins in that it is capable of 
self-assembly with host-derived lipids to form empty spherical particles 22 nM in 
diameter (Liu et al., 1982). This suggests that all the information necessary for this 
assembly process resides in the S region. Formation of the 22 nm particles is 
initiated by insertion of the S-HBsAg into the endoplasmic reticulum (ER) 
membrane. After aggregation of approximately 100 transmembrane monomers, 
assembled complexes are believed to mature by budding into the lumen of the pre-
Golgi compartment, where their mannose asparagine-linked carbohydrates are 
processed to the complex, endoglycosidase H-resistant form (Patzer et al., 1984; 
Huovila et al., 1992). 
S-HBsAg expression is not sufficient, but is required for the envelopment of 
nucleocapsids. L-HBsAg, however, has been shown to be absolutely necessary for 
virion formation (Bruss and Ganem, 1991a; Ueda et al., 1991). M-HB5Ag is 
dispensable for formation of both virion and 22 nm subviral particles (Fernholz et 
al., 1993; Bruss and Ganem, 1991b). Assembly of HBV virions is presumed to 
proceed along a similar pathway to that for 22 nm particles. The kind of particle that 
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is formed seems to be determined by the ratio of S- and L-HBsAg proteins 
coassembling during morphogenesis. The 22 nm spherical particles from serum 
contain only traces of L-HBsAg. A higher proportion of the L-HBsAg coassembling 
with S-HBsAg is found in the filamentous form of HBsAg particles. A still higher 
proportion of L-HBsAg is apparently necessary for virion formation (Heermann et 
al., 1984). However, overexpression of the L-HBsAg leads to the inhibition of 
virion formation (Cheng et al., 1986; Chisari et al., 1986). 
The envelope proteins are synthesised in the ER where they gain a defined 
transmembrane topology. The S-HBsAg is believed to traverse the ER membrane at 
least twice. Four transmembrane ct-helices have been predicted in this polypeptide, 
but only the two N-terminal domains have been shown to be directly inserted in the 
membrane (Fig. 6) (Eble et al., 1987; Prange et al., 1992). These two domains 
corresponding to amino acids 11-28 and 80-98, respectively, are separated by a 
hydrophilic loop of 55 amino acids which is exposed on the cytoplasmic side of the 
membrane (Bruss et al., 1994). The second hydrophilic region of 70 amino acids 
which carries the major surface antigen and a glycosylation site, is predicted to be on 
the luminal side. Both the N and C-terminal sequences are luminally exposed. The 
topology of the M-HBsAg is believed to be very similar to that of the S-HBsAg. 
The PreS2 region does not contain a signal sequence, but the M-HBsAg is 
translocated into the ER lumen by the first signal in its S region (Eble et al., 1990). 
Consequently, the PreS2 region and the major epitope regions of S and M are 
exposed on virions. 
The transmembrane topology of the L-HBsAg is still unclear. PreS regions 
of the L-HBsAg are involved in the envelopment of viral nucleocapsids and binding 
to the host cell, so the PreS regions of the L-HBsAg must be both luminally and 
cytoplasmically exposed. Ostapchuk et al. (1994) showed that PreS regions are 
cytoplasmically disposed when synthesised in a cell free system. Therefore, PreS 
regions could be transported across the membrane to fulfil a dual function in virion 
assembly and attachment to the host cell. Two possibilities have been suggested: (i) 
the PreS regions are post-translationally translocated across the bilayer following 
interactions with core or; (ii) the membrane bilayer itself is attenuated or reorganised 
during budding to expose the PreS regions (Ostapchuk et a!, 1994). Recently, 
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Prange and Streeck (1995) demonstrated that a substantial alteration in the 
transmembrane conformation of the L-HB sAg occurs post translationally, resulting 
in two topologically different populations of L-HiB sAg which dispose their PreS 
regions both to the cytoplasmic and the luminal side of the membrane. Moreover, 
they found that the S region of the L-, M- and 5-HIBsAg is not uniformly oriented in 
the membrane of microsomes, as assayed in a cell free system. This is inconsistent 
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Fig. 6: Topologies of S-, M- and L-HBsAg in the ER Membrane 
The N- and C-terminal ends of the proteins are lumenally disposed as well as the 
entire PreS regions of M- and L-HBsAg. I and II indicate the membrane spanning 
	
helices. The spanning helices marked with a 	are based on model building but 
have not been examined experimentally. Sites where asparagine-linked 
glycosylation occurs are indicated by G. A myristic acid group (MYR) is amide-
linked to glysine at the N-terminus of L-HBsAg. (modified from Ostapchuk et al., 
1994). 
Exposure of the PreS regions on the cytosolic side of ER is important for 
virion formation, perhaps forming a docking site for the nucleocapsids. Recent 
mutation studies by Bruss and Thomssen (1994) showed that the first 102 amino 
acids of the PreSi region (119 amino acids; HBV subtype adw) are dispensable for 
virion formation. This suggests that the sequence between amino acid 103 in the C-
terminal region of the PreS 1 region and amino acid 254 upstream of Signal II in the 
S region might form a docking site for nucleocapsids. More recently, Dyson and 
Murray (1995) used a random hexapeptide library (Scott and Smith, 1990) to explore 
interactions between the HBcAg and L-HB sAg. Filamentous bacteriophages 
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displaying random peptides on their gpffl proteins were used to screen for binding to 
HBcAg. Bound phages were released and amplified via infection of E. coli. After 
several rounds of affinity selection and amplification, a subset of the selected phages 
were grown up individually and the identity of the peptides that bind to HBcAg were 
obtained by sequencing the gpffl gene carrying the insertion. A peptide sequence of 
LLGRMK and some related sequences were selected from the fusion phage library. 
However these specific sequences were not found as a contiguous sequence within 
the sequence of HBsAg, but two related sequences did occur (Fig. 7): residues 63-
65 (LLG) in PreS 1 region and residues 21-26 (LLTRIL) of the S region. These 
suggest that amino acids of the hexapeptide and other related sequences may be 
brought together in the folded protein of HBsAg to form a mimotope. Moreover, the 
interaction of L-HBsAg with HBcAg in a cell free system was inhibited by the 
peptide ALLGRMKG. This information provided the basis for the mutational 
analysis carried out in this project to define the exact docking sites on L-HBsAg. It 
is hoped that with the knowledge of these important sites, inhibiting molecules can 




Fig. 7: Domain structure of L-HBsAg and association with HBcAg 
a, b and c indicate the peptide sequence LDPAFR (19-24), LLG (63-65) of PreSi 
region and LLTRIL (21-26) of S region respectively. (modified from Dyson and 
Murray, 1995). 
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1.4.4 P protein 
The P protein is synthesised from the second cistron of the genomic RNA. 
The P ORF shares homology with the polymerase genes of retrovirus and other 
genetic elements that employ reverse transcription (Toh et al., 1983; Khudyakov and 
Makhov, 1989). Mutational analysis and sequence comparison with other reverse 
transcriptases show that the P protein consists of three domains: terminal protein 
(TP), polymerase or reverse trancriptase (P01) and RNAse H (RH). The TP is 
attached to the 5'-end of the RNA pregenome and primes DNA synthesis. The RH 
activity degrades the RNA template in the hybrid molecule of RNA pregenome and 
minus strand DNA (Barterschlager and Schaller, 1988; Radziwill et al., 1990). All 
available data suggest that the P protein binds to the encapsidation signal E on the 
RNA pregenome which consists of some 70 nucleotides close to the 5'-end of the 
genomic RNA (Pollack and Ganem, 1993a; Knaus and Nassal, 1993). Rieger and 
Nassal (1995) demonstrated that the signal can form a characteristic bipartite stem-
loop structure which may represent the actual P protein binding site. A more 
detailed discussion of the interaction between the P protein and the genomic RNA is 
presented in section 1.5. 
1.4.5 X protein 
The X protein (HBxAg) comprising 154 amino acids and with a molecular 
weight of 16.5 kDa, is a product of the X ORF. HBxAg is a multifunctional protein 
that displays a variety of independent activities, many of which could be important 
for virus infection or the development of carcinoma. 
Chronic HBV infection has been demonstrated as a risk factor in the 
development of human hepatocellular carcinoma, HCC (Buendia, 1992; Slagle et al., 
1992). The mechanism of HBV involvement in liver carcinogenesis remains 
obscure, but several studies have suggested a possible role for HBxAg which 
transactivates gene expression of viral and cellular regulatory elements in the 
development of HCC (Hu et al., 1990; Zhou et al., 1990; Balsano et al., 1991; Twu 
et aL, 1993). Indeed insertion of the HBxAg gene under its own promoter into mice, 
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resulted in pathological changes in the liver, which culminated in the development of 
HCC (Kim et al., 1991). 
Several studies have clearly demonstrated that HBxAg can function as a 
transactivator of a wide variety of viral and cellular transcriptional control elements. 
These include Simian virus 40 (SV40), Rous Sarcoma virus, human 
immunodeficiency virus (HIV), MHC class I and class II, P inteferon , c-myc, 
interleukin 8, intercellular adhesion molecule 1, RPB5 subunit of RNA polymerase 
II, TATA-binding protein, a putative DNA repair protein, and UV-damaged DNA 
binding protein (UV-DBB) (Twu and Schloemer, 1987; Seto et al., 1988; Siddiqui 
et al., 1987; Twu and Robinson, 1989; Hu et al., 1990; Zhou et al., 1990; Balsano et 
al., 1991; Mahe etal., 1991; Hu etal., 1992; Cheong etal., 1995., Lee etal., 1995; 
Qadri et al., 1995). HBxAg has also been shown to transactivate HBV promoters; 
PreSi, PreS2, X and enhancer I or II (reviewed in Rossner, 1992). On the other 
hand, HBxAg does not interact directly with DNA (Siddiqui et al., 1987; 
Avantaggiati et al., 1993). This fact has led to the speculation that HBxAg acts 
indirectly, possibly by modifying the activities of cellular factors that modulate 
transcription, rather than direct binding of a specific DNA sequence by X protein 
(Rossner, 1992; Slagle et al., 1992). In this respect, several reports have shown that 
HBxAg stimulates the Ras-Raf-Map kinase cascade, which lead to enhanced cell 
proliferation and the activation of transcription factors AP- 1 and NF-xB (Cross et 
al., 1993; Benn and Schneider, 1994; Natoli et al., 1994). Recently Doria et al., 
(1995) showed that cytoplasmic HBxAg is a dual specificity activator of 
transcription, which activates Ras-Raf-Map kinase signal transduction pathways in 
the cytoplasm and stimulates HBV enhancer Tin the nucleus. 
The broad gene-regulating function of HBxAg suggests that it may not only 
regulate the expression of HBV transcripts but may also modify the biochemical 
environment by transactivating cellular genes in infected cells to facilitate viral 
replication. The mechanism of transactivation by HBxAg is currently unclear, 
however, the understanding of this mechanism may provide information of value in 
the development of compounds to inhibit the replication of }-IBV. 
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1.5 Replication of HEY 
Due to the narrow host range of HBV and the lack of a routine cell culture 
system to propagate the virus, study of the replication of HIBV has been heavily 
dependent on the closely related animal hepatitis virus systems: DHBV and WHy, 
and most of the available data have been obtained by genetic approaches using 
transfection of cells with HBV DNA. A brief overview of HBV replication is 
shown in Fig. 8 (Nassal and Schaller, 1993). 
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Fig. 8: The Replication of HBV 
Steps involved are: (i) attachment and penetration of the host cell; (ii) uncoating and 
transport of the viral genome into the nucleus; (iii) conversion into ccc-DNA as the 
template for transcription; (iv) RNA synthesis and transport to the cytoplasm; (v) 
translation; (vi) assembly of RNA -containing nucleocapsids; (vii) reverse 
transcription of RNA and (viii) export from the cell as enveloped virions. 
The receptor for binding of the virus to hepatocytes has not been identified. 
However, peptide sequences in the PreS 1 region have been proposed by Neurath et 
al. (1986) and Pontisso et al. (1989) as binding sites of the HBsAg to the cellular 
receptor. Moreover, antibodies against these sequences neutralise the infectivity of 
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HBV in chimpanzees (Neurath et al., 1989). From studies of the binding of 
radiolabelled DHBV particles in primary duck hepatocytes, Schaller (1993) 
predicted that there are about 5 x 103 binding sites per cell with an apparent Kd of 
10.11 M. Hence, isolation of the cellular receptor(s) should eventually lead to the 
construction of infectable cell lines and test animals which could help to address the 
question of virus-host interaction. As a result, peptides or chemical compounds 
homologous to either the attachment sites on the HBsAg or on the receptor could 
then be designed for blocking virus attachment. 
Following uptake of the virion, viral nucleocapsid is transported to the cell 
nucleus in which the genome is converted to a covalently closed circular (ccc) form 
that serves as the template for the transcription of genomic and subgenomic RNAs 
by host RNA polymerase. The genomic and subgenomic RNAs are then transported 
to the cytoplasm and translated into their respective proteins. When sufficient 
amounts of core protein, P protein and RNA pregenome have synthesised in the 
cytoplasm, these components coassemble into core particles (Fig. 9). The P protein 
binds to the c-segment at the 5'-end of the RNA pregenome (Kaus and Nassal, 1993; 
Pollack and Ganem, 1993b; Fallows and Goff, 1995; Rieger and Nassal, 1995). 
Then, HBcAg dimers are attracted to the RNA via their non-specific nucleic acid 
binding domains and assemble into particles. A second specific recognition site on 
the P protein interacts with an additional site between DR2 and DR 1 * at the 3'-end 
of the pregenome, thus maintaining the circular structure of the RNA for replication. 
Reverse transcription of the RNA then begins from the 3' DR1*  towards the 5'-end 
of the RNA, generating negative strand DNA by copying the RNA. Concomitantly, 
the RNAse H activity degrades the RNA template to the very 5'-end, sparing only 
15-18 nucleotides, which serve as a primer for the synthesis of the plus strand DNA 
by copying the first DNA strand to produce partially duplex DNA intermediates 
(Lien etal., 1986; Loeb etal., 1991; Nasssl and Schaller, 1993). 
The assembled capsid is either exported as enveloped virion or returned to 
the nucleus to amplify the intranuclear copies of cccDNA. L-HB5Ag is particularly 
important for virion formation (Bruss and Thomssen, 1994) and hence is probably 
involved in specific interactions with the capsid that result in budding into the 
endoplasmic reticulum (ER). The recognition sites for envelopment of the 
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nucleocapsid have yet to be characterised, but would serve as an excellent target for 
antiviral attack. 
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Fig.9: Nucleocapsid assembly 
RNA pregenome (3.5 kb) serves as a template for the translation of core and P 
proteins. P interacts with the encapsidation signal, & on its own RNA and triggers 
the addition of core protein dimers via their non-specific nucleic acid binding 
domains and complete the capsid shell. The interaction of P protein between DR2 
and the second copy of DR1 (DR1 *) at the 3 '-end of the pregenome induces 
circularization and prepare the RNA for replication. (modified from Nassal and 
Schaller, 1993). 
1.6 Mutagenesis approach to study protein interaction 
Interactions of proteins with other molecules are of fundamental importance 
in biology. An enzyme interacts with a substrate to accelerate a chemical reaction. 
Interaction between myosin and actin stimulate muscle contraction. An antibody 
combines with an antigen to trigger immunological responses. Envelopment of 
HEY requires the interaction between the surface proteins and nucleocapsids. 
Protein-protein interaction depends on steric and electrostatic 
complimentarity of the combining surfaces. When proteins interact with each other 
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and form stable complexes, the surfaces buried between them cover large areas. A 
comparative study by Janin and Chothia (1990) showed the buried surface areas 
between antigen and antibodies, and proteinases and their inhibitors to be roughly 
the same size, 1600 ± 350 A2. They also found that 8 to 13 hydrogen bonds 
contribute to their binding energies, some of them formed by one ionisable group 
with another either neutral or oppositely charged group. 
X-ray crystallography, which can be used to determine the three dimensional 
structure of a protein at atomic resolution, is by far the most powerful method to 
study directly the relationship between the structure and function of a protein, and in 
principle, the intermolecular interactions between two proteins. However, the 
crystallisation of protein-protein complexes is considerably more difficult than the 
crystallisation of the interacting molecule alone. Furthermore, some proteins, 
especially membrane proteins, are very difficult to crystallise. Probably for this 
reason, there is no three dimensional information at atomic resolution on the 
structure of HBsAg and HBcAg. Other methods for structure analysis include 
group specific modification of amino acids and NMR spectroscopy. Although these 
method have yielded much information about protein structures and interactions, 
they can only be used with proteins which are available in large quantity and high 
purity (Creighton, 1984). With the great advances in recombinant DNA technology, 
it is now possible to target those amino acids that potentially play functional or 
structural roles and then delete or replace them with alternate residues to test the role 
of steric constraints, hydrophobic and electrostatic forces, charge, and the placement 
of hydrogen bonds, salt bridges, disuiphide bonds, water, or metals (Cleland, 1995). 
The mutant proteins can then be purified and analysed both biochemically and 
biophysically to determine the effect of the amino acid modifications. 
1.6.1 Site-directed mutagenesis 
The classical approach of inducing mutations in genes included chemical 
mutagenesis, ultra violet light, and ionising radiation. New phenotypic mutants were 
then isolated and studied. However, since the entire organism had been subjected to 
mutagenesis, multiple mutations often arose amongst which mutations occuring in 
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the gene of interest could be very low. With the advent of recombinant DNA 
technology, it is"now possible to specifically change any given base in a cloned DNA 
sequence rather than crudely mutagenising thousands of organisms and then 
screening millions of offspring to isolate a desired mutant (Rossi and Zoller, 1987). 
This powerful technique is known as site-directed mutagenisis, and the method as 
developed by Smith and colleagues was successfully applied to introduce an amber 
mutation in bacteriophage OX 174 (Hutchison et al., 1978). Currently, there are a 
variety of methods available to construct site-specific mutations in vitro. The most 
commonly used method is oligonucleotide-directed mutagenesis. Generally, this can 
be divided into two categories based on the form of the DNA template: single-
stranded template vectors derived from filamentous phages such as Ml 3, fd and f 1; 
and double-stranded expression vectors (Rossi and Zoller, 1987). 
In principle, these two methods are similar; a short mutagenic 
oligonucleotide is hybridised to its complementary sequence of the wild type DNA. 
The oligonucleotide serves as a primer for in vitro enzymatic DNA synthesis of the 
rest of the DNA template by DNA polymerase, forming a heteroduplex molecule 
containing a mismatch introduced at a specific nucleotide via the oligonucleotide 
primer. The newly synthesised DNA strand is covalently closed by DNA ligase and 
used to transform E. coli. The resulting products are two homoduplexes whose 
sequences are either wild type or mutant. The two molecules can then be 
distinguished readily by colony hybridisation with the labelled oligonucleotide as a 
probe or by DNA sequencing. 
Theoretically, mutants arising from oligonucleotide-mediated mutagenesis 
should comprise 50% of the transformants. In practice, this efficiency is very 
seldom realised due to exonucleolytic degradation of the mismatched site and repair 
following transformation of the host (Rossi and Zoller, 1987). Kunkel (1985) 
exploited the properties of host cells which strongly select against the unaltered 
genotype to improve the efficiency of mutagenesis. In this method (Fig. 10), 
bacteriophages are grown on an E. coli host that is deficient in the enzymes 
dUTPase (dut) and uracil-N-glycosylase (ung). The intracellular pool of dUTP is 
thereby greatly increased due to the inability of the cells to convert dUTP to dUMP, 
as a result of which some of the dUTP molecules are incorporated into the DNA in 
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T4 DNA 
polymerase + 
4 dNTP + 





__ mutated oligonuclentide 
place of dTTP. The ung mutation makes the host unable to excise the incorporated 
dUTP. M13 bacteriophages grown in a dufung F strain of E. coli usually contain 
20-30 uracil residues per genome. These uracil-containing templates are then used 
for oligonucleotide-mediated mutagenesis. When an ung strain of bacteria is 
transfected with the heteroduplexs, the template strands are destroyed by uracil-N-
glycosylase, but the in vitro-synthesised mutant strands are not, which results in a 
substantial enrichment of mutant bacteriophages that harbour the mutation. 
single-stranded Ml 3 	 double-stranded product, 	selection for M 13 phages 
template containing uracil residues are not containing mutant of 
uracil residues 	 mutagenic 	 interest 
Fig. 10: Oligonucleotide-mediated Mutagenesis by Kunkel Method 
ssDNA containing a small number of uracil (U) residues in place of thymine is 
prepared from phage propagated in a dufung strain. A synthetic oligonucleotide 
containing the mutation of interest is annealed to the template and treated with T4 
DNA polymerase and T4 DNA ligase to produce a double-stranded circular 
molecule. Introduction of this heteroduplex molecule into a wild-type (dutung) 
strain allows the efficient recovery of mutant DNA. (modified form Sambrook et al., 
1989). 
Alteration of one amino acid for another might sometimes affect the folding 
or stability of the entire protein. Therefore it is difficult to tell from a binding assay 
whether the effect of a mutation is really due to the substitution of a directly 
functional residue or to a non-specific disruption of protein conformation. There are 
several methods available to probe the structural integrity of mutated proteins. 
Biophysical techniques such as X-ray crystallography, NMR spectroscopy, circular 
dichroism spectroscopy and fluorescence spectroscopy can be used to analyse the 
structure of mutant proteins. Thermodynamic analysis can be used to determine the 
Chapter 1: Introduction 	 24 
free energy of thermal or chemical denaturation of mutant proteins as a measure of 
structural integrity (Sondek and Shortle, 1990). The conformation of mutant 
proteins can also be probed by analysing their ability to react with monoclonal 
antibodies that are specific for conformation epitopes (B ass et al., 1991). To date, 
there is no way to predict accurately the perturbations in protein structure caused by 
such alteration. In the case of HBsAg, monoclonal or polyclonal antibodies that are 
specific for the native PreS regions could be used to alleviate this problem. 
1.6.2 Deletion and insertion mutagenesis 
These techniques are useful for mapping the boundaries of the functional 
domain of a protein and determining the overall domain structure of multifunctional 
proteins (Gibbs, 1995). Generally, deletion mutagenesis involves cleaving the target 
area of a DNA molecule with a specific restriction enzyme and then digesting 
random segments of DNA with an exonuclease such as BAL 31 or exonuclease ifi 
for varying lengths of time. The termini generated by the exonucleases must be 
either staggered or blunt, and therefore, the termini are always repaired with either 
DNA polymerase I to fill in 3'-recessed termini, or by nuclease Si treatment to 
cleave off single-stranded termini. The covalently closed forms of a nested set of 
deletion mutants are then generated by treatment with DNA ligases. However, 
theoretically, two out of three of the mutants will alter the translational reading 
frame and a certain percentage of these will create premature stop codons within the 
coding fragment (Rossi and Zoller, 1987). To generate scattered insertions, small 
fragments of synthetic DNA are ligated into the cleavage site. Prasad and Goff 
(1989) used linker insertion mutagenesis to map the p66 subunit of HIV reverse 
transcriptase, which is processed into two smaller subunits p51 and p15. The 
polymerase function was located to the N-terminal portion including the region that 
encodes the pSi subunit, and the RNase H activity was localised to the C-terminal 
portion including the region that codes for p15 subunit. Although these techniques 
may allow rapid identification of functionally important regions, they suffer from the 
disadvantage that protein structure is likely to be disrupted by insertions and 
deletions. 
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1.7 Aims of the project 
A comprehensive understanding of the interaction between HBsAg and 
HBcAg is practically important for rational design of drugs to inhibit the 
envelopment of nucleocapsids. This process begins with the identification of contact 
residues at or near the interface. At the time when this project was initiated, there 
was no information available on the structure of HBsAg and very little was known 
about the structure of HBcAg. Furthermore, no experiments had been reported that 
directly determine or indicate the regions of HBsAg which interact with HBcAg. 
The only hint suggesting the region in HBsAg which might directly interact with 
HBcAg was obtained from affinity selection from fusion phage display libraries 
(Dyson and Murray, 1995), but the amino acid sequence, LLGRMK, implicated in 
the binding with HBcAg appears to be a discontinuous sequence in which the 
residues constituting this sequence are brought together from different positions in 
the L-HB5Ag polypeptide. Chapter 4 therefore focuses on deletion and site-specific 
mutations of L-HB sAg in order to define the exact contact residues involved in the 
interaction. 
Mutagenic analyses of the interaction require that the genes for the 
interacting molecules are cloned and the proteins expressed in substantial quantities 
for biochemical and biophysical assays. As HBsAg could not be expressed 
efficiently in E. coli, the wild-type and mutant proteins were synthesised in vitro 
with rabbit reticulocyte lysates. It is fortunate that HBcAg can be expressed in the 
prokaryotic cell where it assembles into two sizes of particle with morphology 
indistinguishable from nucleocapsids isolated from HBV-infected individuals. 
Chapter 3 addresses the questions concerning the biological and physical properties 
of the HBcAg monomer and the particles it forms: (i) yield improvement of HBcAg 
synthesised in E. coli; (ii) separation of the two kinds of particle and; (iii) 
heterogeneity of HBcAg monomer. 
The goal of the work presented in the final chapter was to evaluate whether 
the deletions and specific changes in L-HB5Ag have affected its binding with 
HBcAg. Initially, the evaluation was performed with immunoprecipitation of the 
interacting molecules with polyclonal antibodies. However, this method does not 
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allow precise discrimination of small changes in the binding. Therefore, steps were 
taken to set up an equilibrium binding assay in solution which allows determination 
of relative dissociation constants. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2A Materials 
2A.1 Chemicals 
The chemicals used in this study were mostly of analytical grade and were 
purchased from BDH Chemicals Ltd, Boehringer Mannheim, Biorad, GIBCO BRL, 
Scotlab, Sigma Chemicals and United States Biochemicals (USB). Solvents were 
supplied by Fisher Chemicals and radioactive reagents were supplied by Amersham 
International plc. 
2A.2 Liquid and solid media 
Media Recipec per litre 
Luria broth (LB) Bacto-tryptone (10 g), Bacto-yeast extract (5 g), Naci (5 g), 
adjusted to pH 7.2 
LB agar As Luria broth plus agar (15 g) 
Minimal agar Agar (15 g), Glucose (20% w/v; 10 ml),vitamin B 1 (625 .ig), 
Spitzizen Saltsa  (200 ml) 
Top layer agar Trypticase (10 g), Naci (5 g), Bactor-agar (10 g) 
2x Yeast tryptone Bacto-tryptone (16 g), Bacto-yeast extract (10 g), Nacl (5 g) 
(YT)  
aSpjtzjzen  salts 0.2% (NH4)2SO4, 0.14% K2HPO4, 0.6% KH2PO4, 0.1% Trisodium 
citrate 0.2% MgSO4. Media was prepared by the department media service. 
2A.3 Antibiotic Solutions 
antibiotic stock concentrationh working concentration 	ig/rnI) 
Ampicillin 100 mg/mi in H20 50 
Chioramphenicol 30 mg/mI in ethanol 30 
Kanamycin 20 mg/mi in H20 20 
Tetracyclin 20 mg/mi in ethanol 20 
bStock solutions of antibiotics dissolved in H 20 were filtered through a 0.22-micron 
filter and all the solutions were kept at -20 °C. 
Chapter 2: Materials and Methods 	 29 
2A.4 Standard solutions and butlers 
S oliition/B uffer Components 
lOx TBE Tris-HCI (0.9 M), boric acid (0.9 M), EDTA (20 mM; pH 8.0) 
PBS K2HPO4 (20mM), KH2PO 4 (5 mM), NaCl (150 mM) 
TE pH 7.6 Tris-HC1 (10 mM; pH 7.6), EDTA (1 mM; pH 8.0) 
TE pH 8.0 Tris-HC1 (10 mM; pH 8.0), EDTA (1 mM; pH 8.0) 
STE Tris-HCI (10 mM; pH 8.0), EDTA (1 mM; pH 8.0), 
NaCl (0.15 M) 
TBS Tris-HC1 (50 mM; pH 7.5), NaCl (150 mM) 
NET-gel Tris-HC1 (50 mM; pH 7.6), NaCl (150 mM), NP-40 (0.1% 
v/v ), EDTA (1 mM), Gelatin (0.25% w/v), NaN3 (0.02% w/v) 
2A.5 Escherichia coli strains 
strain Genotype Reference 
CJ236 dutl, ungl, thi-1, rel All pCJ1O5 (CamrF) Kunkel et al., 
(1987) 
K91Kan HfrC (Ar), thi Smith and Scott, 
(1993) 
SG935 F lac (am), trp (am), pho(am), supC(ts), rspL, S.Goff 
mal (am), htpR (am), tsx: TN1O ion MOO (unpublished) 
TG1 supE, hsdA5, thi, A (lac-proAB), F'[tra D36, Gibson, (1984) 
proAB, lacIq, lacZMvI151 
W31 10IQ F lac with lac!' Bachmann (1972) 
XL1-Blue supE44, hsdRl7, recAl, endAl, gyrA46, 	thi, Bullock et al., 
relAl, 	lac, 	F 	[proAB, 	lad'4 , 	 1acZAM15, (1987) 
Tn lO(Tet r)] 
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2A.6 Plasmids and cloning vectors 
Plasmid Description and selectable Marker Reference 
pAGA9 a derivative of pGP1-2 (Tabor and Richardson, Zahn and Landy, 
(4.68 kb) 1985) carrying the T4 AGA tRNA gene (Mazzara (1996) 
et al., 1981). 	It consists of gene 1 of phage T7 
under the control of the inducible ? 
PL 
 promoter, 
and the gene for the heat sensitive ?. repressor, 
c1857; Amp' Kan' 
pC1TE-2c contains a Cap-Independent Translation Enhancer Novagen 
(3.735 kb) (CiTE) 	sequence 	of the 	encephalomyocarditis catalogue (597 
virus (EMC) RNA 5' non-coding region, which Science Dr. 
functions as an internal entry point for initiation of Madison, 
translation by eukaryotic ribosomes. It also carries WI 53711, 
the T7 promoter for high efficiency in vitro USA) 
transcription with T7 RNA polymerase; Amp' 
pMDHBs3 contains a 1.35 kb-insert of the L-HBsAg gene Dyson and 
(5.131 kb) derived from pHBV130 (Gough and Murray, Murray, (1995) 
1982). The insert is located in the polycloning site 
of the pC1TE-2c vector, with the Eco Ri and Sal I 
sites at the 5'- and 3'-ends, respectively; AmpR 
pMDHBs4 same as pMDHBs3, but it has a 858 bp-insert of Dyson and 
(4.639 kb) the S-HBsAg gene derived from pHBV 130; AmpR Murray, (1995) 
pRl-1 1E contains the coding sequence for amino acids 1-8 Stewart, (1993) 
(4.823 kb) of 3-ga1actosidase followed by 3 linker amino 
acids (Glu,Phe,His) followed by amino acids 3- 
148 of HBcAg, under control of the tac promoter. 
pTacpcore contains the coding sequence for amino acids 1-8 Stewart, (1993) 
(5.378kb) of J-galactosidase followed by 3 linker amino 
acids (Glu,Phe,His) followed by amino acids 3- 
183 of HBcAg, under control of the tac promoter. 
M13mp18 a bacteriophage M13 vector used for subcloning Messing et al., 
(7.25 kb) the L-HBsAg gene for preparation of ssDNA. (1977) 
IPTG and X-gal were used to identify recombinant 
phages; 	these 	form colourless 	plagues, 	while 
nonrecombinant phages form blue plagues. 
pM13- carries a 1.35 kb-insert of theL-HBsAg gene with 
MDHBs3 M13mp18 vector as backbone. 
(8.565 kb)  
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2B METHODS 
2B.1 Preparation of DNA 
i • Phenol extraction and ethanol precipitation of DNA 
Contaminating proteins in DNA solutions were removed by extraction with 
phenol (equilibrated at pH 8.0), phenol:chloroform (1.1), and chloroform. An equal 
volume of these organic solvents was added to the aqueous DNA solution and the 
mixture was vortexed vigorously for 2 to 3 mm. Organic and aqueous phases were 
separated by centrifugation at 15,000 xg, for 5 min at 4 °C. The upper aqueous phase 
containing DNA was recovered and the DNA was precipitated by the addition of 3 
M sodium acetate (pH 5.2; 0.1 vol), and absolute ethanol (-20 °C; 2 vol). This was 
left at -20 °C for 20 min or overnight. Precipitated DNA was recovered by 
centrifugation at 15,000 xg, for 15 min or longer at 4 °C. The pellet was then 
washed with 70% (v/v) ethanol (-20 °C), dried under vacuum, and dissolved in TE 
(pH 7.6 or 8.0) or distilled water. 
ii. Miniprep ofplasmid DNA 
The alkaline lysis method (Birnboim and Doly, 1979; Birnboim, 1983) was 
frequently used to isolate small quantities of plasmids and RE DNAs from bacterial 
cells for the identification of recombinant clones by restriction analysis. 
Well isolated bacterial colonies were grown in LB medium (5 ml) 
supplemented with appropriate antibiotic(s) at 37 °C overnight with shaking (225-
250 rpm). Cells (1.5 ml) were pelleted by centrifugation for 5 min and resuspended 
in ice-cold solution 1(50 mM glucose, 10 mM EDTA, 25 mM Tris-HC1 pH 8.0; 100 
il). The cells were then lysed by the addition of solution II [0.2 M NaOH, 1% (v/w) 
SDS; 200 .tl], mixed well and incubated on ice for 5 mm. Ice-cold solution ifi [5 M 
potassium acetate, 11.5% (v/v) glacial acetate acid; 150 p1] was then added, mixed 
and incubated on ice for 5 mm. The white precipitate was sedimented by 
centrifugation at 15,000 xg for 5 min at 4 °C, and the supernatant transferred to a 
fresh tube. The solution was then extracted once with phenol:chloroform (1:1) and 
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the DNA was precipitated with ethanol (2 vol, 4 °C). The DNA was washed with 
70% (v/v) ethanol, dried and resuspended in TE (25 p1, pH 7.6). 
iii• Large-scale preparation and purification ofplasmid and replicative forms 
(RF) of bacteriophage DNA 
This method, which requires two steps, was used to prepare large quantities 
(-0.5 mg) of highly purified mutant plasmids derived from pMDHBs3 for in vitro 
transcription. It was also used to prepare RF DNA of M13mp18. Firstly, crude 
lysate was prepared by the alkaline lysis method (Sambrook et al., 1989). Secondly, 
PEG precipitation (Lis and Schirif, 1975;Lis, 1980) was applied to purify plasmid 
DNA. 
Cells from overnight culture (250 ml; LB medium) were harvested by 
centrifugation at 4,000 xg for 15 min at 4 °C and resuspended in ice-cold STE (100 
ml). The suspension was then spun under the same conditions and pellets were 
resuspended in solution I (18 ml; ice-cold). Cells were lysed by the addition of 
lysozyme [10 mg/mI in 10 mM Tris-HC1 pH 8.0; 2 ml] and solution II (40 ml). The 
mixture was incubated at room temperature for 10 mm. After the addition of solution 
ifi (20 ml; ice-cold), the mixture was incubated on ice for 10 mm, and the white 
precipitate was separated by centrifugation at 5,000 xg for 15 min at 4 °C. The 
supernatant was then filtered through 4 layers of cheese cloth, isopropanol (0.6 vol) 
was added and the mixture was stored at room temperature for 10 mm. This was 
then spun at 5,000 xg for 15 min at room temperature, and the pellet was washed 
with 70% (vlv) ethanol, dried and dissolved in TE (pH 8.0; 3 ml). An equal volume 
of LiCi (5 M; ice-cold) was added, mixed well and the solution centrifuged at 11,000 
xg, for 10 min at 4 °C. The supernatant was then transferred to a fresh tube 
containing an equal volume of isopropanol and centrifuged at 11,000 xg for 10 mm 
at room temperature. The pellet was rinsed with 70% (v/v) ethanol, dried and 
dissolved in TE (pH 8.0; 0.5 ml) containing DNAase-free pancreatic RNAase (20 
ig/ml). After incubation at room temperature for 30 mm, PEG 6000 [13% (w/v) in 
1.6 M NaCl; 0.5 ml] was added and the solution was centrifuged at 13,000 xg for 10 
min at 4 °C. The DNA pellet was dissolved in TE (pH 8.0; 0.4 ml), extracted once 
with phenol, phenol:chloroform (1:1) and chloroform. DNA was then precipitated 
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with aminonium acetate (10 M; 100 jil) and ethanol (2 vol), washed, dried and 
dissolved in TE (pH 8.0; 0.5 ml). 
iv • Small-scale preparation of M13mp18 ssDNA 
ssDNA produced by this method (Sambrook et al., 1989) was used as 
template for dideoxy chain-termination DNA sequencing (Method 2B.6) 
Well isolated colourless plaques of transformants were grown in LB medium 
(3 ml) containing log phase TG-1 cells (75 tl) as the host. After incubating at 37 °C 
for 5 h, the cultures (1.5 ml) were spun at 15,000 xg for 10 min at 4 °C. The 
supernatant was transferred to a fresh tube and PEG solution [20% (w/v) PEG 6000 
in 2.5 M NaCl; 200 t1] was added, mixed and left at room temperature for 15 mm. 
This was then centrifuged at 15,000 xg, 10 min at 4 ° C and the supernatant was 
removed by aspiration. The pellet was suspended in TE (pH 8.0; 100 uI) and 
extracted once with phenol, followed by chloroform. DNA was precipitated with 
ethanol, washed, dried, and dissolved in TE (pH 8.0; 25 ul). 
v - Preparation of uradil-containing single-stranded DNA 
Plasmid pMl3-MDHBs3, a M13mp18 derivative containing the L-HBsAg 
gene, was used to transform E. coli strain TG-1. The transformant, in the form of 
single-stranded bacteriophage M13-MDHBs3, was grown in E. coli strain CJ236 
(duf ung F) to produce uracil-containing ssDNA which was used as template for 
oligonucleotide-mediated mutagenesis (Method 2B.5.i). This method was originally 
described by Kunkel (1985; Kunkel et al., 1987). 
A single plaque was transferred into 2x YT medium (1 ml) and incubated at 
60 °C for 5 min to kill TG-1 cells. This was vortexed vigorously for 30 s to release 
bacteriophages trapped in the top agar, and then centrifuged at 12,000 xg for 2 min at 
4 °C. Supernatant (50 j.il) was transferred to a flask (500 ml) containing 2x YT 
medium (50 ml) supplemented with uridine (0.25 jig/mI). A mid-log-phase culture 
of E. coli strain CJ236 (5 ml) was added and the culture was incubated at 37 °C for 
6 h with shaking at 250 rpm. The cells were pelleted by centrifugation at 5,000 xg 
for 30 min at 4 °C and the clear supernatant was transferred to a centrifuge bottle. 
An aliquot of the phage suspension(200 ui)  was titered on CJ236 and TG-1 cells. It 
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was found that the titer on strain CJ236 was 5 to 6 orders of magnitude greater than 
on TG-1. To the remaining bacteriophage suspension, PEG solution (15% w/v PEG 
6000, in 2.5 M NaCl; 0.25 vol) was added, mixed and then left on ice for 1 h. The 
precipitated bacteriophage particles were recovered by centrifugation at 5000 xg for 
20 min at 4 °C and the pellet was resuspended in TE (pH 7.6, 4 ml). The suspension 
was vortexed vigorously for 30 s, and then left on ice for 1 h. The suspension was 
vortexed one more for 30 s and spun at 5,000 xg for 20 min at 4 °C. The supernatant 
was transferred to a polypropylene tube, extracted twice with phenol, once with 
phenol: chloroform (1:1), ethanol precipitated, washed, and dissolved in TE (pH 7.6; 
200 il). 
vi. Quantitation of DNA 
The concentration of DNA in solution was measured by its absorbance at 260 
nm and 280 nm with a spectrophotometer (UNICAM model SP 500 Series 2). An 
0D260nm of 1.0 represents a concentration of 50 jig/mI for dsDNA and 40 jig/mI for 
ssDNA. The ratio OD 260nmIOD280nm provides an estimation of the purity of the 
nucleic acid. A value of 1.8 indicates a reasonably pure preparation of DNA 
(Sambrook et al., 1989). 
2B.2 Resolution and recovery of DNA fragments 
Agarose gel electrophoresis was routinely used to separate, characterise, and 
purify DNA fragments. 
i. Agarose gel electrophoresis and photography 
Mini agarose gels [5 cm x 7.5 cm; 7 cm x 10 cm; 1% (w/v)] were used to 
check the integrity of DNA and identify the existence of the appropriate inserts in 
recombinant clones after digestion with restriction enzymes. Gels containing 
ethidium bromide (0.5 j.ig/ml) were prepared and electrophoresed in 1 x TBE. Prior 
to loading, DNA samples were mixed with loading buffer [0.42% (w/v) 
bromophenol blue, 0.42% (w/v) xylene cyanol FF, 50% (vlv) glycerol; 0.1 vol] and 
electrophoresis was carried out horizontally at constant voltage (60-100 V) for an 
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indicated period of time (usually, 30 min to 2 h). DNA size markers (GIBCO BRL, 
1 kb Ladder; 5 .tg) were loaded adjacent to the DNA samples in order to estimate the 
size of DNA fragments. DNA fragments were visualised on a transilluminator (UUP, 
INC), and photographs were taken with a UVP camera linked to a video copy 
processor (MiTSUBISHI). 
ii. Isolation and purification of DNA fragments from agarose gels 
Prior to the ligation step in cloning processes (Method 2B.3), DNA inserts 
and vectors that had been digested with restriction enzymes, were separated, 
recovered and purified with the following protocol (provided by Epicentre 
Technologies). 
DNA fragments were separated with low melting point agarose gels (1 to 
1.5% w/v; GIBCO BRL), and visualised by UV illumination (UVP, model UVGL-
58). Zones containing target fragments were cut out from the gels, weighed, and 50x 
GELase buffer [2 M bis-(2-hydroxyethyl)-imino-tris(hydroxymethyl)-methane (pH 
6.0), 50 mM EDTA, 2 M NaCl; 2 tl per 100 mg of gel slice] was added. These were 
incubated at 70 °C until the gels were completely molten (around 20 mm). The 
temperature of the molten gels was then equilibrated to 45 °C and GELaseTh 
(Epicentre Technologies) was added (1.5 U per 80 mg of 1.5% w/v gel; 1 U per 80 
mg of 1% w/v gel). After incubation at 45 °C for 1 h, DNA fragments were 
precipitated with ammonium acetate (5 M, pH 5.2; 1 vol) and ethanol (2 vol). The 
DNAs were dissolved in distilled water and were then ready for ligation. 
2B.3 Cloning into plasmids and bacteriophage M13 vectors 
The following procedures were used to insert DNA fragments encoding the 
L-HBsAg gene and mutants derived from it into plasmid pC1TE-2c and M13mp18 
vector. 
i - Digestion of insert and vector with restriction endonucleases 
The vectors were cleaved at their multiple restriction sites with two different 
restriction enzymes to generate linear molecules with incompatible termini, sticky, 
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or blunt ends. The enzymes were also used to digest the fragment to be inserted so as 
to produce termini compatible with those of the vectorS. In general, 1-5 U of 
restriction endonuclease were used per pg of DNA and incubated for 2-5 h with 
buffer and temperature conditions recommended by the supplier of the enzymes. 
Digestion reactions were terminated by heating at 65 °C for 10 mm. The vectors 
were phenol extracted and ethanol precipitated prior to dephosphorylation. 
Restriction enzymes used in cloning: 
Enzyme Ix incubation buffer Supplier 
Eco RI Tris-HC1 (50 mM, pH 7.5), M902  (10 mM), NaC1 (100 Boehringer 
mM), DTT (1 mM). Mannheim 
Sal I Tris-HC1 (50 mM, pH 7.5), M902  (10 mM), NaC1 Boehringer 
(100 mM), DTT (1 mM). Mannheim 
Sma I Tris acetate (33 mM), Mg acetate (10 mM), K acetate Boebringer 
(66 mM), DTT (0.5 mM); pH 7.9. Mannheim 
ii. Dephosphorylation 
After linearisation of the vectors, calf intestinal alkaline phosphatase [CIP; 
Boehringer] was used to remove their 5'-phosphate in order to prevent 
recircularisation during ligation. The reaction (50 p1) consisted of DNA (20 pg in 44 
p1 H20), 10 x CIP buffer [0.5 M Tris-HC1 (pH 8.5), 1 mM EDTA] and CIP (24 
U/pl; 1 p1). For 5'-recessed DNA, the mixture was incubated at 37 °C for 1 h, 50 °C 
for 30 min and 75 °C for 20 mm, whereas for 5'-blunt-ended DNA the reaction was 
incubated at 37 °C for 1 h. CIP was inactivated with phenol:chloroform (1:1) 
extraction and DNA was ethanol precipitated and dissolved in TE (pH 7.6; 20 p1). 
iii• Ligation 
Before ligation, inserts and the dephosphorelated vectors were run on LMP 
agarose gels and the desired fragments isolated and purified (Method 2B.2.ii). 
Ligation was performed with a three-fold molar excess of inserts (100-200 ng) in a 
reaction mixture [50 mM Tns-HC1 (pH 7.6), 10 mM DTT, 500 pg/ml BSA; lop'] 
containing T4 DNA ligase (Boehringer; 1 U) and incubated at 16 °C overnight. 
For ligation of blunt-end DNA fragments, 5 U of ligase was used and incubated at 
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22 °C overnight. Ligation products (1 and 5 tl) were then used to transform 
competent E. coli (Method 2B.4). 
2B.4 Introduction of DNA into E. coli cells 
This method for transformation was described by Cohen et al. (1972) and 
Dargert and Ehrlich (1974). 
i - Preparation of competent cells 
To 50 ml of LB (supplemented with the appropriate antibiotic), an overnight 
culture of an E. coli strain (1/10 dilution) was added. The culture was grown at 37 
°C with shaking (200-250 rpm) to an OD 600nm between 0.3 and 0.4. The cells (25 ml) 
were chilled on ice for 30 mm, pelleted by centrifugation at 2,000 xg for 15 min at 4 
°C, and resuspended in ice-cold CaCl 2 (0.1 M; 10 ml). After 30 min incubation, the 
cells were repelleted and resuspended in ice-cold CaC1 2  (0.1 M; 2 ml) and kept for 
30 min on ice. 
ii - Transformation of competent cells with plasmid DNA 
Plasmid DNA (5-50 ng) or a ligation reaction mixture (Method 2B.3.iii) was 
mixed with competent cells (200 tI) and left on ice for 30 mm. Cells were then heat-
shocked for 2 min at 42 °C, LB (1 ml) was then added, and incubated at 37 °C for 1 
.h. Cells (50 tl and 200 .tl) were then plated on appropriate selective LB agar and 
incubated overnight at 37 °C. 
iii. Transfection of competent cells with bacteriophage M13 DNA 
RF M13mp18 DNA (5 ng) or recombinant constructs derived from it (5 tl of 
a ligation reaction; Method 2B.3.iii) was mixed with competent cells (200 .il), left 
on ice for 30 mm, and heat-shocked at 42 °C for 2 mm. Log phase TG- 1 cells 
(OD600nm 0.6 to 0.8; 200 .tl) were then added to the mixture, mixed well, and melted 
top layer agar (3 ml) containing X-gal (20 mg/mi in dimethylformamide; 40 j.tl) and 
IPTG (200 mg/mi; 4.tl) was poured into the tube, gently mixed and poured on LB 
agar plates. The plates were incubated overnight at 37 °C, and white and blue 
plaques were counted the next day. 
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2B.5 Mutagenesis 
i - Oligonucleotide-mediated mutagenesis (Kunkel, 1985) 
• Oligonucleotides 
Negative sense oligonucleotides designed for site-directed mutagenesis of the 
L-HBsAg coding sequence were synthesised by the Oswel DNA service, University 
of Edinburgh (later moved to University of Southampton). 
ohgoa poitionb sequence - mutation InduLed 
K38A 1049-1069 CAGGTGTCCQGTFGGGATFG Lys-38 -Ala 
K46A 1074-1093 GCTCCTACCGCGTFGGCGTC Lys-46 - Ala 
64Random 1129-1147 CTCCACCCCNNAAGGCCTC Leu-64- Random 
L63/G65- 1124-1152 GAGGGCTCCACNNCAAANNGCCTC Leu-64 and Gly-65 - 
Random CGTGC random 
R88A 1200-1218 CTGACTGGQATFGGTAGA Arg-88 - Ala 
R92A 1213-1233 GGGTAGGCTGCQFCCTGACT Arg-92 - Ala 
R102A 1240-1262 ATGAGTGGTFGCCAGAGGTGGAG Arg-102 - Ala 
R124A 1307-1327 CCTCTCACTQQGGGATCTFGC Arg-124 - Ala 
R126A 13 14-1334 ATACAGGCCTQCACTCTGGG Arg-126 - Ala 
R156A 1402-1422 CCCCAATCQçCGAGAAGATIG Arg-156 - Ala 
R187A 1498-1517 TGTGAGGAFQFGTCAACA Arg-187 - Ala 
P192Amber 15 13-1530 GACTCTGCTATATFGTGA Pro-192 - Amber 
C21 lAmber 157 1-1588 TGGCCAAQCACACGGTA Cys-21 1 - Amber 
F243Amber 1667-1684 AAGATGATCTAACGCCGC Phe-243 - Amber 
Q2640chre 1729-1747 AACATACCTTAATAGTCCA Gln-264 - Ochre 
K3230chre 1905-1922 TAGGAATFTCCGAAAGC Lys-323 - Ochre 
V3470chre 1976-1998 GGGAAAGCCCTTAGAACCACTGA Val-347 - Ochre 
L372 Amber 2050-2069 GGGACTCTAGATGCTGTACA Leu-372 - Amber 
a oligonucleotide descriptions differ from those given by Oswel and have been adopted to 
describe the mutation induced, bin  the numbering system of Pasek et al., 1979. C  nucleotides 
printed in italics (and underlined) identify the base changes used to induce mutations. 
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• Phosphorylation of oligonucleotides 
Prior to the mutagenesis reactions the oligonucleotides (150 pmole) were 
phosphorylated with T4 polynucleotide kinase (D-50 1, ICMB, University of 
Edinburgh; 1 U), in Kinase buffer [50 mM Tris-HC1 (pH 7.6), 10 mM M902, 5 mM 
DTT, 0.1 mM; spermidine HC1, 0.1 mM EDTA (pH 8.0); 20 p1] in the presence of 
0.5 mM ATP. The reactions were carried out at room temperature (24-26 °C) for 1 h 
and terminated by heating at 70 °C for 10 mm. 
• Primer extension 
The phosphorylated oligonucleotides (15 pmole) were annealed with M13-
MDHBs3 (Method 2B.1.v; 0.5 pmole) in annealing buffer [20 mM Tris-HC1 (pH 
7.5), 10 mM M902, 50 mM NaCl, 1 mM DTT; 10 p1] at 80 °C for 5 min and 
transferred to a beaker containing water at 80 °C and the mixtures were allowed to 
cool slowly to room temperature. The oligonucleotide-template mixtures were then 
added to mutagenesis reaction buffer [1 mM dNTPs, 1 mM ATP, 20 mM Tris-Ci 
(pH 7.5), 10 mM MgCl2, 10 mM DTT; 10 p1] containing T4 DNA polymerase 
(Boehringer; 5 U) and T4 DNA ligase (Boehringer; 3 U). The reaction mixtures were 
incubated at 0 °C for 5 mm, at room temperature (24-26 °C) for 5 mm, and at 37 °C 
for 2 h and were used to transfect competent E.coli strain TG-1 cells (Method 2B.4 
iii). ssDNAs were prepared from the transformants (Method 2B.1.iv) and DNA 
sequencing (Method 2B.6) was performed to determine the mutations that had been 
introduced. The L-HBsAg coding segment of the desired mutant was excised from 
the M13mp18 vector by digestion with Eco R I and Sal I and ligated into the 
pCITE-2c vector (Method 2B.3). 
ii • Deletion mutagenesis with BAL 31 exonuclease 
• Calibration of BAL 31 exonuclease activity 
A series of seven two-fold dilutions of (2 Ml)  BAL 31 exonuclease (GIBCO 
BRL; 1.4 U) was carried out with BAL 31 buffer [600 pM NaCl, 12 mM CaCl 2, 12 
mM M9021  20 mM Tris-HC1 (pH 8.0), 0.2 mM EDTA (pH 8.0); 2 p1]. Aliquots 
(1 Ml)  of these enzyme dilutions were then used to digest Eco RI linearised 
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pMDHBs3 DNA (0.55 rig) in BAL 31 reaction mixture (10 .il) at 37 °C for 30 mm. 
The reactions were terminated by adding of EGTA (200 mM, pH 8.0; 1.il) and 
heated at 65 °C for 5 mm. The molecular weight of the digested DNAs was 
analysed by electrophoresis in 0.8% (w/v) agarose gel. The dilution of BAL 31 
which had totally digested the DNA was used in a large-scale digestion, as described 
below. 
• Generation of nested deletions of linearised plasmid 
pMDHBs3 (20 rig) DNA that had been linearised with Eco RI was digested 
with BAL 31 (3.13 U) in BAL 31 buffer (361 .t1) at 37 °C. At 1 min intervals, 
samples of the reaction mixture (45 .il) were removed and heated at 65 °C for 5 mm 
in the presence of EGTA (200 mM, pH 8.0). After that, the DNAs were precipitated 
with ethanol and dissolved in H 20 (20 .il). The DNAs were then repaired with T4 
DNA polymerase (Boehringer; 1 U) in polymerase buffer [20 mM Tris-HC1 (pH 7.6), 
1 mM M902, 0.1 mM DTT; 30 !.t1] in the presence of dNTPs (0.05 mM) as 
substrates. These reactions were incubated at room temperature for 15 min and 
Kleonow fragment of E.coli DNA polymerase I (Northumbria Biologicals; 5 U) was 
added and incubated at the same temperature for 15 mm. The repaired DNAs were 
precipitated with ethanol and each of the DNA pellets was dissolved in H 20 (17 i1). 
Liberation of 5'-end truncated genes from the vector DNA 
The above DNAs were digested with Sal I (10 U) and electrophoresed in 
1.5% (w/v) agarose gel to separate the 5'-end truncated L-HBsAg DNA fragments 
(target fragments) from their vector component. Target fragments were recovered 
(Method 2B.2 ii) and subcloned into M13mp18 vector that had been digested with 
Sal I and Sma I (Method 2B.3). 
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2136 DNA sequence determination 
Sequencing reactions were performed by the dideoxynucleotide chain 
termination method of Sanger and Coulson (1975; Sanger etal., 1977). 
i - Single stranded DNA sequencing 
The primer for the polymerase reaction was annealed to its template as 
follows. A microcentrifuge tube containing ssDNA (100 ng/.tl; 8 pi), primer 
(1 pmole/pl; 1 Ml)  and 10 x TM (100 mM Tris-HC1 pH 8.5, 50 mM MgC12 ; 1 Ml) 
was heated at 80 °C for 5 min and then allowed to cool at room temperature (10-15 
mm), centrifuged briefly, and aliquoted (2 Ml)  to four wells (labelled A, C ,G and T) 
of a microtiter plate which contained nucleotide mixes (A, C, G and T respectively, 
as shown in the following table; 2 pl).  Kienow reaction mix (9 mM Tris-HC1 pH 8.0, 
9 mM DTT, 0.2 U E. coli DNA polymerase I Kienow fragment, 0.56 pCi (X-[35S] -
dATP; 2 Ml)  was then added to each well, mixed gently by tapping and incubated at 
room temperature for 15 mm. This was followed by the addition of chase mix (0.25 
mM dNTP; 2 Ml)  and incubation continued for a further 20 mm. The reaction was 
stopped by adding gel loading dye [0.5% (w/v) xylene cyanol, 0.5% (wlv) 
bromophenol blue, 10 mM EDTA in formamide; 2 Ml].  Prior to electrophoresis, the 
reaction mixtures were heated at 90 °C for 5 min and quickly chilled on ice. 
Nucleotide mixes (volumes in p1) 
A C G I 
0.5 mM dCTP 500 25 500 500 
0.5mMdGTP 500 500 25 500 
0.5 mM dTTP 500 500 500 25 
10mMddATP 1 - - - 
10mMddCTP - 8 - - 
10mMddGTP - - 16 - 
10 mM ddTTP - - - 50 
TE (pH 8.0) 500 1 000 1 000 1 000 
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• Denaturing polyacrylamide gel electrophoresis and autoradiography 
The sequencing reaction products were separated on a 420 mm x 180 mm x 
0.3 mm, 6% polyacrylamide gel [60 ml of: 6 M urea, 5.7% (w/v) acrylamide, 0.3% 
bisacrylamide, lx TBE, polymerised by adding 300 p1 of 10% (w/v) ammonium 
persuiphate and 75 p1 TEMED]. Usually, the gel was pre-electrophoresed for 30 
min in 1 x TBE, before the reaction mixtures (3 p1) were loaded in sharkstooth comb 
wells. Electrophoresis was performed at a constant power of 60 W for the indicated 
period of time. After electrophoresis, the gel was soaked with fixer [10% (v/v) acetic 
acid; 10% (v/v) ethanol] for 20 min, transferred to blotting paper, dried under 
vacuum at 80 °C for 40 min and autoradiographed against an x-ray film (DUPONT). 
After the appropriate length of time, the film was developed using an X-O GRAPH 
COMPACT x 2 automatic X-ray film processor. 
ii • Automated DNA sequencing 
The automation of manual sequencing steps was developed by research at the 
California Institute of Technology (Smith et al., 1986). In this method, the steps 
were not fully automated. Sequencing and gel electrophoresis were still performed 
manually. However, the detection and analysis of DNA sequences by a machine have 
greatly increased the number of bases that can be determined per reaction. 
Thermal cycle sequencing was carried out using the ABI PRISM TM Dye 
Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer). To a 
microcentrifuge tube (0.5 ml), the following reagents were added: template (0.1 pg 
ssDNA or 0.4 pg d5DNA), terminator ready reaction mix [ddNTP-dye terminator, 
dNTP, Tris-HC1 (pH 9.0), M902, thermal stable pyrophosphatase, AmpliTaq DNA 
polymerase (FS); 8 p1] and primer (3.2 pmole). The reaction mixture (20 p1) was 
overlaid with mineral oil (40 p1) and subjected to the following temperature profile: 
96 °C for 30 s, 50 °C for 15 s and 60 °C for 4 mm, 25 cycles. The sequencing 
products were precipitated by adding 3 M sodium acetate (pH 4.6; 0.1 vol) and 95% 
(v/v) ethanol (2.5 vol), washed with 70% (v/v) ethanol (250 p1) and vacuum dried. 
Electrophoresis of sequencing reaction products was performed by Nicola Preston 
and Sandra Bruce (ICMB) on an automated sequencer (ABI Prism 377), and the data 
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obtained were analysed using Sequence Navigator DNA and protein sequence 
comparison software (Applied Biosystems). 
2.B.7 In vitro transcription and translation 
Plasmid pMDHBs3 and mutated derivatives (30 tg) were first linearised 
with Sal I, then purified with phenol, phenol:chloroform (1:1) and chloroform 
extraction and precipitated with 3 M sodium acetate (pH 5.2; 0.1 vol) and ethanol 
(100%; 2 vol) overnight. The linearised DNAs (1.tg) were used as templates in 
reaction mixtures [80 mM HEPES-KOH (pH 7.5), 24 mM M902, 2 mM 
spermidine, 40 mM DTT; 20.tl I containing 7.5 mM rNTPs and T7 RNA polymerase 
(Promega, Madison, WI; 600 U). Transcriptions were performed at 37 °C for 2 h 
and the synthesised RNAs (2 M1  aliquots) were kept at -70 °C. Prior to translation 
reactions, the synthetic RNAs were diluted 10-fold and samples of these dilutions 
(1 tl) were added to reaction mixtures (9 .t1) containing rabbit reticulocyte lysate 
(Promega, Madison, WI; 5 tl), amino acid mixture minus methionine (20 tM), 
[35  S]-methionine (1 CiJmol, Amersham; 0.35 jil), Mg(OAC) 2 (0.6 mM), KCI (120 
mM) and DTT (2 mM). Reactions were carried out at 30°C for 2 h in the presence or 
absence of HBcAg (0.6 jig). 
i • Determination ofpercent incorporation of [35S]-Met  and the yield of 
translation products 
Translation mixtures were diluted (1:50; 100 jil) with 1 M NaOH containing 
2% (v/v) H202 and incubated at 37 °C for 10 mm. These were then diluted to 1 ml 
with 25 % (v/v) ice-cold TCA containing 2% (w/v) casamino acids and left on ice 
for 30 mm. These mixtures (250 jil) were placed onto glass microfibre filters 
(Whatman, 2.1 cm diameter), which were situated in scintillation vials. The filters 
were washed three times with 5% (v/v) TCA (3 ml) and once with acetone (3 ml), 
each at interval of 10 mm. The washing solutions were removed by aspiration and 
the discs dried at 60 °C for 20 mm. Scintillation liquid (Ecoscint A, National 
Diagnostics, Atlanta; 5 ml) was added and radioactivity was determined with a 
liquid scintillation spectrometer (Beckman, LS 7 000). To determine total counts 
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present in the reaction mixtures, the TCA-treated reaction mixtures (5 i)  were 
spotted directly onto filters, dried and counted. 
The percentage of the [35S]-methionine incorporated into translation products 
was calculated with the following formula: 
Percent incorporation = (cpm of washed filter/cpm of unwashed filter x 50) x 100 
From these values, the amount of [35S]-methionine in each reaction mixture, and the 
number of methionine residues in each polypeptide, the total amount of peptide 
synthesised in each translation system was determined. 
2B.8 Protein purification and analysis 
i Analysis of the yield of HBcAg synthesised in E. coli supplemented with 
T4AGA tRNA 
E. coli strain W3 11OIQ containing plasmids pTacpcore (encoding full-length 
HBcAg) and pAGA9 (encoding T4 AGA tRNA), or placpcore alone, or without the 
two plasmids were grown in LB medium (80 ml, supplemented with appropriate 
antibiotics) at 38 °C with shaking (-200 rpm) to an OD6 00nm approximately 0.8, and 
IPTG (0.5 mM) was added. The culture was then split into two flasks, one continued 
shaking at 38 °C and the other was shaking at 42 °C (waterbath shaker) for 15 mm 
and then continued shaking at 38 °C. The 42 °C-heat treatment for the second flask 
was a precautionary step to ensure all the heat sensitive X repressors, c1857, driven by 
the Plac  promoter of the pAGA9 plasmid were completely denatured. After 24 h 
incubation, cells were pelleted by brief centrifugation, resuspended in loading buffer, 
boiled and analysed on SDS-PAGE (213.8.vi). 
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ii - Purification offull-length and truncated HBcAg particles 
The method for purification of HBcAg particles was initially described by 
Murray et al., (1984) with some modification by Dyson and Murray (1995). 
Several E. coli strains harbouring plasmids pTacpcore or Rd-i 1E, 
respectively, encoding full-length or truncated HBcAg were grown at 37 °C with 
shaking (250 rpm) in LB (500 nil) supplemented with ampicillin (100 tg/ml). The 
expression of HBcAg was induced with IPTG (0.5 mM) when the cultures reached 
OD600nm around 0.8 to 1.0. After 16-20 h of shaking, the cells were harvested by 
centrifugation at 4,000 xg for 15 min at 4 °C and the pellet suspended in lysis buffer 
[50mM Tris-HC1 (pH 8.0), 0.1% (v/v) Triton; 12 ml]. M902  (4 mM), lysozyme (50 
mg/nil; 48 iil) and DNase 1 (7.5 mg/mI; 30 .tl) were then added to the suspension 
which was shaken gently (on orbital shaker) at room temperature for 2 h. The cell 
extract was recovered by centrifugation at 11,000 xg, for 20 min at 4 °C and 
precipitated by ammonium sulphate (35% saturation). The precipitate was 
centrifuged with the same conditions, the pellet resuspended in TBS (150 p1), 
dialysed against two changes of TBS (2 1) at 4 °C overnight. The dialysed solution 
was applied to 8-40% sucrose gradients (in TBS; 12 ml), and centrifuged at 
100,000 xg (TH641 rotor, Sorvall) for 5 h at 4 °C. Fractions (0.5 ml) were collected 
by punching a hole at the bottom of the tube and those containing HBcAg were 
pooled and concentrated with a 300 kDa cut-off MICROSEP filter (Flowgen). 
iii• Separation of large and small particles of HBcAg 
After the first sucrose gradient centrifugation, the preceding and succeeding 
fractions of the peak containing HBcAg particles were pooled separately and 
dialysed against TBS (2 1) at 4 °C overnight. The dialysed HBcAg particles were 
then concentrated to 100 M1  with a 300 kDa cut-off MICROSEP filter and layered 
on top of 8- 40% sucrose gradients, and centrifuged at 100,000 xg for 5 h at 4 °C. 
The above steps were repeated until two separate peaks containing large and small 
particles were obtained. The peaks were then pooled, dialysed and concentrated 
separately. The monodispersity of these particles was analysed by light scattering 
(Method 2B.8.v). 
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iv • Determination of HBcAg concentration with the Bradford assay. 
Protein samples were diluted to 40 j.tl with TBS in a disposable tube. Then, 1 
ml of lx Bradford dye [0.01% (w/v) Coomassie blue G-250, 4.75% (v/v) ethanol, 
8.5% (v/v) phosphoric acid] was added and vortexed immediately. The mixture was 
left at room temperature for 10 min and the OD59 5 measured with a spectrophoto-
metre (UNICAM, model SP 500 series 2). Protein concentration was determined 
from a standard curve obtained from measurements with BSA (2.5, 5, 7.5, 10, 15 
and 20 jig) in the same way. All samples were analysed in triplicate. 
v - Light scattering analysis of HBcAg 
The dispersity of HBcAg particles was analysed with a dynamic light 
scattering instrument (DynaPro-801, PROTEiN SOLUTIONS Ltd). The operation 
of. the instrument was assisted by Professor Malcolm Walkinshaw (Department of 
Biochemistry, University of Edinburgh) according to the user manual. Purified, and 
separated large and small particles of HBcAg (0.1 mg/mi; 150j.il) were injected into 
a sample cell through Whatman Anatop TM  plus syringe filters (0.1 jim porosity). 
The sample were illuminated by a miniature solid state laser of approximately 25 
mW power and 780 nm wavelength. Scattered light at 90° angle was detected and 
analysed with the autocorelation function to deduce the translational diffusion 
coefficient (DT) of the molecules in the sample cell. The hydrodynamic radius (R h) 
of the molecules was calculated from D 1 through the Stokes-Einstein equation: 
Rh=kbT/ 6 ItI1DT 
where kb is Boltzman's constant, T is the absolute temperature in degrees Kelvin, 
T1 is the solvent viscosity. The instrument assumes the viscosity of water, 
= 1.019 x 10 Nsm 2 . 
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vi. SDSpolyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were fractionated by SDS-PAGE (Laenmli, 1970) with a 
discontinuous buffer system. A Mini-Protein II gel apparatus (BioRad) was used and 
gels were prepared with the following recipes: 
Separating gel Stacking gel 
15% (w/v) 	5% (w/v) 
polyacrylamide mix a 	 : 	15 ml 	1.66 ml 
4 x lower buffer b 	 : 	7.5 ml 	- 
4 x upper buffer C 	2.50 ml 
H20 	 : 	7.5 ml 	5.84 ml 
10% w/v ammonium persulphate 	: 	187.5 .tl 	66.6 p1 
TEMED 	 : 	30.0 p1 	26.0 p1 
a 30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide 
b  containing 1.5 M Tris-HC1 (pH 8.6), 0.4% (wlv) SDS 
containing 0.5 M Tris-HC1 (pH 6.8), 0.4% (w/v) SDS 
Protein samples (1 to 2 p1) were prepared by mixing with lx loading buffer 
[62.5 mM Tris-HC1 (pH 6.8), 2% (w/v) SDS, 10% (v/v) glycerol, 0.2% (w/v) 
bromophenol blue, 50 mM DTT; 5 vol] and boiling for 5 mm. Electrophoresis was 
performed in Tris-Glycine Buffer [3% (w/v) Tris, 14.4% (w/v) glycine, 0.1% (w/v) 
SDS; pH 8.4] at a constant current of 30-35 mA for 45-60 mm. Gels were stained 
with coomassie brilliant blue R-250 [0.5% (w/v); in 25% (v/v) isopropanol and 
10% (v/v) acetic acid] for 5-10 min at room temperature with gentle agitation and 
destained in solution containing methanol (10% v/v) and acetic acid (10% v/v) 
overnight. 
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2B.9 Isolation of protein for microsequence analysis 
The following procedure was used to isolate protein fragments with lower 
molecular weight than full-length HBcAg monomer (-22kDa, 192 residues) which 
assemble into HBcAg particles. First of all, denatured HBcAg particles were 
fractionated by SDS-PAGE at neutral pH. The proteins were then transferred to a 
polyvinylidene difluoride (PVDF) membrane and stained with coomassie blue. 
Bands of interests were excised and analysed with an automated protein sequencer. 
i • SDS-PAGE 
The method used was that described by Moos et al., (1988) in which a 
polyacrylaniide gel was preelectrolised with glutathione to eliminate the by-products 
of acrylamide polymerisation, followed by electrophoresis at a lower pH to reduce 
the blockage of amino termini of the proteins. 





polyacrylamide mixa : 	 20 ml 0.666 ml 
4 x gel bufferb : 	 10 ml - 
H20 : 	 9.7 ml 3.033 ml 
10% (w/v) ammonium perssulphate : 	 0.14 ml 0.025 ml 
TEMED : 	 0.026 ml 0.025 ml 
a 30% (w/v) acrylaniide, 0.8% (w/v) bisacrylamide 
b containing 10.3 1% (w/v) bis-Tris, 0.66% (vlv) HCl; pH 6.61 
The gel was preelectrophoresed in lx gel buffer containing glutathione 
(1 mM final concentration) in the upper buffer reservoir, at 10 mA for 45 mm. The 
gel was left overnight at room temperature, buffer was then decanted and wells 
blotted with filter paper. Prior to electrophoresis, protein samples were boiled 
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for 5 min in the presence of lx loading buffer (Method 2B.8.vi) and loaded 
into the wells. The gel was then electrophoresed in lx upper reservoir buffer 
[0.05% (w/v) mercaptoacetic acid, 1% (w/v) N-tris-(hydroxymethyl)-methyl-2-
aminoethanesulfonic acid (TES), 2.37% (w/v) bis-Tris, 0.1% (wlv) SDS; pH 7.25] 
and 1 x lower reservoir buffer [1.3 1% (w/v) bis-Tris, 0.114% (v/v) HC1 ; pH 5.9] at 
10 mA until the bromophenol blue dye reached the bottom of the gel (- 80 mm). 
ii. Electroblotting ofprotein onto PVDF membrane 
The gel was removed from the electrophoresis cell and soaked in transfer 
buffer [10 mM 3-(Cyclohexylanñno)-1-propanesulfonic acid (CAPS) pH 11 in 10% 
(vlv) methanol] for 5 mm. Meanwhile, a PVDF (ProB1ott, Applied Biosystems) 
membrane was cut to approximately the same size as the gel, soaked with methanol 
for a few seconds, and transferred to a dish containing transfer buffer. A gel 
'sandwich' was assembled in a blotting cassette submerged in transfer buffer with 
the following order: a Scotch-Brite pad, one sheet of blotting paper cut to the gel 
size, the gel, the PVDF membrane, another sheet of blotting paper and another 
Scotch-Brite pad. The blotting cassette was placed in the electroblotting apparatus 
(BioRad, Trans-Blot cell) containing transfer buffer by facing the membrane towards 
the anode side of the tank. Electroblotting was conducted at constant voltage of 50 
V, at room temperature for 30 mm. After electrophoresis, the membrane was 
removed from the sandwich and rinsed with H 20. 
iii • Coomassie blue staining and band excision 
The membrane was soaked in absolute methanol for a few seconds and 
transferred to staining solution [0.1 %(w/v) coomassie blue R-250 in 40% (v/v) 
methanol] and gently agitated for 5 mm. The membrane was then destained with 
50% (v/v) methanol by agitating until bands became clearly visible (-30 mm). 
Protein bands of interest were excised with razor blades, placed in microcentrifuge 
tubes, dried at room temperature and stored at -20 °C. The samples were sequenced 
on an automated protein sequencer (Applied Biosystem) and analysed by Dr. Andy 
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Cronshaw (WELMET, Edinburgh protein characterisation facility, University of 
Edinburgh). 
2B.10 Analysis of interactions between HBsAg and HBcAg 
i - Immunoprecipitation with anti-HBcAg rabbit polyclonal serum 
Immunoprecipitations were carried out at 4 °C by mixing 40x diluted 
translation mixtures [NET-gel buffer containing 2 mM DTF; 200 p1] with anti-
HBcAg rabbit polyclonal serum (1 jig) and rolled gently for 1 h. Protein A 
sepharose (Pharmachia; 10 p1 of a 50% slurry) was then added and rolling continued 
for a further 1 h. The immunoprecipitated complexes were recovered by 
centrifugation and washed four times with NET-gel buffer and once with 10 mM 
Tris-HC1 (pH 7.6) containing 0.1% (v/v) NP-40. For every washing, the complexes 
were left rolling gently for 20 mm. The last traces of the final wash from the 
sepharose pellets, and the wails and lids of the centrifuge tubes were removed by 
aspiration. These pellets were then heated together with SDS gel loading buffer [50 
mM Tris-HC1 (pH 6.8), 100 mM DTT, 2% (w/v) SDS, 0.1% (w/v) bromophenol 
blue, 10% (v/v) glycerol; 10 p1] at 100 °C for s mm. The protein A-sepharose was 
removed by centrifugation at 15,000 xg for 2 min at room temperature. The 
supernatants were analysed by 15% (w/v) SDS-PAGE. (Method 2B.8.vi). Gels were 
dried and [35S]-labelled products were visualised by autoradiography and analysed 
on a phosphoimager (Molecular Dynamics). 
ii - Development of an HBsAg-HBcAg binding assay in solution 
The experimental establishment of a binding assay to determine the affinity 
constant of HBsAg-HBcAg complexes is described below. A detailed discussion of 
the purposes and theoretical background behind each step is presented in Chapter 5. 
• Time course experiment of the L-HBsAg binding to HBcAg coated wells 
Two sets of strip plates (Costar) with U-shaped polystyrene wells were 
coated with HBcAg (10 pg/mI in TBS buffer; 120 p1) overnight at room temperature 
with gentle agitation and washed three times with PBS. Then, one set of the plates 
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was blocked with BSA (10 mg/mI in TBS) at 4 °C (cold room) for 2 h, the other at 
room temperature (27 °C) with the same conditions. Afterwards, a constant 
concentration of [ 35S]-L-HBsAg (100 tl of 200x dilution of in vitro translation 
reaction mixtures with NET-gel buffer containing 2 mM DTT) was pipetted into the 
HBcAg coated wells and incubated for different time periods (1, 2, 3, 4, 5, 6, 20, 24, 
28.5 and 48 h) at 4 °C and at room temperature. After each incubation period, the 
relevant strip representing a point on a time course was detached from the plate and 
washed five times with NET-gel buffer containing 2 mM DTT. Wells were air dried 
and placed in scintillation vials containing scintillation liquid (Ecoscint A National 
Diagnostic, Atlanta; 5 ml) for quantitation of radioactivity with a scintillation 
counter (BECKMAN, LS 1701). A negative control was carried out with the same 
conditions but in the absence of [35S]-L-HBsAg  (an in vitro translation reaction that 
did not contain mRNA encoding for the L-HB5Ag). Each time point was analysed in 
triplicate. 
Determination of the amount of [35S]- L-HBsAg captured on HBcAg coated 
wells (input-output relationship) 
Two sets of plates were prepared with coating conditions as above and 
blocked with BSA at 4 °C. Various dilutions of in vitro translation mixtures (1/20, 
1/40, 1/80, 1/160, 1/320, 1/640, 1/1280 and 1/2560) were pipetted into the coated 
wells of the first plate and incubated under the same conditions as above. After 
incubation, wells were washed five times with the same buffer as above and 
radioactivity counted. This experiment was repeated separately, with wells coated 
with 7.5, 5.0 and 2.5 g/ml of HBcAg. Each dilution of the in vitro translation 
mixtures was assayed in triplicate. 
• Determination of relative dissociation constants (KId)  of HBsAg-HBcAg 
complexes 
HBcAg at various concentrations (0.01-80 pM, in NET-gel buffer containing 
2 mM DTT) was incubated with a constant amount of HBsAg (1:50 or 1:100 
dilution of in vitro translation mixtures with the same buffer) for 24 h at 4 °C, in a 
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final volume of 500 .tl. An aliquot (100 tl in triplicate) of the mixtures was then 
transferred to a U-shaped well that had been coated with HBcAg (2.5 jig/mi; 
conditions as above) and blocked with BSA (10 mg/mi). After 1 h incubation at 4 
°C, the wells were washed 5 x with NET-gel buffer containing 2 mM DTT, dried 
and radioactivity counted. 
• Determination of K/1  values with the Scatchard plot 
The Scatchard equation derived for the above binding assay in solution is: 
(cpm0-cpm)/ (cpm0[C])= 11Kdrd - [(cpm0-cpm)/cpm0]/ Kd' 
The mean value ± standard deviation of counts per minute (cpm) measured by the 
scintillation counter (which reflects the concentration of free [35S]-HBsAg in 
solution) at various concentrations of HBcAg ([C])  was calculated and the value was 
subtracted from the counts per minute obtained for the well containing no HBcAg 
(cpm0). The value obtained was then devided by cpm0 to generate fraction bound, Y, 
[(cpm0-cpm)/cpni,,]. A plot of Y/[C] versus Y gives a straight line of slope equal to 
-1/Kd'. The theoretical background of the derivation of the Scatchard equation is 
described in Charpter 5. 
Determination of K/el  values with the curve fitting method 
A plot of Y versus [C] was prepared and a curve fitted to these points using 
equations for one binding site or two binding sites (GraFit TM  version 3.0 Erithacus 
Software ltd). 
Equation for one binding site: 
Y = {[C] . B/(Kd' + [C])} + background 
where B.a,, is the maximal binding and background is the background value of Y. 
Equation for two binding sites: 
Y = ([C]. Bl/(Kdl' + [C])} + {[C] . B, 2 I (K'+ [C])} + background 
where Kdlml  and K4 j2' 1 represent the dissociation constants for the high- and low-
affinity sites respectively. B 1 and B 2 refer to maximal binding for the high-
and low-affinity sites respectively. 
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iii • Inhibition of HBsAg binding to HBcAg by synthetic peptides 
[35S] -1-1BsAg synthesised in rabbit reticulocytes was diluted 100-fold with 
NET-gel buffer (plus 2 mM DTT) containing various concentrations of synthetic 
peptide (100 nM to 1 mM). An aliquot of these mixtures (100 jil, in triplicate) was 
incubated in HBcAg coated wells (10 j.ig/ml; as in 2B.10.ii) for 24 h at 4 °C. Then, 
wells were washed five times with NET-gel buffer (plus 2 mM DTT) with 10 mm 
intervals and placed in scintillation vials for quantitation of radioactivity. Peptides 
LDPAFR, LEDPASR and EDPASR were synthesised by the Department of 
Chemistry, University of Edinburgh. Peptide LLGRMKG was provided by Biogen 
Inc., Cambridge, MA, USA. 
iv. Phage binding assay in solution 
This method was established by Dyson et al., (1995). Various concentrations 
of HBcAg (0.16 nM to 251 nM in TBS containing 20 mg/mi BSA) were incubated 
with a constant concentration of purified phage 2A-8 (1/200 dilution of 8 x 10 
pfu/j.tl; in TBS containing 20 mg/mI BSA) for 18 h at 4 °C. In addition, a tube 
containing only phage was prepared. Then, an aliquot (100 .il) of the mixtures was 
transferred to a HBcAg-coated well (2.0 ig/ml; see 2B.10.ii) and incubated for 1 h 
at 4 °C. Wells were then washed six times with TBS containing BSA (20 mg/mI). 
Phages bound to the wells were eluted by incubation with elution buffer (0.1 M HCl, 
titrated to pH 2.2 by addition of solid glycine; 200 j.il) for 10 mm. Solutions from 
each well were transferred to microcentrifuge tubes containing Tris-HCI (1 M, pH 
9.5; 37.5 .t1) and vortexed for 20 s. The amount of phage recovered from each well 
was determined by titration as plaque forming units (pfu) as follows: An aliquot 
(1/100 dilution in TBS containing 1 g/l gelatin; 10 Ml)  of the mixtures was added to a 
suspension of K91Kan cells (300 Ml)  grown to OD600nm 0.8. Melted top layer agar 
(equilibrated to 45 °C; 3 ml) was then poured into the tubes containing phages and 
cells, gently mixed and the mixtures poured on L-agar plates containing kanamycin 
(100 jig/mI). The plates were incubated overnight at 37 °C and plaques counted the 
next day. All assays were performed in triplicate. 
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• Determination Of K / 1  values with the curve fitting method 
The mean value ± standard deviation of plaque forming units (pfu) 
determined at various concentration of HBcAg ([C])  was divided by pfu obtained for 
the well in the absence of HBcAg (pfu 0). The ratios were then plotted against [C] 
and a curve fitted to these points using one binding site equations (GraFit TM  version 
3.0 Erithacus Software ltd). 
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CHAPTER 3 
HBcAg PARTICLES: YIELD IMPROVEMENT, 
HETEROGENEITY AND FRACTIONATION 
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3.1 Introduction 
HBcAg comprises 183 residues and can be divided into two domains; the 
first 140 amino acids are sufficient for self-assembly (Zlotnick et at., 1996), and the 
C-terminal sequence is very rich in arginine residues which closely resembles 
protamines and is believed to interact with nucleic acids (Pasek et at., 1979). 
HIBcAg has been successfully expressed in E. coli for nearly two decades now 
(Pasek et al., 1979) and E. coli is still the host of choice in our laboratory and 
elsewhere for routine large scale production of HBcAg particles. In the prokaryotic 
cell, HBcAg assembles into icosahedral particles morphologically resembling those 
found in infected liver (Cohen and Richmond, 1982). Two sizes of particle are 
produced: large and small particles containing 240 and 180 monomers, respectively 
(Crowther et at., 1994). When the extremely basic protamine-like region (residues 
149-183) is removed, the HBcAg still assembles into particles, but the packaging of 
RNA is abolished (Borisova et al., 1989; Gallina et at., 1989; Birnbaum and Nassal, 
1990; Hatton et at., 1992; Zheng et at., 1992; Ulrich et al., 1993). Furthermore, and 
of practical importance, the yield of truncated HBcAg lacking the protamine-like 
region in E. coti is much greater than that of full-length HBcAg (Zheng et at., 1992; 
Stewart, 1993). 
In this chapter, three questions concerning the HBcAg are addressed: 
: How to improve the yield of full-length HBcAg synthesised in E. coti? 
: How to separate the large and small particles of HBcAg? 
(iii): Are the purified HBcAg particles homogeneous? 
3.2 Results 
3.2.1 Codon usage in the RBcAg gene 
Fig. 1 la displays the codon usage of HBcAg gene (strain adyw), 
summarising the number of codons used and the total number of amino acids 
encoded. Although 55 of the 61 possible codon triplets are used to synthesise 
HBcAg, it is clear that codon usage is not random and there is a predominance of 
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Fig. 11: 
Codon usage in HBcAg gene. The 61 possible triplets encoding the 20 different 
amino acids are listed on the cenral vertical line, xy. The total number of each 
triplet used in the coding region of the HBcAg gene is represented by bars on the 
right of the xy line. Bars on the left of the line show the number of amino acid 
residues encoded by each triplet. 
Positions of arginine codons in the HBcAg gene. The HBcAg gene is 
represented by the vertical bold line, (5'- to 3 ')from the bottom to the top, and the 
scale is shown on the left. The six different codons for Arg are represented by 
different symbols as indicated at the lower right of the diagram. Each codon 's 
position is indicated on the right of the symbols. 
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certain codons, especially AGA, the most frequently used codon, which comprises 
6% of all codons in the HBcAg gene and 46% of the Arg codons. It is also 
interesting to note that the codons for Arg residues are the most abundant in the 
HBcAg gene, comprising 13% of all the codons, and 67% of these codons are 
located at the 3'-end of the HBcAg mRNA encoding the protamine-like region (Fig. 
1 lb, codons 149-183). Furthermore, 50% of the Arg codons in this region are 
AGA. Thus, there is a strong bias towards the use of codon AGA, particularly at the 
3'-end of the mRNA encoding full-length FIBcAg. 
3.2.2 Enhancement of HBcAg synthesis in E. coli by T4 AGA tRNA 
supplementation 
To improve the yield of full-length HBcAg synthesised in E. coli, the plasmid 
pAGA9, carrying the T4 AGA tRNA gene under the control of the inducible FL 
promoter, was introduced into a W3 11OIQ strain containing pTacpcore plasmids 
encoding full-length HBcAg, driven by the tac promoter. With cells harbouring 
pTacpcore plasmids, a 22 kDa protein band, corresponding to full-length HBcAg, 
was produced after induction with IPTG (Fig. 12a, lanes 6 and 7). Cells harbouring 
both pTacpcore and pAGA9 showed a significant increase in HBcAg synthesis as 
shown by a more intense 22 kDa band (Fig. 12a, lanes 9 and 10). In order to 
quantitate the yield of HBcAg produced, the dried gel was scanned (Hewlett 
Packard, Scanjet llcx) and the image analysed with ImageQuant software 
(Molecular Dynamics). A rectangle was drawn along lanes 7 and 10, and the 
average pixel value along the length of the rectangle was integrated by the software 
that reported the results as a line graph and area under each peak was expressed as a 
percentage of the total protein in order to compensate for any differences in loading 
or staining between tracks. Fig. 12b shows the graphs obtained from lanes 7 and 10 
which are superimposed on eachother. It is clear that the synthesis of HBcAg has 
increased as indicated by a higher and wider peak (asterisk) corresponding to the 22 
kDa band in lane 10. The area under the peak that represents the amount of HBcAg 
synthesised relative to the total cell protein, increased from 13.7% to 20.8% (a 50% 
increase) when cell were supplemented with T4 AGA tRNA. In one litre cultures, 
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Fig. 12. 
Coomassie blue staining of crude cell extracts separated on SDS-
Polyacrylamide gel (15%). W31 1OIQ cells (lanes 2 to 4) , W31 1 OIQ cells 
harbouring pTacpcore plasmids (lanes 5 to 7), and W3110IQ cells harbouring 
pTacpcore and pAGA9 plasmids (lanes 8 to 10) were induced with IPTG (lanes 3, 4, 
6, 7, 9 and 10) or without IPTG (lanes 2, 5 and 8). After IPTG induction, cells on 
lanes 4, 7 and 10 were shaken at 42 °C for 15 min before incubate at 38 °C for 
overnight. Lanes 1 and 11 show the molecular weight marker (in kDa) and purified 
HBcAg, respectively. 
Quantitation of HBcAg in crude cell extracts. Graphs obtained from area 
integration of a rectangle drawn along lanes 7 and 10 of above gel are 
superimposed on another and peaks correspond to 22 kDa band are indicated by . 
Image Quant software (Molecular Dynamics) was used to integrate the area under 
each peak and results were reported as percent total (data not shown). Horizontal 
axis corresponds to the distance along the rectangle and the left end of the graph 
corresponds to the top of the rectangle. The units on the y axis are arbitrary. 
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the yield of HBcAg particles approximately doubled, from about 5 mg to 10 mg. 
3.2.3 Heterogeneity in purified HBcAg particles 
When purified particles of the full-length HBcAg, either freshly prepared or 
having been kept for a few months, were subjected to SDS-PAGE in the presence of 
DTT (100 mM), the protein not only gave a sharp band with an apparent molecular 
weight of -22 kDa , but also a smear of less intense bands below the sharp band 
(Fig. 13a). However, when the arginine-rich carboxy end was truncated, the protein 
migrated as a single band with the expected molecular mass of the monomer, -17 
kDa (Fig. 13b). To examine the components of the diffuse bands, the products from 
full-length HBcAg fractionated on a polyacrylamide gel were transferred to a PVDF 
membrane and stained with Coomassie blue. The sharp band of 22 kDa and diffuse 
bands were separately excised from the membrane and analysed with an automated 
protein sequencer (Method 213.9). The first six amino acids of the N-terminus of 
the proteins in both the smear and intense bands were sequenced and found to be the 
same, that is TM1TDS. This sequence corresponds to residues 2 to 7 of the f3-
galactosidase sequence fused to the N-terminus of HBcAg, resulting from the 
cloning vector. The first amino acid of the -galactosidase sequence, methionine, 
was not detected in any of the samples. 
3.2.4 Separation of the large and small particles of HBcAg with sucrose 
gradient centrifugation 
As HBcAg assembles into particles, it can be easily separated from other 
host components with sucrose gradient centrifugation. Fig. 14a shows a typical 
sedimentation profile of full-length HBcAg particles on a sucrose gradient (8-40% 
w/v) after spinning at 100,000 xg for 5 h. The bell-shape peak of fractions 2 to 10 
was found to contain a mixture of different sizes of HBcAg particles by light 
scattering. As the sedimentation rate is dependent upon particle mass, the early 
fractions of the peak should be enriched in large particles and later fractions in small 
particles. The first two fractions and the last fraction of the peak (from 3 sucrose 
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gradients) were therefore pooled and concentrated separately. These preparations 
were then overlaid on separate sucrose gradients (8-40%) and centrifugation was 
repeated as above. It is clear that the HBcAg particles sedimenting at different 
positions resulted in two separated peaks with some overlapping on the edge of the 
peaks (Fig. 14b). The first two and the last fractions of peak 1 and 2, respectively, 
were separately pooled and concentrated, and examined with light scattering. 

















Fig. 13 SDS-PAGE offull-length and truncated HBcAg 
Particles comprising purified full-length (a, lane 2) and truncated (b, lane 2) HBcAg 
(2 jig) were analysed on 15% polyacrvlamide gels and stained with Coomassie blue. 
The specific band is indicated by an arrow head and the smear below the 22 kDa 
band is indicated by a vertical dashed line. Lane 1 is the molecular weight markers 
(in kDa). 
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Fig. 14: Fractionation of large and small particles of HBcAg with sucrose 
gradient centrifugation 
Separation of HBcAg particles from host cell components. Ammonium sulphate 
precipitated fractions from cell extracts containing particles of full-length HBcAg 
were layered on top of a sucrose gradient and centrifuged at 100,000 xg for 5 h. 
Fractions (0.5 ml) were collected and protein concentration was determined with the 
Bradford assay. The arrow on top of the diagram indicates the direction of 
sedimentation. 
Separation of large and small particles of full-length HBcAg. Fractions 3 and 
4, and fraction 9 of above sucrose gradient were separately pooled and 
concentrated, and layered on top of two sucrose gradients. Centrifugation and 
fractionation were carried out as before. Graphs obtained are superimposed on 
each other. 
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3.2.5 Light scattering analysis of unfractionated and fractionated core particles 
The results of light scattering measurements on the purified but 
unfractionated HBcAg particles (corresponding to fractions 3-9 of Fig. 14a) are 
shown in Table 1. Guidelines used to interpret the polydispersity, base line and sum 
of squares (SOS) parameters in the monomodal analysis are summarised in 
the legend of Table 1. The unfractionated HBcAg particles were found to be 
polydisperse. Tables 2 and 3, respectively, represent the light scattering 
measurements on fractionated large (fractions 3 and 4 of peak 1, Fig. 14b) and small 
(fraction 9 of peak 2, Fig. 14b) HBcAg particles. Five to 10 measurements were 
taken at four different temperatures (4, 10, 20 and 30 or 37 °C) and their mean 
values are shown in the last row of each sub-table. For measurements indicating 
polydispersity with a low base line (1.002-1.005) and SOS noise (<20), a bimodal 
regression (Autopro, Dynamics) was utilised to resolve the size distribution more 
accurately, and each component is printed in italics below the measurements. 
The sample of large particles was generally monodisperse, for most of the 
measurements (24 out of 27) indicated a monodisperse size distribution which could 
be resolved with a single exponential autocorrelation decay function. Although three 
of the measurements at 4 and 20 °C showed polydispersity, bimodal regression 
analysis indicated two discrete populations in which a vast majority of the 
components were large HBcAg particles, as judged by the scattering amplitude 
recorded for the major component. The contaminants, which were present in a very 
small amount, are unlikely to be the small HBcAg particles because the molecular 
weight for the second component is less than one tenth that of the small HBcAg 
particles. The average DT increased as the temperature of the sample cell was 
increased, but the hydrodynamic radius (Rh) decreased and was estimated to be 20.6, 
19.2, 18.4 and 18.0 nm at 4, 10, 20 and 30 °C, respectively. 
Around one third of the light scattering measurements on the small core 
particles indicated polydispersity (Table 3), but in general the size distributjon of the 
particles was primarily monomodal as indicated by the low base line (<1.005). 
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# Ampa Diffnb Radius Polydc Estd MW Based sos e 
Coeff (nm) (nm) (kDa) line Error 
1 0.693 67 19.8 11.0 4046 1.021 147.029 
2 0.697 66 20.1 11.1 4182 1.025 131.795 
3 0.709 63 21.0 11.7 4662 1.022 127.706 
4 0.700 65 20.3 11.3 4318 1.022 120.734 
5 0.705 64 20.8 11.5 4559 1.022 122.476 
6 0.705 67 20.0 11.1 4158 1.016 105.937 
7 0.689 67 19.8 11.0 4044 1.024 99.847 
8 0.705 65 20.4 11.4 4369 1.015 104.235 
x 	0.700 	66 	20.3 	11.3 	4292 	1.021 	119.970 
Table 1: Light scattering measurements of unfractionated HBcAg particles at 4°C 
aAmplitude: the scattering amplitude recorded for this component. This is 
proportional to the intensity of the light scattered by particles of a given radius. 
bTranslational diffusion coefficient (D T) for this component (x10' 3m2/s) 
cPolydispersity value indicates the standard deviation of the spread of particle sizes 
(in nanometer) based on the average radius measured. If the value is less than 
15% of the average radius measured, it is reported as "-- ", which indicates a 
monodisperse solution, otherwise a value is generated for a polydisperse sample. 
dBase line parameter represents the completeness of the regression applied 
(autocorrelation function) during the analysis. A baseline of 1.000 indicates that 
the actual size distribution can be fully resolved by the theoretical single 
exponential autocorrelation function or standard Gaussian distribution. A 
monomodal regression with a high baseline indicates that the size distribution does 
not fit within a standard Gaussian distribution. Interpretation of base line 
parameters is as follows: 
Base line parameter 	 Interpretation 
	
0.997-1.001 	distribution is monomodal 
1 .002-1 .005 distribution is primarily monomodal 
> 1.005 	size distribution is polydisperse 
eSum of squares (SOS) parameter represents the amount of residual noise or error 
associated with the autocorrelation function. The higher the SOS parameter, the 
wider the size distribution. Interpretation of SOS parameters is as follows: 
SOS parameters 	 Interpretation 
1.000-5.000 	negligible error, low noise 
5.000-20.000 somewhat significant background error 
> 20.000 	high noise/error due to high polydispersity 
in size distribution 
#: number or measurement; : mean values; Estd MW: estimated molecular weight 
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(a)at4±O.5 °C 
# Ampa Diffn° Radius Polyd' Estd MW Based SOSe 
Coeff (nm) (nm) (kDa) line Error 
1 0.665 65 20.3 ---- 4296 1.000 5.531 
2 0.663 64 20.7 4484 1.004 3.250 
3 0.662 64 20.8 4566 1.003 3.529 
4 0.674 65 20.6 4436 1.002 4.422 
5 0.680 65 20.5 4396 1.006 6.285 
6 0.681 62 21.3 7.5 4826 0.999 4.452 
0.670 60 22.0 ---- 5212 0.997 1.678 
0.025 936 1.4 6 
7 0.672 64 20.6 6.0 4437 1.011 3.101 
0.629 59 22.1 5252 1.008 1.950 
0.050 186 7.1 336 
8 0.689 66 20.1 ---- 4176 1.002 5.483 
9 0.694 64 20.7 4486 1.005 3.643 
10 0.706 65 20.3 4314 1.002 2.900 
x 	0.679 	64 	20.6 	1.3 	4442 	1.003 	4.260 
(b)at 10±0.3°C 
1 0.608 83 19.0 3660 1.003 2.708 
2 0.550 82 19.5 3891 1.009 3.147 
3 0.595 82 19.4 3831 1.005 2.031 
4 0.621 83 19.1 3733 1.003 3.047 
5 0.642 84 18.9 3599 1.000 1.870 
x 0.603 83 19.2 	0.0 3743 1.004 2.561 
(c) at 20±0.3°C 
1 0.742 113 18.5 	5.4 3453 1.001 3.766 
0.734 110 18.9 3602 1.000 1.358 
0.030 2572 0.8 1 
2 0.731 115 18.4 3377 1.000 2.856 
3 0.723 115 18.4 3409 1.000 1.584 
4 0.713 116 18.1 3256 1.000 3.162 
5 0.722 114 18.5 3419 0.996 0.725 
6 0.719 116 18.3 3330 1.002 1.627 
0.725 115 18.4 	0.9 3374 1.000 2.287 
(d) at 30 ± 0.3 °C 
1 0.747 152 17.9 3167 1.001 1.140 
2 0.724 152 18.1 3241 1.002 3.521 
3 0.701 153 17.9 3158 1.002 2.083 
4 0.675 150 18.1 3281 1.001 3.710 
5 0.663 151 17.6 3265 0.998 14.529 
6 0.645 155 17.4 	---- 3034 1.001 7.574 
x 0.692 152 18.0 0.0 3139 1.001 5.426 
Table 2: Light scattering measurements offractionated large HBcAg particles 
Description of the data measured and calculated is shown in Table 1. The data for 
bimodal analysis are printed in italics. The temperature of the sample cell is shown 
on top of each table. 
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(a) at4±0.3 °C 
# Amps Diffnb Radius Polydc Estd MW B ased sose 
Coeff (nm) (nm) (kDa) line Error 
1 0.695 73 18.0 3226 1.010 3.564 
2 0.707 72 18.4 7.2 3411 1.004 6.748 
0.643 80 165 2582 0.984 3.702 
0.087 18 71.8 92162 
3 0.711 72 18.5 3427 1.003 4.473 
4 0.714 73 18.1 5.3 3279 1.008 3.772 
0.708 72 18.4 ---- 3393 1.007 1.220 
0.029 2844 0.5 0 
5 0.718 72 18.6 3489 1.004 4.627 
6 0.704 73 18.2 3305 1.004 3.383 
x 	0.708 73 18.3 2 3356 1.005 4.428 
(b)at 10±0.3°C 
1 	0.676 91 17.5 2984 1.005 3.372 
2 0.664 90 17.8 3122 1.001 4.671 
3 	0.648 92 17.3 6.8 2904 1.004 3.907 
0.444 117 13.5 1610 0.997 1.461 
0.214 54 29.1 10325 
4 	0.651 91 17.5 2984 1.001 4.228 
5 0.650 91 17.6 3032 1.002 3.581 
6 	0.633 90 17.7 6.9 3080 1.001 4.689 
0.612 85 18.7 3525 0.999 1.867 
0.035 627 2.5 27 
x 	0.654 91 17.6 2.3 3018 1.002 4.075 
(c)at2O±0.3°C 
1 	0.734 128 16.4 5.8 2557 1.004 4.653 
0.716 122 17.0 2805 1.003 1.831 
0.034 1101 1.9 ---- 13 
2 	0.735 129 16.4 2556 1.003 2.535 
3 0.706 128 16.5 2596 1.002 4.325 
4 	0.716 130 16.2 5.6 2490 1.001 4.571 
0.705 126 16.7 ---- 2659 1.000 1.264 
0.035 2221 0.9 2 
5 	0.706 127 16.6 2630 1.000 2.958 
x 0.719 128 16.4 2.3 2566 1.002 3.808 
(d) at 37 ± 0.4 °C 
1 	0.643 204 15.9 2382 1.003 9.843 
2 0.617 199 16.2 6.3 2498 1.002 9.668 
0.363 277 11.6 1111 0.998 6.357 
0.265 128 25.0 7149 
3 	0.591 210 15.6 2267 1.005 17.328 
4 0.553 197 16.4 2567 1.004 10.592 
5 	0.525 200 16.3 2520 0.999 18.088 
6 0.490 209 16.5 2240 1.005 29.791 
x 	0.570 203 16.0 1.1 2412 1.003 15.885 
Table 3: Light scattering measurements offractionated small HBcAg particles 
Description of the data measured and calculated is shown in Table 1. The data for 
bimodal analysis are printed in italics. The temperature of the sample cell is shown 
on top of each table. 
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Bimodal analysis of the polydisperse measurements showed that the solution 
contains a small amount of larger size molecules with a radius two- to five-times 
bigger than the average radius of small HBcAg particle (# 2 of a, # 3 of b, and # 2 of 
d). Small molecules, less than 30 kDa, were also detected (# 4 of a, # 6 of b, # 2 and 
# 4 of c), but the solution was free of the large HBcAg particle. The average radius 
of small HBcAg particle was estimated to be 18.3, 17.6, 16.4 and 16.0 nm at 4, 10, 
20 and 37 °C, respectively. 
3.2.6 Reducing and non-reducing SDS-PAGE of LlIBcAg particles 
Fig. 15a shows the results of SDS-PAGE of unfractionated truncated, 
unfractionated full-length, and fractionated large and small full-length 1{BcAg 
particles, under reducing or non-reducing conditions. The densities of bands in lanes 
2 to 9 of the gel were quantitated with ImageQuant software (Molecular Dynamics) 
which reported the results as line graphs and the area under each peak was expressed 
as a percentage of the total (Fig. 15b). 
The unfractionated truncated HBcAg protein migrated as a single band at 
the expected apparent molecular mass of a monomer, -17 kDa, under reducing 
conditions (Fig. 15a and b, lane 2). Under non-reducing conditions, -83% of the 
protein migrated as monomers of -17 kDa, and -17% as dimers of -34 kDa (Fig. 
15a and b, lane 3). When unfractionted full-length, and fractionated large and small 
full-length HBcAg particles were analysed on reducing SDS-PAGE, -50% of the 
protein migrated as a sharp band with an apparent molecular mass of -22 kDa, and 
the other half of the protein migrated with a greater mobility forming a diffuse 
banding pattern (Fig. 15a and b, lanes 4, 6 and 8). Under non-reducing conditions, 
-40% of the protein did not enter the gel, - 20 to 30% migrated as a diffuse band in 
the region of the dimer with apparent molecular mass between 34 and 42 kDa, and 
-30% migrated as monomer and smear bands as observed under the reducing 
conditions (Fig. 15a and b, lanes 5, 7, and 9). 
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Fig. 15: 
SDS-PAGE of HBcAg particles under reducing and non-reducing conditions. 
An aliquot (2 pg) of unfractionated particles of truncated (lanes 2 and 3), and full-
length HBcAg (lanes 4 and 5), fractionated large particles of full-length HBcAg 
(lanes 6 and 7), and fractionated small particles of full-length HBcAg (lanes 8 and 
9) was added to 2x SDS loading buffer (1 vol) in the presence of DTT (200 mM, 
reducing conditions, lanes 2, 4, 6, and 8) or absense of DIT (non-reducing 
conditions, lanes 3, 5, 7, and 9). All samples, reduced or non-reduced, were boiled 
for 5 min prior to electrophoresis. Cooled samples were loaded into the wells of a 
15% SDS-polyacrylamide gel for electrophoresis. The gel was stained with 
Coomassie blue and dried between two sheets of cellulose membrane backing. 
Lanes 1 and 10 are molecular weight markers under reducing condition. 
Scanning and quantitation of bands along gel tracks of the above gel. 
With Image Quant software a rectangle was drawn along lanes 2 to 9 and the 
average pixel value along the rectangle was integrated and the results plotted as a 
line graph. Each graph corresponds to a lane of the above gel which is shown in the 
upper left corner of each graph. The area under the peaks was expressed as a 
percentage of the total and is shown on top of the peaks. The units on the y axis are 
arbitrary. 
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3.3 Discussion 
HBcAg is highly enriched in Arg residues particularly in the C-terminal 
region. 46% of these residues are encoded by the triplet AGA and more importantly, 
67% of these codons in the reading frame are clustered at the 3'-end of the HBcAg 
mRNA. Codons AGA and AGG, are amongst the rarest codons in genes of E. coli, 
AGA occurring at the level of 2.4% of total Arg codons and 0.14% of all codons 
(Aota et al., 1988). Direct measurements of the level of AGA tRNA have shown 
that it is present in extremely low concentration during all phases of cell growth 
(ilcemura, 1982; Saxena and Walker, 1992; Emilsson et al., 1993). As far as the 
HBcAg gene is concerned, there is overall bias towards the use of this extremely rare 
codon to synthesise the product. Furthermore, it has been known through the works 
of Zheng et al (1992) and Stewart (1993) that the expression of truncated HBcAg, 
which lacks the Arg-rich C-terminal region, is much greater than that of full-length 
HBcAg. 
The result presented in section 3.2.2 showed that supplementation of E. coli 
with T4 AGA tRNA resulted in a 50% increment in HBcAg synthesis as measured 
by SDS-PAGE of crude cell extracts. A two-fold increment was observed when the 
sucrose gradient purified HBcAg particles was measured by the Bradford assay. The 
former quantitation method showed a lower increment in the protein synthesis 
because only the 22 kDa intense band was taken into consideration and it is clear 
from the SDS-PAGE of purified HIBcAg particles that the HBcAg monomers, not 
only migrated as an intense band with an apparent molecular weight of 22 kDa, but 
nearly half of the proteins migrated as a smear below the sharp band. If the less 
intense bands were taken into account the increment is expected to be higher than 
50%. 
Further analysis of the smear bands with sequencing showed that the proteins 
have the same N-terminal sequence with the 22 kDa monomer. This suggests that 
around 50% of the HBcAg monomers have probably been proteolysed near the C-
terminus, or prematurely terminated during the translation process due to 'queueing' 
of ribosomes at the 3'-end of HBcAg mRNA which is extremely rich in Arg codons. 
Attempts were made to eliminate the smaller species and hence improve the yield of 
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HBcAg by expressing the protein in a protease deficient strain (SG935), but no 
improvement was achieved. An unsuccessful effort was also reported by Theng et 
al., (1992) who tried to eliminate the low molecular weight species by inclusion of 
protease inhibitors. Besides, it has been shown by several groups that rare codons 
can induce premature termination (Robinson et al., 1984; Misra and Reeves, 1985); 
frameshifting (Spanjaard and Van Duin, 1988), and decoupling of transcription from 
translation (Bonekamp and Jensen, 1988; Sorensen et al., 1989), which in turn can 
lead to strong negative overall effects on the gene expression. Therefore it is likely 
that the rare Arg codons at the 3'-end of the HBcAg mRNA causes heterogeneity of 
the monomer which migrated with different mobility in a SDS-polyacrylamide gel. 
The yield of full-length HBcAg is significantly improved by T4 AGA tRNA 
supplementation but the level of expression is still not as high as that of truncated 
HBcAg, which was estimated to be five-fold higher than that of full-length HBcAg. 
This suggests that other factors might contribute towards the low level. These 
include: (i) the protamine-like region might be, to some extent, toxic to the host cell 
because several groups have demonstrated that this region has a non-specific nucleic 
acid binding motif which incorporates the host cell's nucleic acids into BIB cAg 
particles (Borissova et al., 1989; Gallina et al., 1989; Birnbaum and Nassal, 1992; 
Ulrich et al., 1993), and indirectly, this might affect the overall level of gene 
expression; (ii) the mRNA of full-length HBcAg might adopt different secondary 
structure from that of truncated HBcAg, because the former is longer and its 3'-end 
contains a high frequency of Arg codons, which could make the transcript less 
stable and more susceptible to degradation by RNase. 
Using cryoelectron microscopy and image reconstruction, Crowther et al., 
(1994) showed the large and small particles of 1H1BcAg comprise 240 and 180 
subunits, respectively. Assuming the molecular mass of a subunit as 22 kDa and no 
nucleic acid is incorporated in HBcAg particles, the large HBcAg particle would 
have a mass of —5,280 kDa, and the small particle —3,960 kDa. By exploiting the 
difference in mass between the two different sizes of HBcAg particle, it is possible, 
in principle, to separate these particles with sucrose gradient centrifugation. Indeed, 
as expected, the large and small HBcAg particles sediment at different positions on a 
8-40% sucrose gradient at 100,000 xg. Nearly five months after this observation, 
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Zlotnick et al. (1996) published a similar finding. 	Using an analytical 
ultracentrifugation they showed that large and small particles sendiment at 45s and 
40s, respectively. 
Light scattering analysis of the two species resolved on a sucrose gradient 
showed that their size distribution is primarily monodisperse and no appreciable 
cross contamination was observed between the two species. In some measurements, 
particularly for small HBcAg particles, small amounts of lower and higher molecular 
weight particles were detected. This may be due to broken or aggregated HBcAg 
particles during preparation of the sample for analysis. It appears that the 
hydrodynamic radius (Rh) of the large and small HBcAg particles, derived from DT, 
using the Stokes-Einstein equation (Method 2B.8.v), is reduced when the 
temperature of measurements was increased (from 4 °C to 30 °C or 37 °C). A 
possible explanation for this observation is that the formula in the software linked 
directly to the light scattering instrument assumes that the viscosity of water 
(T=1.019x10 3 Nsm 2) remains constant at different temperatures. In fact the 
viscosity of the solution used (50 mM Tris-HC1, 100 mM NaCl) is higher than this 
and decreases as the temperature increases. The average Rh calculated for the large 
and small HBcAg particles at different temperatures (4, 10, 20 and 30 or 37 °C) is 
estimated to be 19 and 17 nm, respectively, which is 2 nm longer than that 
determined by Crowther and colleagues (1994) with cryoelectron microscopy and 
image reconstruction. However, the difference in size (diameter) between the large 
and small HBcAg particles determined by light scattering is in good agreement with 
their measurements. 
Both the large and small HBcAg particles gave identical results when 
analysed on SDS-PAGE, under reducing or non-reducing conditions, suggesting that 
the particles are made up from the same building blocks. Under reducing conditions, 
these particles showed heterogeneity in monomer, even though the particles were 
generally found to be monodisperse in size distribution. Zheng et al., (1992) 
reported that the last amino acid of the monomer, Cys 183, is always involved in a 
disulphide bond with the Cys 183 of a different monomer to form a dimer, and Cys 
61 always forms an additional disulphide bond with the identical residue between 
Chapter 3: HBcAg Particles: yield improvement, heterogeneity and fractionation 72 
two dimers. If this is, indeed, the case and all the full-length HBcAg monomers are 
homogenous in length, the protein would have not entered the gel under non-
reducing conditions due to the formation of a large lattice of protein between the 
monomers. However, it appears that only a part of the protein (40%) did not enter 
the gel and the rest migrated as a dimer of variable size and corresponding monomer 
bands. The N-terminal sequence analysis showed that some of the monomers most 
probably lack the C-terminus, either caused by premature termination of translation 
or protease degradation, thus eliminating the possibility of disulphide bond 
formation between two Cys 183 residues. Another possibility is that Cys 61 is 
partly, but not always, involved in interchain disulphide bonds because some of the 
full-length HBcAg did, in fact, migrate as a monomer and, moreover, most of the 
truncated HBcAg (-80%) migrated as monomer under non-reducing conditions. 
In summary, the three questions addressed earlier in this chapter have been 
answered: (i) the yield of full-length HBcAg expressed in E.coli can be improved by 
T4 AGA tRNA supplementation. This approach substantially reduced the time and 
cost spent to produce and purify the protein in bulk for further characterisation; (ii) 
the large and small HBcAg particles can be separated by sucrose gradient 
centrifugation. This method, although time consuming, is capable of consistently 
producing homogeneous HBcAg particles, and allows studies to be done on the 
interaction of the two different sizes of HBcAg particle with surface proteins and 
fusion-phages; (iii) clearly, full-length HBcAg subunits that assemble into HIBcAg 
particles are heterogeneous at their C-terminus. However, more work would have to 
be carried out to clarify whether the heterogeneity is caused by incomplete synthesis 
of the protein or protease degradation of the carboxy end. 
Chapter 3: HBcAg Particles: yield improvement, heterogeneity and fractionation 73 
CHAPTER 4 
MUTAGENESIS AND IN VITRO 
EXPRESSION OF SURFACE ANTIGEN 
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4.1 Introduction 
The mutagenesis strategies applied in this study were based upon the 
information obtained from affinity selection from bacteriophage display libraries 
against HBcAg (Dyson and Murray, 1995). A peptide sequence of LLGRMK and 
some related sequences that should mimic the docking site on the HBcAg particle 
were selected; moreover, the interaction between HBsAg and HBcAg was inhibited 
by the synthetic peptide ALLGRMKG. However, this specific sequence was not 
found in HBsAg, but two related sequences did occur: residues 63-65 (LLG) in the 
PreS 1 region and residues 21-26 (LLTRIL) of the S region. This suggests that at 
least some of the amino acids of the hexapeptide sequence may be brought together 
in the folded protein of HBsAg to form an essential contact area for HBcAg. 
Therefore, progressive deletion of the N- and C-termini of L-HBsAg was performed 
to define the minimum stretch of amino acids that contains the exact contact 
residues. 
4.2 Results 
4.2.1 N-terminal deletion mutagenesis of L-HBsAg with BAL 31 exonuclease 
The steps involved in generating a series of N-terminal truncated L-HBsAg 
are schematically represented in Fig. 16: (i) plasmid pMDHB53, which contains an 
insert of 1.35 kb L-HB5Ag coding region, was linearized with Eco RI, (ii) a set of 
deletions from both ends of the plasmid was generated by digestion with BAL 31 
exonuclease, (iii) the 5'-end deleted L-HB sAg coding sequence was separated from 
the vector by digestion with restriction endonuclease Sal I and agarose gel 
electrophoresis, (iv) the deleted fragments were then eluted from the gel and ligated 
to M13mp18 vector that had been digested with Sal I and Sma I, (v) ligation 
products were used to transform E. coli strain TG- 1, (vi) well isolated colourless 
plaques of transformants were propagated in TG-1 cells, ssDNA was extracted from 
the bacteriophage and sequenced, (vii) RF DNA harbouring the desired deletions 
were extracted from the cells, (viii) the deleted L-HBsAg DNAs were released from 
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Fig. 16: Schematic representation of the steps involved in generation of a series of 
N-terminal deletion mutants of L-HB5Ag 
PlasmidpMDHBs3 contains an insert of 1.35 kb of the L-HBsAg gene. The vector is 
located in the polycloning site of the pCITE-2c vector, with the Eco RI and Sal I 
sites at the 5'- and 3 '-ends, respectively. Immediately upstream of this insert is a 
586 bp copy of the encephalomyocarditis virus (EMC) RNA 5' non-coding region 
which initiates translation by eukaryotic ribosomes. This region is known as Cap-
Independent Translation Enhancer or CITE. The CITE sequence is located 
downstream of the 77 promoter to provide efficient transcription with 77 RNA 
polymerase. Refer to text for the explanations of the steps involved in generation of 
N-terminal deletion mutants(section 4.2.1, pg 75). 
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the M13mp18 vector and inserted into pC1TE-2c vectors, (ix) in vitro transcription 
and translation were carried out to produce the N-terminal truncated L-1{B sAg. 
A total of 69 transformants were analysed with DNA sequencing, from which 
30 mutants ranging from 1 to 150 amino acids deleted from the N-terminus of L-
HBsAg were obtained. Around two thirds of the deletions altered the ORF of the L-
HBsAg gene. Mutants N16, NA24, NMO, NA54, N60, N77 and Nz\126 gave 
rise to a correct reading frame in the pC1TE-2c vector were transcribed with 17 
RNA polemerase, and their mRNAs were translated with rabbit reticulocyte lysates 
supplemented with [35S]-methionine. To ensure that the proteins expressed were of 
the correct size, aliquots of the translation reactions were subjected to SDS-PAGE 
(Fig. 17). Translation of the L- and S-FIBsAg mRNAs produced bands of 39 kDa 
and 24 kDa, respectively, which correspond to the unglycosylated forms of the L-
and S-FIBsAg. Translation of the deletion mutants gave rise to protein bands that 
decrease gradually in molecular mass depending on the number of amino acids that 
have been deleted. In addition, the intensity of the deletion protein bands decreased, 
especially NA126 and S-HB5Ag, due to the deletion of the Met residues in the PreS 
regions. 
4.2.2 C-terminal deletion mutagenesis of L-HBsAg 
The coding segment of L-HBsAg was excised from pMDHBs3 and cloned 
into the RF DNA of M13mp18 that had been digested with Eco RI and Sal I. Uracil-
containing ssDNA was prepared from E. coli strain CJ236 and stop codons were 
introduced at various positions in the coding sequence by oligonucleotide-mediated 
mutagenesis. The C-terminal deletion mutants are schematically represented in 
Fig. 1 8a. and the stop codon introduced is indicated at the end of each construct. 
The five shortest mutants (CA108, Ci136, CA163, CA191and Cz210) were 
constructed by Dr. M.R. Dyson, and the nucleotide changes for the other mutants 
(CA242, CA263, Ct322, C346 and CA371) as determined by DNA sequencing are 
shown in Fig. 18b. The coding sequences of these mutants were then excised from 
Ml 3mp 18 and inserted into pCITE-2c vectors to serve as template for transcription. 
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Fig. 17(a): Schematic representation of L4tBsAg and the N-terminal deletion 
mutants. 
The diagram at the top represents the postulated domain organisation of L-HBsAg. 
The L-HBsAg of HBV subtype adyw is 389 amino acids long with three major 
regions: PreSl (residues 1-108); PreS2 (residues 109-163); and S (residues 164-
389). Four predicted transmembrane he/ices (Stirk et al., 1992) in the S region are 
indicated by circles. I (residues 171-191); II (residues 240-261); III (residues 323-
347); and IV (residues 352-3 72). The lines beneath the L-HBsAg represent the N-
terminal deletion mutants. The number at the beginning of each mutant indicates 
the number of residues deleted from the N-terminus of L-HBsAg. The abbreviated 
descriptions of the mutants are shown at the right of each mutant 
(b): In vitro translation products of the N terminal deletion mutants 
Lanes: 1 (L-HBsAg); 2 (NA16); 3 (N424), 4 (NA40); 5 (NA54); 6 (NA60); 7 (NA 77); 
8 (NA126); 9 (S-HBsAg), and 10 (negative control; minus nzRNA). Molecular 
weight standards in kDa are shown on the left of the gels. Aliquots (0.5 p1) of in 
vitro translation reaction mixtures were separated by 15% SDS-PAGE. The gel was 
dried and the products visualised by autoradiography after overnight exposure. 
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Fig. 18: 
Schematic representation of L-HBsAg and C-terminal deletion mutants 
The diagram at the top represents domain organisation of L-HBsAg. C-terminal 
deletion mutants are shown beneath the L-HBsAg. The number at the end of each 
mutant indicates the final amino acid in the mutant. Each mutant was named as 
shown at the left. 
Nucleotide sequence of C-terminal deletion mutants 
Each panel represents an electrophero gram obtained from automated sequencing of 
a mutant. The nucleotide sequence of the non-coding strand is shown, read from left 
to right, 3' to 5'. The nucleotide changes are indicated by . Stop codons 
introduced in the mutants are as follows (expressed as coding sequence, i.e. 
complementary to the sequence read from the traces): CA242 (T17'-243--9TAG); 
C4263 (CAA-264--TAA); Ci322 (AAA-323--TAA); Cii346 (GTA-347--4TAA) and; 
Cii371 (TFG-372 —TAG). 
In vitro translation products of the C-terminal deletion mutants 
Lanes: 1 (CA108); 2 (CA136); 3 (CL1163); 4 (CA191); 5 (Czt210); 6 (C4242); 7 
(C4263); 8 (Cii322); 9 (Cii346); 10 (CA371); and 11 (L-HBsAg). Molecular weight 
standards in kDa are shown on the left of the gels. Aliquots (0.5 41) of in vitro 
translation reaction mixtures were separated by 15 % SDS-PAGE. The gel was 
dried and the products visualised by autoradiography. 
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In vitro translation was subsequently performed in rabbit reticulocyte lysates 
supplemented with [35S]-methionine and the products analysed on SDS-PAGE 
(Fig. 18c). 
4.2.3 Random mutagenesis of LLG (63-65) of the PreSi region 
Since the peptide sequence LLG (63-65) was implicated in the mimotope 
formation, oligonucleotide-mediated mutagenesis was carried out to change these 
amino acids. Two degenerate oligonucleotides were designed: L64Random and 
L63/G65Random. L64Random introduces changes at codon 64 (Leu) to 14 other 
possibilities, whereas L63/G65Random mutates Leu (63) and Gly (65) together to 
give rise to 196 possible mutations. 
For the first attempt of this experiment, a 30:1 ratio of oligonucleotide to 
template was used. Twenty of the transformants derived from the mutagenesis 
reaction with L64Random were sequenced but no mutant was obtained. From the 
mutagenesis reaction with L63/G65Random, 22 out of the 36 sequenced 
transformants proved to be mutants (Table 4a), but most of them were single base 
changes. This shows that the conditions used favoured single base mutation. 
In order to introduce mutations at codon 64 (Leu) using oligonucleotide 
L64Random and to increase the double mutation at codon 63 (Leu) and 65 (Gly) 
with oligonucleotide L63/G65Random, the oligonucleotide:template ratio was 
reduced to 10:1. In addition, the oligonucleotide-template annealing conditions were 
altered: for L64Random, the mixture was heated at 80 °C for 5 min and then plunged 
immediately into ice water; for L63/G65Random, the mixture was heated at 80 °C 
for 5 min and then allowed to cool down at room temperature. Ten transforrnants 
from each mutagenesis reaction were sequenced. The former reaction produced 
three mutants (Table 4b) and nine out of the ten transformants of the latter reaction 
were mutants (Table 4c), most of them being double base changes. Mutants L63H, 
L64E, G65R, L631UG65R and L63A1G65E were selected for further analysis and 
their nucleotide changes are shown in Fig. 19. 
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(a) 
L(63) 	L(64) G(65) no of transformants 
CIT TTG GGG 14 
A(H) 2 
G(R) 1 
C(P) . 1 
GC(A) 1 
A(H) C 	(R) 1 
C (R) 4 
A 	(R) 2 
I (W) 5 
C 	(A) 1 
A (E) 1 
I 	(V) 3 
(b) 
L(63) 	L(64) 	G(65) 	no of transformants 
CTT TTG GGG 7 
GA(E) 	 1 
G (V) 1 
C 	(S) 	 1 
(c) 
L(63) 	L(64) G(65) no of transformants 
CIT TTG GGG 1 
C(P) 1 
GC (A) A 	(B) 1 
C (P) AC (R) 1 
GC(A) C 	(R) 1 
AC(T) A (R) 1 
AT(M) 1 
CC 	(P) 1 
TA (amber) 1 
C 	(R) 1 
Table 4: Random Mutagenesis of LLG(63-65) of PreSi 
The codons encoding LLG(63-65) are shown on the second row of each table, 
underline indicates the mutated nucleotides. The nucleotide changes for every 
mutant are shown beneath the codon and the corresponding amino acid is shown in 
parentheses. (a) The muta genesis reaction was performed with oligonucleotide 
L63/G65Random using a 30 to 1 primer:template ratio, heated at 80 °C for 5 mm 
and allowed to cool slowly to room temperature by putting in water at 80 °C. (b) 
The muta genesis reaction was performed with oligonucleotide L64Random using a 
10 to 1 primer:template ratio, heated at 80 °Cfor 5 min and plunged into ice water. 
(c) The muta genesis reaction was performed with primer L63/G65Random using the 
conditions in (b) but the primer-template mixture was allowed to cool to room 
temperature. 
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Fig. 19: Nucleotide sequence of mutants at codons 63-65 (LLG) of PreSl 
region. 
The nucleotide sequences of the non-coding strands are shown on the left, starting 
from the horizontal line to the left of the photographs of the autoradio graphs and 
reading upwards, 5' to 3'. Lanes from left to right represent A, C, G and T. 
Mutants L63H, G65R, L63H/G65R and L63A/G65E were generated using 
mutated oligonucleotide L63/G65Random. Mutant G64E was generated using 
oligonucleotide L64Random. Mutated nucleotides are indicated by *• The codons 
encoding LLG (63-65) and the changes introduced are shown in Table 4. 




























































4.2.4 Substitution of positively charged amino acids with alanine 
Since two out of six residues of the selected sequence, LLGRMK, from the 
fusion phage library are positively charged, it is likely that some of the positively 
charged amino acids in the PreS regions and helix I, might be brought together to 
form a discontinuous docking site for HBcAg. Furthermore, charged amino acids are 
more likely to be located on the surface of a protein (Chothia, 1976; Janin 1979), 
and substitution of these residues is less likely to cause structural perturbations 
because residues exposed to solvent are more tolerant to variation (Bowie et al., 
1990). The charged residues are also capable of forming hydrogen bonds and ion 
pairs and are therefore likely to be involved in the recognition of ligands. To 
investigate this further, Lys-38 and Arg at positions 88, 92, 102, 124, 126, 156 and 
187 were individually substituted with Alanine. Alanine was chosen as a 
replacement residue because it is commonly located in both buried and exposed 
positions, and most importantly, it does not contribute new hydrogen bonding, 
sterically bulky, or unusual hydrophobic side chains. As shown in Fig. 20 the first 
two nucleotides of the codons code for these residues were mutated to G and C 
by site directed mutagenesis. It is quite likely that more than one residue from 
different segments of L-HBsAg may be involved in the contact with HBcAg, 
therefore two to five amino acids were substituted simultaneously to evaluate the 
contribution of certain amino acids towards the interaction (Fig. 21). An additional 
quintuple mutant (L63H1R88A1R92A/R102AIR187A+4a.a), containing a 4-amino 
acid (QPTP) insertion at position 97 of PreS 1 which occurred erroneously during 
mutagenesis, was also analysed. The mutated coding regions were inserted into the 
pCITE-.2c vector to serve as template for in vitro transcription and translation. SDS-
PAGE analysis showed that all the mutated proteins were expressed at levels 
comparable to that of the wild-type (data not shown). 
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Fig. 20: Substitution of positively charged amino acids with alanine 
The non-coding sequences of wild-type and mutants are shown at the left and right, 
respectively, of each panel. All sequences are read from left to right, ACGT, and 
from bottom to top, 5' to 3'. Mutation of Arg and Lys codons required substitutions 
of the first and second nucleotides with G and C; these are indicated by *• The 
nucleotide sequence of mutant K38A was analysed with an automated sequencer 
and the sequence from left to right represents the non-coding strand from 5' to 3'. 
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Fig. 21: Positively charged amino acid substitutions and multiple mutations in 
the PreS regions and helix I of L-HBsAg. 
The top diagram represents the PreS regions and a part of the S region of L-HBsAg. 
The positions of amino acid substitutions are indicated on the top of the diagram. 
Single amino acid mutations are indicated by arrows. Multiple mutations are shown 
on the lines beneath the arrows. The abbreviations of the multiple mutations are 
shown at the left below each mutant. 
4.3 Discussion 
The structure of HBsAg is not known at present, although models for the 
topology of the S-, M-, and L-HBsAg in the ER membrane have been proposed 
based on computer modelling (Stirk et al., 1992; Berting et al., 1995), binding of 
monoclonal antibodies (Heermann et al., 1984), antigenic determinants (Gavilanes et 
al., 1982), post-translational modification and protease accessibility (Bruss and 
Ganem, 1991b; Bruss et al., 1994; Ostapchuk et al., 1994; Bruss and Vieluf, 1995; 
Prange and Streeck, 1995). However, there has been no chemical or structural 
analysis of the lipid component of the virion, which also might play a role in the 
structural organisation of the HBsAg. The only hint suggesting the region in HBsAg 
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which might directly interact with HIBcAg was obtained from affinity selection from 
fusion phage display libraries with HBcAg (Dyson and Murray, 1995), but the 
region, LLGRMK, implicated in binding with FIBcAg appears to be a discontinuous 
sequence in which the residues constituting this region are brought together from 
different positions in the L-HBsAg. Therefore large number of deletion and amino 
acid substitution mutants were generated and the effect of these mutations on the 
interaction with HBcAg is discussed in detail in chapter 5. 
Rabbit reticulocyte lysates, an eukaryotic cell free system, were chosen to 
express the mutated HBsAg because attempts in our laboratory to overexpress the 
full-length L-HBsAg in E. Coli have so far failed (M.R. Dyson and S.A. Petukhov 
personal communication). Although HBsAg has been successfully overproduced in 
yeast and animal cells (Valenzuela et al., 1982; Murray et al., 1984), the proteins 
synthesised form particles having similar properties to the 22 nm particles released 
by virally infected human cells, which would not be suitable for the study of the 
interaction between HBsAg and HIBcAg, particularly in determination of the regions 
and amino acids forming the contact area with HBcAg. For this study, rabbit 
reticulocytes offered several advantages: (i) the ability to incorporate amino acids 
labelled with [35S]-methionine  into HBsAg which allows detection of the labelled 
protein by autoradiography, phosphoimager, or scintillation counting; (ii) it can be 
used conveniently to verify the size of a mutant synthesised from a modified gene; 
(iii) reducing agents such as DTT can be added to avoid the formation of disuiphide 
bonds, which is particularly important for HBsAg because it has been shown that 
S-HBsAg forms dimers and oligomers in the secreted subviral particle (Huovila et 
al., 1992; Wunderlich et al., 1996). The major limitation of this system is that only 
a very small amount of product is synthesised in a reaction, estimated to be around 
10 15  mole per .tl of reticulocyte. 
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CHARACTERISATION OF THE INTERACTION 
BETWEEN SURFACE AND CORE ANTIGENS 
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5.1 Introduction 
The PreS regions of L-HB sAg contain the hepatocyte receptor binding site 
(Neurath et at., 1986) and have been found on the external surface of 
HBV(Heermann et at., 1984; Kuroki et at., 1990; Mimms et al., 1990). They have 
also been found in the cytosolic side of cellular membrane vesicles (Bruss et at., 
1994; Ostapchuck et al., 1994; Bruss and Vieluf, 1995; Prange and Streeck, 1995). 
These findings suggest two crucial roles for these regions: (i) attachment of the 
virion to host cells and; (ii) virion assembly. The second function of the PreS 
regions was further supported by the observation that in a cell free system, 
nucleocapsids interact directly with L-HBsAg, but not with S-HBsAg (Dyson and 
Murray, 1995). Furthermore, L-HBsAg produced in the absence of microsomal 
membrane was still able to interact with nucleocapsid (Dyson and Murray, 1995), 
indicating that the interaction does not require post-translational processing of the L-
H1BsAg such as membrane translocation (Eble et al., 1986), acylation (Persing et at., 
1987) or glycosylation (Patzer et al., 1986), which occur naturally in vivo. However, 
the exact docking site for HBcAg and specific amino acids involved in the 
interaction have not yet been identified. The goal of the work described in this 
chapter was to evaluate the effects of deletion and specific amino acid substitutions 
of the L-HBsAg (Chapter 4) on the interaction with HBcAg. To further understand 
the strength of the interaction that ultimately provides insight into the basic 
principles governing the virion assembly in host cells, an equilibrium binding assay 
in solution was established which allows the determination of relative dissociation 
constants. 
5.2 Results 
5.2.1 Immunoprecipitation with anti-HBcAg rabbit serum 
Jnimunoprecipitation of the N- and C-terminal deletion mutants (Chapter 4) 
was performed following their interaction with HBcAg in order to define the 
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minimum contiguous sequence of amino acids required in L-HBsAg. At first 
translation reactions with the mutants were carried out in the presence and absence 
of HIBcAg, then anti-HBcAg rabbit serum was added to form immune complexes 
with HBcAg. Staphylococus protein A covalently linked to sepharose beads 
(Goding, 1978) was used to precipitate the antibody-antigen complexes. The 
complexes were dissociated by heating in SDS-loading buffer, fractionated by 
SDS-polyacrylamide gels, and the surface antigen mutants were detected by 
autoradiography and phosphoimager analysis. 
Fig. 22 shows the immunoprecipitation results with the N-terminal deletion 
mutants. In the presence of HBcAg, a major band of immunoprecipitated product 
was obtained with full-length L-HBsAg, NA16 and N24, but the intensity of the 
precipitated band significantly decreased with NA40, N54 and Nz60, and only a 
very small amount of precipitated product was detected with N77, NM26 and 
S-FIBsAg after prolonged exposure (second lane of each mutant). These bands were 
absent from the precipitation of translation reactions that did not contain HBcAg 
(last lane of each mutant). Phosphoimager analysis further supported the observation 
that deletion of 40 amino acids from the N-terminus dramatically reduced the 
interaction, but deletion of 126 residues from the same end did not completely 
abolish it (Fig. 23). 
On the other hand, immunoprecipitation of the C-terminal deletion mutants 
showed that protein bands of CA191, C210, CA242, C263, CA322, CA346 and 
CA37 1 were brought down by anti-HBcAg rabbit serum in the presence of HBcAg 
(Fig. 24 second lane of each mutant). However, no immunoprecipitation products 
were observed for CA 108, CA 136 and CA 163. The negative controls performed in 
the absence of HBcAg gave small quantities of precipitate with mutants CA191 and 
longer (last lane of each mutant), which was probably caused by non-specific 
binding of the polyclonal serum to the translation products. However, these 
background bands were very faint compared to those in the presence of HBcAg. 
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Fig. 22: Immunoprecipitation of N-terminal deletion mutants with ~ 
rabbit anti-HBcAgpolyclonal serum. 
The mutants are indicated in the box on top of everyfour lanes. For each mutant, in 
vitro translation was carried out in the presence (+) or absence (-) of HBcAg (lanes 
1 and 3for each mutant). immunoprecipitation (+) was then performed with rabbit 
anti-HBcAg serum (lanes 2 and 4 for each mutant). Numbers to the left of each gel 
show the positions of molecular weight standards expressed in kDa. Translation 
and immunoprecipitation products were examined by 15% SDS-PAGE and 
autoradiography. The period of exposure for (a),(b) and (c) was 12 h, and for (d) 











N-terminal deletion mutants 
Fig. 23: Phosphoimager quantitation of immunoprecipitation products 
of N-terminal deletion mutants. 
The ratio of the immunoprecipitation product for each construct was calculated 
with the following formula: (counts of the major immunoprecipitation band in lane 
21counts of the major translation product in lane 1) - (counts of the background 
band in lane 41counts of the major translation product in lane 3), and the 
percentage (%) of immunoprecipitation product was calculated by considering the 
precipitated product of L-HBsAg as 100%. 
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Fig. 24: Immunoprecipitation of C-terminal deletion mutants with 
rabbit anti-HBcAg polyclonal serum. 
The mutants are indicated in the box on top of everyfour lanes. For each mutant, in 
vitro translation was carried out in the presence (+) or absence (-) of HBcAg (lanes 
1 and 3 of each mutant). Immunoprecipitation (+) was then performed with rabbit 
anti-HBcAg serum (lanes 2 and 4 of each mutant). Numbers to the left of each gel 
show the positions of molecular weight standards expressed in kDa. Translation 
and immunoprecipitation products were examined by 15% SDS-PAGE and 
autoradiography. 
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5.2.2 Development of an equilibrium binding assay in solution 
The method employed here for measuring relative dissociation constants 
(Kd') between HBsAg and HBcAg in solution was first described for antibody-
antigen reactions (Friguet et al., 1985) and later adapted and modified for general 
use to determine the affinity constants of C4BP-HPS (C4b-binding protein with 
human protein S; Nelson and Long, 1991) and fusion phage-substrate complexes 
(Dyson et al, 1995) in solution. In the established assay, various concentrations of 
HBcAg were incubated with a constant concentration of [ 35S]-HIB5Ag, that had been 
synthesised in a cell free system, until equilibrium was reached. The concentration 
of free [35S]-HBsAg at equilibrium was quantitated by incubating an aliquot of the 
reaction mixture in HBcAg-coated wells for a short time period; wells were then 
washed and bound [35S]-HB5Ag  was measured by scintillation counting of 
radioactivity. 
The method is only valid if the following four criteria are fullfilled: (i) the 
temperature is kept constant throughout the experiment; (ii) the binding equilibrium 
is reached; (iii) the equilibrium in the solution is undisturbed during the subsequent 
incubation of the mixture in the HBcAg-coated well and; (iv) the concentration of 
the free [ 35S]-HBsAg in solution is proportional to the radioactivity measured by a 
scintillation counter. 
A time course study of the [ 35S] L-HBsAg binding to the HBcAg-coated 
wells showed that equilibrium was reached after 6 h at room temperature or after 24 
h at 4 °C (Fig. 25). This also shows that the binding rate of these molecules at room 
temperature is greater than that at 4 °C, which can be determined from the initial 
slope of the curves. After 24 h incubation, the counts at 4 °C were two times higher 
than those obtained at room temperature, therefore the temperature was kept 
constant at 4°C throughout the assay. 
Fig. 26 displays a linear relationship between the concentration of [ 35S] L-
HBsAg and the cpm measured in scintillation counting. Various dilutions of 
translation reaction mixtures containing the [ 35S] L-HBsAg were incubated in wells 
coated with HBcAg for 1 h. After washing, the wells were placed into scintillation 
vials for counting. The cpm was directly proportional to the concentration of the 
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• room temperature 
o 4 °C 
negative control 
0 	10 	20 	30 	40 	50 
time (h) 
Fig. 25: Time course experiment of [35S] L-HBsAg binding to 
HBcAg-coated wells. 
A constant concentration of [35S] L-HBsAg (200x dilution of in vitro translation reaction) 
was incubated with HBcAg-coated wells (10 Jig/mi) for different time periods at room 
temperature and at 4 °C. cpm was obtained from scintillation counting and represents the 
arithmetic mean ± standard deviation of triplicate. Negative control was carried out with 
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Fig. 26: Linear relationship between cpm and concentration of 
[35S] HBsAg. 
Various dilutions of in vitro translation mixtures were incubated for 1 h at 4 °C with 
HBcAg-coated wells (10 pg/mi). The wells were washed and radioactivity (cpm) was 
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[35S] L-HBsAg over a four log range. This linear relationship allows the 
determination of the free [35S]-HBsAg concentration at equilibrium by scintillation 
counting. 
The amount of the free HBsAg molecules bound to the HBcAg-coated on the 
solid phase must be very low in order to prevent any perturbation of the equilibrium 
in solution. To show that this requirement was fulfilled, varying dilutions of in vitro 
translation mixtures were incubated for 1 h in wells previously coated with HBcAg 
and the contents of each well were then transferred to a second coated well and 
incubated under identical conditions. The bound [35S] L-HBsAg in the first and 
second sets of wells were then determined. Initially, 10 jig/mi of HBcAg was used 
to coat the wells, however it was found that the amount of the free [35S] L-HIBsAg 
bound to the wells was greater than 10%, which was deduced from the slopes of the 
straight lines obtained with the two sets of wells (Data not shown). Attempts were 
then taken to reduce the HBcAg concentration immobilised on the solid phase to 
7.5, 5.0, and 2.5 jig/mi. Fig. 27 shows that with 2.5 jig/mI of HBcAg used for 
coating the wells, the slopes differ by 9.6%. At this level, it is unlikely that the 
equilibrium in solution will be significantly disturbed. 
5.2.3 Mathematical and graphical analysis of binding data 
Table 5 representatively shows the experimental data collected for the 
interaction between L-HB5Ag and one of its derivatives, NA77, with HBcAg. The 
data were then analysed with the Scatchard plot and with non-linear hyperbolic 
curve fitting to obtain the Kd' values. 
i The Scatchard plot 
At equilibrium, the reaction between HBsAg and HBcAg in solution can be 
represented as follows: 
s+C<- sc 	 (1) 
Here S is the free HBsAg, C represents the free HBcAg, and SC refers to the 
HBsAg-HBcAg complex. The interaction is presumed to be bimolecular and 
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y 2nd one hour 
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Fig. 27: Determination of the amount of e5sj L-HBsAg captured on 
HBcAg coated wells with scintillation counting 
Various dilution of in vitro translation mixtures were incubated for 1 hr at 4 °C with 
HBcAg coated wells (2.5 1ug/ml) and the solution in each well were then transferred 
to another coated well and incubated under the same conditions. The wells were 
washed and radioactivity was counted with scintillation counter. The counts of the 
first and second sets of the wells are the arithmetic mean ± standard deviation of 
tripicate. The difference between the slopes of the straight lines was deduced from 
the ratio (S1 -S2)/S 1 , in which S 1 and S2 are the slopes obtained with the first and 
second sets of the wells respectively. 
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[C] (pM) 	cpm 	Y=cpm0-cpm/cpm0 Y/[C] (pM') 
80 323±21 0.896±0.007 0.011±0 
40 398± 16 0.872±0.005 0.022±0 
20 547 ±7 0.824±0.002 0.041±0 
10 808 ±27 0.742 ± 0.006 0.074 ± 0.001 
5 1230±3 0.604±0.001 0.121±0 
2.5 1655 ± 30 0.467 ± 0.009 0.187 ± 0.004 




[C] (pM) 	cpm 	Y=cpm0-cpm/cpm0 	Y/[C] (pM) 
5 345 ± 34 0.948 ± 0.005 0.190 ± 0.001 
2.5 573 ±30 0.914 ± 0.005 0.366 ± 0.002 
1.25 714 ± 68 0.893 ± 0.010 0.715 ± 0.008 
0.625 1086±38 0.837±0.006 1.339±0.010 
0.313 1190±110 0.821±0.017 2.624±0.054 
0.156 1272± 56 0.809±0.008 5.188±0.052 
0.078 1544± 108 0.768±0.016 9.850±0.210 
0.039 1718 ± 225 0.742 ± 0.033 19.026 ± 0.857 
0.02 2077±56 0.689 ± 0.008 34.433 ± 0.417 
0 6670±298 
(cpmo) 
Table 5: Data obtained from binding assays of HBcAg with mutant Nii77 (a) 
and wild-type L-HBsAg (b). 
The experiments were carried out at 4 °C with various concentration of HBcAg, [C]. 
Counts per minute (cpm) was obtained from scintillation counting for 5 min and 
represents the arithmetic mean ± standard deviation of triplicate. cpm obtained for 
the sample containing no HBcAg was designated cpm o. Fraction bound, Y, was 
calculated from cpmo-cpmlcpmo. 
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reversible, and the system is defined to have one identical and non-interacting set of 
binding sites, in which the probability of binding to any one site is the same as the 
probability of binding to any other site and occupancy of one site does not affect the 
probability of binding to any other. Phenomenologically, the dissociation constant, 
Kd, of this equilibrium can be defined as 
Kd = [S][C]/[SC] 	 (2) 
The fraction, Y, of the HBsAg bound to the HBcAg is given by 
Y = [SC]/ ([SC] + [S]) 	 (3) 
By combining equations (2) and (3), the Scatchard equation can be derived to give 
Y/[C]=(l -  Y)/Kd 
	
(4) 
As shown previously (Fig. 26), the free [35S]-HBsAg  was proportional to the 
quantity determined by scintillation counting, therefore the ratio between the free (5) 
and total (S i) HIBsAg concentrations can be written as follows: 
[S] = [S e] (cpm/cpm0) 	 (5) 
where cpm0 refers to counts per minute obtained for the well containing no HBcAg, 
and cpm is the counts per minute read for wells with different concentrations of 
HBcAg. According to mass conservation equation, S, S and SC are related to each 
other 
[SC] = [Se] - [5] 	 (6) 
Combination of this relationship with equation (5) gives 
[SC] = [Se] (cpm0-cpm)/cpm0 	 (7) 
and substitution into equation (4) and appropriate rearrangement gives 
(cpm0-cpm)/cpm0[C] = Kd 1 - Kd" (cpm0-cpm)/cpm, 	 (8) 
When the starting concentration of HBcAg, [Cr],  is in large excess over the [S e] (the 
lowest concentration of HBcAg used in this study was 500-fold in excess compared 
to that of HB5Ag). Thus, [SC] becomes negligible compared to [C e] and [C] can be 
approximated well by [Ce].  If the assumptions underlying development of equation 
8 are true, then, a plot of (cpm 0-cpm)/cpm0[C] against (cpm0-cpm)/cpm0 (or Y/[C] 
against Y) gives a straight line of slope equal to - 1/Kd or Ka. 
Fig. 28 shows these plots for L-HBsAg and NA77 with the data from Table 5. 
The plot for N77 was linear with a Kd value of 3.0 ± 0.3 jiM (Fig. 28a), but the 
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Fig. 28: Linear and concave Scatchard plots 
(a) Scatchard graph of mutant Nii77 binding to HBcAg. The data points were fitted 
with a straight line using the GraFitTM  software. The equation y = mx + c was used 
to calculate the slope (m) of the line. (b) Scatchard plot of L-HBsAg binding to 
HBcAg. The single exponential decay function provided in the software was used to 
fit the points. The straight lines were fitted by eye to the apparently linear extreme 
parts of the curve (broken lines) and through all the data points (inset) to illustrate 
the incorrect procedures to obtain Kd values. 
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plot for L-HB sAg was with different limiting slopes at low and high 
concentrations of HBcAg (Fig. 28b). Initially, when this plot was encountered, there 
was a strong, naive temptation to put two lines through the points (Fig. 28b, inset) or 
the apparently linear end parts (limbs) of the curve (Fig. 28b, broken lines) by the 
least square method under some subjective influences, and then ascribe one of the 
lines, that of deeper slope, to a high affinity site and the other to a low affinity site. 
In fact, the slopes of these lines are complicated functions of site parameters (Klotz, 
1971) and generally unsuitable for evaluation of binding constants. To avoid 
misinterpretation of non-linear Scatchard plots, many authors have suggested the 
use of non-linear fitting of appropriate binding equations as a more reliable method 
for data analysis (Reich et al., 1972; Hancock et al, 1979; Munson and Rodbard, 
1980; Hulme and Birdsall, 1992). 
ii non-linear fitting of hyperbolic equations 
For a simple interaction involving only one class of identical and non-
interacting binding sites, equation 4 can be rearranged to give a hyperbola-like 
equation: 
Y=[C]/ [C] + Kd 	 (9) 
The hyperbolic function starts at 0 when [C]=  0 (all HBsAg remain free in solution; 
cpm=cpm(,) and rises to maximal binding, B=1 (cpm=0), as [C] increases. When 
half of the total HBsAg molecules are engaged in a HBsAg-HBcAg complex (i.e. 
Y=1/2 or cpm=1/2 cpm0), Kd=  [C]. 
The hyperbolic relationship between Y and [C] for the interaction between 
NA77 with HBcAg is shown in Fig. 29a. The hyperbolic curve was fitted to the data 
points using the equation for one binding site of the GraFit TM  software. The Kd" 
calculated by the software for the interaction was 2.7 ± 0.2 .tM, which is in good 
agreement with that determined by the Scatchard plot (Fig. 28a; Kd = 3.0 ± 0.3 
tiM), and the difference is within the range of standard error. 
For a system with two classes of independent binding sites, with respective 
dissociation constants Kdl and Kd2  for high- and low-affinity sites, the equivalent 
of equation 9 is as follows: 
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Fig. 29: Curve-fitting binding data with hyperbolic functions 
Graph of Y versus [C] for the binding of Nz177 to HBcAg using the same 
experimental data as in Fig. 28a. The curve was fitted to the points using a 
hyperbolic function for one binding site (GraFitTM). Inset: [C] was plotted as a 
function of log jo  [C]. 
The binding data for the interaction of L-HBsAg with HBcAg (Table 5b) was 
plotted with linear and semi-log scales (inset) for the [C] axis. The points were 
fitted with the equation for two binding sites with the same software. 
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Y={ [C]/[C]+ Kdl } + { [C]I[C]+ Kd2} (Cornish-Bowder, 1995) 	(10) 
The data of L-HBsAg binding to HBcAg (Table 5a) which yield a biphasic 
Scatchard plot (Fig. 28b) were fitted with the equation for two binding sites 
(GraFit) and the plot is shown in Fig. 29b. The relative dissociation constants for 
the high- and low-affinity binding sites were 3.2 ± 0.5 nM (Kd l ) and 1.6 ± 0.7 .tM 
(Kd 2), respectively. 
5.2.4. Interaction of large, small and unfractionated HBcAg particles with 
L-HBsAg 
The binding of L-HBsAg to unfractionated HBcAg particles exhibiting two 
widely differing dissociation constants, suggests the existence of two classes of 
binding sites between the molecules. Since two populations of HBcAg particles, 
large and small, are present in the system, it may have been thought that each species 
displayed different binding sites. To investigate this further, the binding experiment 
was carried out with fractionated large and small HBcAg particles. The Scatchard 
plots for the binding of L-HBsAg to large and small HBcAg particles (Fig. 30a and 
b) showed the same biphasic pattern to that of unfractionated HBcAg particles (Fig. 
30c). The Kd'  values determined by curve fitting the data points to a double 
hyperbolic function (Fig. 30d) are summarised in Table 6. 
HBcAg particles Kdj re1  (nM) 	Kd2re1  (.tM) 
unfractionated 	4.7 ± 0.9 	1.4 ± 0.9 
large 	3.6±0.9 	1.9± 1.0 
small 	5.0 ± 1.4 	0.4 ± 0.2 
Table 6: Relative dissociation constants of L-HBsAg binding 
to unfractionated, large, and small HBcAg particles 
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Fig. 30: Graphical presentation of the binding data collected for the interaction 
of large, small and unfractionated HBcAg particles with L-HBsAg 
Scatchard plots for the binding of L-HBsAg to large (a), small (b) and 
unfractionated (c) HBcAg particles. The curves were fitted to the points using the 
single exponential decay equation of GraFitTM  software. The Y axes of the graphs 
were also plotted as loglo as shown in insets. The three sets of binding data were 
combined in a semi-logarithmic graph (d) and the points were curve fitted with the 
equation for two binding sites. 
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5.2.5 Binding of fusion phage to large, small and unfractionated HBcAg 
particles 
Dyson and colleagues (1995) showed that the interaction of fusion phages 
with unfractionated HBcAg particles gave rise to linear Scatchard plots, indicating 
an identical set of non-interacting binding sites present in the system. To find out 
whether the separated large and small HIBcAg particles have the same docking sites 
for fusion phages, phage particles carrying peptide RSLLGRMK (designated 2A-8; 
residues R and S preceding the fusion hexapeptide, LLGRMK, were mutated from G 
and A of the gpffl protein; Dyson M.R., unpublished data) were used to interact with 
the separated core particles. Scatchard analysis of the binding data yielded linear 
plots (Fig. 31 a) and many of the data points at high concentration of HBcAg were 
squeezed into a small region of the figure near the intercept on the Y axis. In order 
to present the experimental data uniformly, the fraction of free phage remaining in 
solution was plotted against the log io [C], and the curves were fitted to the points 
using the hyperbolic function for one binding site (Fig. 3 ib). A comparison between 
Kd' values calculated by the two methods is shown in Table 7. 
HIBcAg particles 	J< rel (a) (iJ) Kd rel (b) 
unfractionated 	0.11 ± 0.01 	0.10 ± 0.01 
large 	0.11 ± 0.01 	0.11 ± 0.02 
small 	0.07 ± 0.01 	0.06 ± 0.01 
Table 7: Relative dissociation constants ofphage 2A8 binding 
to unfractionated, large and small HBcAg particles 
a Relative dissociation constants calculated by linear regression of the Scatchard 
plots(Fig. 31a). b  Relative dissociation constants calculated by curve fitting to a 
hyperbolic function (Fig. 31b). 
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Fig. 31: Graphical presentation of the binding of phage 2A-8 to large, 
small and unfractionated HBcAg particles. 
Data points at high concentration of HBcAg are extremely compressed in the 
Scatchard plots (a), but they are uniformly distributed in the semi-logarithmic graph 
(b). Data points are mean ± standard deviation of triplicate determinations. 
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5.2.6 Interaction of N- and C-terminal deletion mutants with unfractionated 
HBcAg particles 
Following expression in rabbit reticulocyte lysates supplemented with [35S]-
methionine, the mutated proteins were subjected to the equilibrium binding assay in 
order to evaluate the effects of the mutations on the binding to HBcAg. The 
collected binding data were analysed with the Scatchard plot and non-linear curve 
fitting, and the Kd'  values derived are given in Table 8. The data points were fitted 
to the curves shown using equations for one binding site (Fig. 32a and b) or two 
binding sites (Fig. 33). The results show that mutants N24, Ci263, C322, CA346 
and CA37 1 bind to HBcAg with high- and low-affinities, whereas, only one affinity 
was observed for the binding of mutants NMO, NA54, N60, N77, NA126, C19l, 
C210, and Ci242 to HBcAg. Those mutants showing two affinities gave rise to 
biphasic Scatchard plots as was shown by full-length L-HBsAg (Fig. 34). Linear 
Scatchard plots were obtained for those mutants showing one affinity (Fig. 35). 
5.2.7 Interaction of amino acid substitution mutants with unfractionated 
HBcAg 
The effects of single and multiple mutations in the L-HBsAg on the binding 
to HBcAg were also evaluated with the equilibrium binding assay. Table 9 shows 
the Kdt  values obtained with the non-linear curve fitting method. All of the single 
amino acid substitution mutants displayed high- and low-affinities with Kd1'  values 
ranging from 2 to 34 nM, while Kd2' values appeared to be more than 500 nM. 
Replacement of both Arg 92 and 102 together by Ala gave rise to one affinity (Kd1el = 
51 ± 8 nM). Multiple mutation with Leu 63 to His and Arg 88, 92, 102 and 187 to 
Ala caused more than an 80-fold reduction in the affinity. Furthermore, only one 
affinity was detected for these mutants. 
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mutant 	two binding sitesa 	 one binding site 	weakd 
affinity 
Kdl ' (nM) Kd2'  (.iM) 	Kd' (iM)b 	
rel 










2.2 ± 0.4 
1.5 ± 0.1 
2.2 ± 0.3 
2.7 ± 0.2 
6.0 ± 0.8 
2.5 ± 0.5 
1.5 ± 0.2 
2.1 ± 0.1 
3.0 ± 0.3 


















10.9 ± 3.0 
1.2 ± 0.3 
1.2 ± 0.7 
1.3 ± 0.3 
4.4 ± 0.4 
11.0 ± 0.3 
1.6 ± 0.2 
4.4 ± 0.3 
10.9 ± 0.1 




Table 8: Relative dissociation constants of N- and C-terminal deletion 
mutants for HBcAg 
The values were derived from the equilibrium binding assay in solution at 4°C and 
represent mean ± standard error. The KdTd  values for wild type are the mean offour 
determinants peiformed in triplicate. 
a For mutants displaying two affinities, Kd]Tt  and Kd2 rel values were determined by 
curve-fitting the binding data with the equation for two binding sites. 
For mutants showing one affinity, two methods were used to calculate the Kd' 
values: 
b curve-fitting the data points with one binding site equation (Fig. 32)and, 
linear regression analysis of the data points of the Scatchard plots (Fig. 35). 
d the KdTd  values for weak affinity mutants (> 15 pM) were estimated from the 
concentration of HBcAg required to inhibit half of the total concentration of HBsAg. 







 MO Y 	 0.6 
IIIIIIIIdIIII, 
	
0.6 	 0.8 - 0 NMO 
0.4 	 0.4 - 	N77 
0.2 r0.2 	 0 
0 	0.01 	0.1 	1 	10 	100 
 [C] (tiM) 
0 	Ir i 	I 	I 	 I 	I 	I 	I 	I 
0 10 20 	30 40 
[C] (tM) 
1 	I I 
--A- --- 
— — — -v — 0.8 - 	Ar — 
0.6 ' 	 NM26 
0.8 ACM9I 






0.2 	 0 - 
-! 	 00.1 	1 	10 	100 
0 T i 	I 	I 	I 	I 	I 	I 	I 
0 10 20 30 40 50 60 70 80 90 
[Cl (jiM) 
Fig. 32: N- and C-terminal deletion mutants showing one affinity 
The binding data collected (mean ± standard deviation of triplicate) for the mutants 
as indicated on the left of the inserts were plotted as linear and semi-log scales 
(inserts). The curves were fitted to the points with the hyperbolic function for one 
binding site equation and the Kd'  values generated are given in Table 8. 

















0 	0.01 	0.1 	1 	10 	100 
[C] jM 
Fig. 33: Semi-logarithmic representation of the binding of N- and C- terminal 
deletion mutants to HBcAg with two different affinities 
The double hyperbolic curves were fitted to the binding data with the equation for 
two binding sites. KdJTel  and Kd2Te1  values derived from this operation are presented 
in Table 8. Data points are mean ± standard deviation of triplicate determinations. 
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Fig. 34: Biphasic Scatchard plots for N- and C-terminal deletion mutants 
showing two different affinities. 
The mutants are indicated in the upper part of each graph. All curves were fitted to 
the points with the single exponential decay function (Grafit) except mutant Nz124 
which was fitted to the double exponential decay function. Inserts show the Y axis of 
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Fig. 35: linear Scatchard graphs for N- and C-terminal deletion mutants 
The experimental data shown in Fig. 32 were converted into Scatchard plots. The 
symbols representing the mutants are indicated at the upper right of the graphs. 
Straight lines were put through the points using linear regression of GraFitTM.  The 
Kd' values derived from the slopes of the lines are shown in Table 8. 
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amino acid substitution two binding sites one binding site 
Kd '  (nM) 
Kd1 	(nM) Kd21  (pM) 
wild type 3 ± 1 1.0 ± 0.6 
K38A 8±5 1.1±0.7 
L63H 11 ± 4 2.4 ± 0.9 
L64E 12 ± 7 1.8 ± 1.2 
065R 2 ± 0.4 0.7 ± 0.1 
R88A 4± 1 0.9± 0.4 
R92A 34 ± 3 1.0 ± 0.5 
R102A 12 ± 3 0.6 ± 0.3 
R124A 14± 2 1.6 ± 1.0 
R126A 12± 3 1.0± 0.9 
R156A 15 ± 1 3.2 ± 2.0 
R187A 4± 1 0.7± 0.3 
L63A/G65E 23 ± 5 1.2 ± 0.8 
L63H1R187A 18±7 2.0± 0.9 
R92AIR102A 51±8 
L63HIR88AIR102AIR187A 362 ±96 
L63HIR88AIR92AIR102AIR187A 288 ± 54 
L63HJR88AIR92AIR102AIR187A+4a.a 234 ± 23 
Table 9: Binding affinities of amino acid substitution mutants for HBcAg 
rel and Kd2d  values were obtained by curve fitting the binding data with the 
equation for two binding sites, whereas Kd"el  values for mutants showing one 
affinity were determined with the equation for one binding site. The values for wild 
type are the mean of three determinants performed in triplicate. 
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5.2.8 Inhibition of L-HBsAg binding to HBcAg by synthetic peptides 
Dyson and Murray (1995) showed that the synthetic peptide LDPAFR, 
corresponding to amino acids 19-24 of the PreS 1 and also the epitope for 
monoclonal antibody MA 18/7 (Heermann et al., 1984), inhibits the association of 
L-HBsAg with HBcAg at a 50% inhibition concentration of around 350 riM. More 
recently, the structure of large HBcAg particles has been resolved to 7.4 A with 
electron cryo-microscopy and image reconstruction, and a schematic diagram of the 
amino acid positions in the monomer has also been proposed (Böttcher et al., 1997; 
see Fig.4, pg. 10). Interestingly, residues LEDPASR (corresponding to residues 76-
82 of subtype adyw) located at the tip of the monomer show some similarities with 
the PreS 1 epitope sequence. Furthermore, this region constitutes a big portion of the 
immunodominant loop (residues 74-89) of the protein and was speculated to be 
involved in the interaction with the surface proteins. It is, therefore, of interest to 
investigate whether the peptide LDPAFR may resemble the tip of the nucleocapsid 
spike and bind to a region on L-HBsAg, thus inhibiting the binding of HBsAg to 
HBcAg. 
Two peptides of differents length, EDPASR and LEDPASR, which 
correspond to the residues at the tip of the nucleocapsid spike were synthesised and 
used in the inhibition experiments, and the results are shown in Fig. 36. The peptide 
LLGRMKG, selected from the fusion phage display libraiy against HBcAg and 
included as a positive control, inhibited the interaction between L-HBsAg and 
HBcAg with 50% inhibition at a peptide concentration of -100 iiM. Clearly, both of 
the peptides EDPASR and LEDPASR did not inhibit the interaction, even at 1 mM 
concentration. The negative effect of peptide EDPASR was strongly supported by 
the fact that a combination of this peptide with LLGRMKG did not further inhibit 
the interaction. However, peptide LDPAFR showed some inhibition at 1 mM 
concentration, but this was a three-fold higher concentration than that observed by 
Dyson and Murray (1995). This difference could be due to reaction conditions used; 
i.e., incubation for 24 h (equilibrium) rather than 2.5 h that used by them. 
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Fig. 36: Inhibition of L-HBsAg binding to HBcAg by synthetic peptides 
A constant concentration of [35S]L-HBsAg  (100-fold dilution of a translation 
reaction) was mixed with serial dilutions of peptides ranging from 0 to 1 mM. The 
mixtures were then incubated in wells coated with HBcAg for 24 h, at 4 °C. The 
wells were then washed and radioactivity determined by scintillation counting. The 
symbols representing the peptides are indicated in the inserted box. The points are 
arithmetic mean ± standard deviation of triplicate determinations. 
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5.3 Discussion 
5.3.1 Methods to study HBsAg-HBcAg interaction: from qualitative to 
quantitative 
A major limitation to studies of the interaction between HBsAg and HBcAg 
is that one of the interacting components, HBsAg, cannot be expressed to a 
substantial amount in rabbit reticulocyte lysates to give adequate quantities of the 
protein for analysis in an ideal condition with most of the conventional protein-
protein interaction methods such as surface plasmon resonance (SPR), nuclear 
magnetic resonance (NMR), light scattering, chemical cross linking, chemical 
modification or protection, etc. To overcome this problem, the parent and mutant 
proteins were radiolabelled with [35S]-methionine and their binding to HBcAg was 
identified qualitatively with immunoprecipitation and studied quantitatively by a 
newly established binding assay. 
In combination with phosphoimager analysis, the first method provides 
estimations of the binding affinity relative to the wild-type. However the data 
obtained could not be used for quantitative evaluation because the anti-core 
antibodies may compete for the same binding site with HBsAg. Furthermore, this 
method is not sensitive enough to discriminate between binding affinities that differ 
in magnitude by two- or three-fold, as may often result from a single amino acid 
substitution. Therefore attempts were taken to set up an equilibrium binding assay 
that allows quantitative description of the binding affinities of truncation and amino 
acid substitution mutants in order to gain a more complete picture of the contact sites 
that are involved. 
The original technique described by Friguet et al. (1985) to determine the 
dissociation constants between antigens and antibodies was based on an enzyme-
linked immunosorbent assay (ELISA) for measuring free antibody in solution using 
immobilised antigens. In the study described here, the sensitivity of the detection 
method was improved by labelling HBsAg with [35S] and measuring radioactivity by 
scintillation counting. This permits the measurement of a very small concentration 
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of HBsAg, as low as 1011  M, and thus eliminated the main constraint regarding the 
low yield of the protein synthesised in a cell free system. 
Friguet et al., (1995) also showed that the method can be used reliably to 
measure values of equilibrium constants without the need to purify the antibody to 
homogeneity or to titrate the antibody in the preparation, provided that the total 
antigen concentration is at least 10-fold in excess over the total antibody 
concentration. This is particularly useful for the case of HBsAg, because the protein 
cannot be overexpressed and it would be difficult, laborious, and time consuming to 
purify each of the mutant proteins. It is, therefore, the analogous assay that was 
performed with crude rabbit reticulocyte lysates and the concentration of total 
HBcAg [C s] was always kept sufficiently in excess (>500-fold) of the HBsAg 
concentration. This requirement, however limits a precise measurement of Kd values 
smaller than 10 10 M. 
In addition to the minor modification of the detection method itself, non-
linear regression and Scatchard analyses were applied concurrently to analyse the 
binding data and to extract dissociation constants from them. Other than that, the 
experimental and theoretical basis for the equilibrium binding assay remain the same 
as those of the prototype assay. The dissociation constants obtained with this method 
were regarded as relative rather than true values because: (i) the interaction was 
assumed to be bimolecular, although there is a possibility that one molecule of 
HBsAg binds to a dimer of HBcAg because HBcAg particles are made from dimer 
intermediates. If this is the case, the number of HIB sAg molecules remaining free in 
the solution will be twice the amount calculated above and thus the dissociation 
constants will be two-fold lower; (ii) the free HBcAg concentration [C] was 
approximated by the total HBcAg concentration [Cd because the HBcAg was in 
large excess over HBsAg. These assumptions were used throughout this study to 
calculate dissociation constants, and should affect all the values to a similar degree, 
and thus a relative comparison should be valid. 
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5.3.2 Do fusion phage and L-HBsAg bind at the same docking site on HBcAg? 
When Scatchard analysis was performed on the binding data of L-HBsAg 
with HBcAg, an upward-curved Scatchard plot was obtained. As described in 
several reports (Rosenthal, 1967; Dalquist, 1978; Zierler, 1989; Bordbar et al., 
1996), such phenomenon could be due to one or both of the following factors: (i) the 
system has two or more classes of binding sites with different affinities but 
occupancy to one site does not change the affinity of the binding to any other; (ii) 
there is a negative cooperativity in binding, in which binding at one site decreases 
the affinity of others. Examples of interactions displaying this kind of plot are: 
sodium n-dodecyl sulphate (SDS) with bovine catalase (Beyhi, 1986) and rabbit anti-
pazobenzoate with its hapten p-iodobenzoate (Nisonoff and Pressman, 1958). 
Clearly, the phenomenon is unlikely to be due to different species of HBcAg 
particles because the Scatchard plots of the fractionated small and large HBcAg 
particles have the same pattern, and their high affinities determined by non-linear 
regression were in good agreement with that of unfractionated HBcAg. This 
observation suggests that although HBcAg assembles into two sizes of particles with 
different triangulation number, these particles still possess the same binding sites for 
L-HBsAg. 
Unlike L-HIB sAg, the phage particles selected from a random hexapeptide 
display library against HBcAg particles showed linear Scatchard plots (Dyson et al., 
1995) when their binding constants were analysed with a method that also was 
adapted from Friguet et al. (1985). Employing the same method with one of the 
phage derivatives carrying the peptide RSLLGRMK, but with fractionated large and 
small HBcAg particles, revealed no significant difference in the Kdj'  values. 
Furthermore, only one affinity was observed for the interactions. These results, 
together with the observations with L-HBsAg, suggest that the phages displaying 
specific ligands on their gpffl proteins bind to HBcAg in a different manner from 
that of L-HBsAg. This is no doubt due to the fact that the ligand mimics part of the 
contact areas in HBsAg, perhaps fitting into a 'cleft' on the surface of HBcAg. 
Whereas L-HBsAg and HBcAg might interact with each other over a large area, 
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small peptides derived from the selected phages may mimic part of the essential 
contact areas and will therefore hinder L-HBsAg from binding to HBcAg. 
Peptides EDPASR and LEDPASR, which correspond to a linear sequence at 
the tip of HBcAg monomer, did not inhibit L-HBsAg from binding to HBcAg, but 
the peptide LDPAFR, which coincides with the epitope for monoclonal antibody 
MA1 8/7, did inhibit the interaction, but with a small effect at 1 mM concentration. 
Clearly, this result rules out the speculation that peptide LDPAFR resembles the 
structure of the tip of HBcAg monomer and somehow associates with L-HBsAg to 
prevent it from interacting with HBcAg. It is more likely that the peptide shares the 
same binding site on HBcAg with the sequences selected from the phage display 
library (LLGRMK, YLLRFR, LLGRFK, LLGRFR and other related sequences; 
Dyson and Murray, 1995) because the first and the last two residues of the 
hexapeptide appear in several of the selected sequences. Moreover, it has been 
shown by Dyson and Murray (1995) that the peptide LDPAFR not only inhibits 
L-HB sAg, but also the phage bearing amino acid sequence LLGRMK from binding 
to HBcAg. 
5.3.3 Dissection of two binding domains in L-RBsAg 
Recent analysis of the transmembrane topology of L-HB sAg in transfected 
cells or in vitro indicated that this protein adopts more than one transmembrane 
orientation, so that the PreS regions are disposed to both the cytoplasmic and 
luminal sides of the ER membrane (Prange and Streeck, 1995). It is most likely that 
the cytosolly disposed PreS regions offer docking sites for the envelopment of the 
viral nucleocapsid, while the luminally disposed PreS regions become exposed on 
the surface to serve as a receptor binding domain. Immunoprecipitation of the N-
terminal deletion mutants showed that a 40 amino acids deletion from the N-
terminus of L-HBsAg dramatically reduced its interaction with HBcAg, and a 77 
amino acids deletion caused a further reduction in the interaction. This suggests that 
the PreS 1 region plays a major role in the interaction. On the other hand, 
immunoprecipitation of the C-terminal deletion mutants indicated that the PreS 
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regions alone are not sufficient for interaction with HBcAg, an additional 28 amino 
acids of the S. regions including the hydrophobic helix I being required to form a 
better docking site for HBcAg. 
Equilibrium binding assays in solution showed that the interaction between 
L-HBsAg and HBcAg is mediated by two binding sites which extend beyond the 
PreS regions. Binding of mutants containing only the PreS regions (CA 108, CA 136, 
and CA 163) was too weak for accurate measurement by curve fitting or Scatchard 
analysis (Fig. 37). However, the affinity increased to 4.4 jiM (still a relatively weak 
interaction) for mutant CA191 which contains the PreS regions and helix I of the S-
HBsAg. Also this truncation was judged to bind HBcAg in the immunoprecipitation 
assay (Fig. 24). This suggests that the additional 28 amino acids at the C-terminus 
of the PreS regions provide extra contact sites or perhaps form a better docking site 
for HBcAg than can be provided by the PreS regions alone. However, mutant 
CA210, which has 19 amino acids more than CA191 and was expected to exhibit 
stronger binding, actually showed a 2.5-fold reduction in Kd'  value compared with 
CA191. This further suggests that the N-terminal 191 amino acids of the L-I{BsAg 
form a binding domain that was sterically hindered by the additional 19 amino acids 
at the C-terminus of this fragment. Nevertheless, this domain might contribute 
towards part of the interactions provided by the full length L-HB sAg because mutant 
CA191 binds to HBcAg with a significantly weaker affinity, Kd' =4.4 jiM, which is 
around 1000-fold weaker than the Kd1'  of the wild type, suggesting that the N-
terminal binding domain fills part or one of the binding sites on HBcAg and that 
additional contacts might be made with a second binding domain. The existence of 
the first binding domain is supported indirectly, perhaps, by several individual 
reports showing that the entire PreS regions are not co-translationally translocated 
into the ER lumen and remain at the cytosolic side (Ostapchuk et al., 1994; Bruss et 
al., 1994; and Prange and Streeck, 1995). 
To locate the second binding domain, stop codons were introduced at various 
positions further downstream in the L-HBsAg gene, before and after the postulated 
hydrophobic helices II, ifi, and IV (mutants CA242, CA263, CA322, CA346 
and CA371). Interestingly, mutants with a stop codon after helix II (see Fig. 37) 
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Fig. 37: Change in the relative dissociation constant relative to wild type 
for N- and C- terminal deletion mutants. 
The diagram at the top represents domain organisation of L-HBsAg and, the N- and 
C-terninal deletion mutants. Four predicted transmembrane helices in the S-region 
are indicated by ovals, and their amino acid positions are printed in parenthesis. 
The vertical lines beneath each mutant represent the ratio of the KdTd  of the 
corresponding mutant over the high-affinity (Kd1'') of L-HBsAg. Mutants displaying 
two affinities are indicated by asterisk and their KdJTd  values were used in 
comparison with the high affinity of the wild type. Please refer to Table 8 (pg. 106) 
for the Kd rel values for the mutants. 
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exhibited two binding affinities indicating the existence of a second binding 
domain. However, the wild type-affinities were only fully restored in mutants 
(CA322, CA346 and C371) which contain the second hydrophilic loop of the S 
region. 
These results, together with those from other smaller C-terminal deletions, 
suggest that some of the amino acids between hydrophobic helices I and ifi are 
necessary for constituting a second functional binding domain which may lie next to, 
and perhaps overlap or interact with the N-terminal binding domain in order to 
optimise interaction with corresponding binding sites on the core particle. Each 
domain may provide a principal binding site for its corresponding target site on 
HBcAg and its partner may contribute additional stability to the association. 
Disruption of either one of these binding domains by N- or C-terminal deletions 
from full-length L-l{BsAg , as shown with mutants NA40, NA54, NA60, NA77, 
NA126, CA191, CA210, and C242, resulted in linear Scatchard plots with much 
weaker binding affinities (more than 500-fold weaker) than those of full-length L-
HBsAg. This further supports the existence of a synergistic interaction between the 
two binding domains which governs the high affinity binding with HBcAg. 
Recently, Poisson et al.(1997) demonstrated that two synthetic peptides, one 
corresponding to the 13 C-terminal amino acids of PreS 1 plus the 8 N-terminal 
amino acids of PreS2, and the other to amino acids 56 to 80 of the S region bound 
directly to HBcAg. Again this supports the argument that two distinct binding 
domains occur in L-HB5Ag. 
The high affinities of mutants N24, C322, C346 and C37 1 for HEcAg 
are similar to that of the wild type, implying that the first 24 amino acids and the last 
66 amino acids, which include the putative hydrophobic helices ifi and IV (Stirk et 
al., 1992; Berting et al., 1995) of S-HBsAg are not critical for the interaction. It also 
implies that the epitope of monoclonal antibody Ml 8/7 with peptide sequence 
LDPAFR of residues 19-24 of the PreS 1 region is unlikely to contribute to the 
interaction. When 40 residues of the L-HBsAg were deleted from the N-terminus, 
only one affinity was detected with a Kd'  of 2.2 iM which is around 700-fold 
weaker than that of wild type. Further deletion of the PreS 1 and PreS2 regions 
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(mutants NL\40, Ni54, NA60, N77, NM26), further decreased but did not totally 
eliminate the interaction, as demonstrated by both the immunoprecipitation and 
equilibrium binding experiments. These results corroborate the finding that deletion 
of 102 amino acids of the PreS 1 region of the HEY subtype adw (corresponding to 
subtype adyw amino acid 91) does not prevent virion maturation (Bruss and 
Thomssen, 1994). A possible explanation for this observation is that the second 
binding domain may still interact weakly with HBcAg to mediate assembly of the 
virus, although the first binding domain was partially disrupted. Surprisingly, our 
results show that S-HB5Ag still binds to the HBcAg, but with a very weak affinity 
(>80 p.M) which suggests that the S region could provide an extra weak contact 
with HBcAg which is consistent with the finding that a 25-residue peptide 
corresponding to amino acid sequence 56-80 in the S region interacts with HBcAg 
(Poisson et a!, 1997). 
Binding results from the deletion mutants show that two interdependent 
binding domains which extend to the second hydrophilic loop of the S region 
(between helices II and III) are required for strong interaction with HBcAg. From 
simple topological consideration, the domains might protrude into the cytoplasm in 
order to interact efficiently with the corresponding binding sites on HBcAg. 
Therefore, it is likely that the first and second hydrophobic helices lie on the surface 
of the membrane or inside the binding domains, rather than spanning the membrane 
as predicted (Eble et al., 1986, 1987; Simon et al., 1988). The cytosolic location of 
these binding domains may influence the topology to the succeeding hydrophobic 
helices ifi and W near the C-terminus of the S region, which were shown not to be 
involved in the interaction. However, this model is highly speculative, because the 
study was carried out in a cell free system. Nevertheless, it provides a 
straightforward explanation of the heterogeneous orientation of the S region of L-, 
M-, and S-HBsAg, in which the second hydrophilic loop carrying antigenic 
determinants can be both cytosolly and luminally disposed (Prange and Streeck, 
1995). In addition, it accounts for the partial glycosylation of the envelope proteins 
at Asn-146 in the S region (Eble et al., 1987). 
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5.3.4 Amino acid residues critical for the interaction between L-HBsAg and 
HBcAg 
The interaction of the L-HBsAg with HBcAg was inhibited by the peptide 
ALLGRMKG and other related sequences selected from a random hexapeptide 
display library with purified }{BcAg (Dyson and Murray, 1995). These sequences 
could reflect a region of the L-HBsAg that contacts the nucleocapsid, but they do 
not occur as a contiguous sequence in the L-HBsAg sequence and therefore they 
probably represent a mimic of the docking sites for HBcAg. However, three out of 
six matching residues from the sequence LLGRMK were identified at positions 63-
65 (LLG) in the PreS 1 region and residues 21-26 jTlL) in hydrophobic helix I of 
the S region (Dyson and Murray, 1995). The latter peptide sequence is unlikely to 
contribute to the interaction because this is not inhibited by the peptide ALLTRILG, 
but the role of tripeptide LLG (63-65) in the interaction was tested by introducing 
point mutations in this region. Substitution of Leu-63 with His and Leu-64 with Glu 
each individually reduced the high affinity interaction 4-fold, whereas mutant G65R 
slightly enhanced it (Fig. 38). A double mutant, L63A1G65E displayed an 8-fold 
decrease in Kd1'.  Since these mutations did not dramatically weaken the interaction 
with HBcAg, it is difficult to draw definite conclusions about the contribution of 
residues LLG (63-65) to the interaction. 
The impact of positively charged amino acids within this domain was then 
examined because two positively charged amino acids appear in the fusion phage 
sequence (LLGBMJ). To minimise the effects on protein folding, these amino acids 
were exchanged for Ala. Mutation of Lys-38, Arg-102, Arg-124, Arg-126 and Arg-
156 all individually reduced the interaction by 2- to 5-fold (Fig. 38). However, the 
affinities of mutants R88A and R187A were very similar to that of the wild type, 
suggesting these two positively charged amino acids are not required for the 
interaction. Single substitution of Arg-92 to Ala decreased the binding affinities 
more than any other single mutation tested, around 11-fold relative to the wild type. 
It is thus likely that Arg-92 is involved in the interaction. This was further supported 
by double mutation of Arg-92 and Arg-102 to Ala which caused a further 7 fold 
decrease in affinity. The multiple mutations, L63HJR88AIR102AIR187A and 
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51 
L63H/R88A1R92A/R102A /R187A +4 a.a 
Fig. 38: The effect of single, double, and multiple mutations on the 
relative dissociation constant. 
The diagram at the right represents the PreS and part of S regions. The positions of 
the amino acid substitutions are indicated on the right of the diagram. The changes 
made are indicated by arrows. The ratio of the high-affinity (KdJ') of the single 
amino acid mutation over the high-affinity of the wild type is represented by a dark 
line on the left of each arrow. The impacts of double and multiple mutations are 
shown by light lines. Please refer to Table 9 (pg. 111)for the KdTd  values. 
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L63HIR88AIR92AIR 102AIR 1 87A, reduced the affinity - 100-fold, but insertion of 4 
amino acids (QPTP) at position 97 of the quintuple mutant, which was believed to 
disrupt the conformation of the PreS regions, did not decrease the affinity further. 
This implies that a second binding domain in the S region is involved in the 
interaction with HBcAg. 
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Summary and Conclusion 
Envelopment of HBV is thought to be triggered by the interaction of 
cytoplasmic nucleocapsids with surface proteins inserted in the ER membrane of its 
host cell. However, very little is known about this event since the virus cannot be 
propagated in cell culture. A precise definition of the interaction between HBsAg 
and HBcAg requires a high resolution structure showing the locations of interacting 
groups at or near the interface. In the absence of structural information, 
identification of interacting residues with a mutagenesis approach is a bit like 
looking for a needle in a haystack, especially when the contacting area may be large 
and involves many residues. In order to map the binding sites in L-HBsAg, a series 
of N- and C-terminal deletion mutants were generated by BAL 31 exonuclease and 
introduction of stop codons at various positions in the coding sequence. Site-
directed mutagenesis was also applied to introduce specific amino acid substitutions 
in L-HBsAg, particularly in the PreS regions, to disrupt intermolecular interactions. 
Biochemical and biophysical analyses of the interaction require the 
expression of the mutant proteins and their counterpart in appropriate systems. It is 
unfortunate that HBsAg cannot be expressed efficiently in E.coli. Alternatively, 
rabbit raticulocyte lysates, an eukaryotic cell-free system, were used to express the 
parent and mutant proteins. To compensate for the low yield of the biosynthetic 
products, they were labelled with [35S] which permits their detection with 
autoradiography and scintillation counting. Unlike the HBV surface proteins, 
HBcAg can be produced easily in E.coli, and supplementation of the cell with T4 
AGA tRNA significantly improved its yield. In the prokaryotic cell, HBcAg 
assembles into large and small particles. These particles can be separated from each 
other by sucrose gradient centrifugation and their size distribution was found to be 
essentially monodisperse by light scattering, but their monomers were heterogeneous 
at the C-terminal region, probably due to incomplete synthesis of the protein or 
protease degradation at the carboxy end. 
Following mutagenesis and expression, the next challenge was to 
characterise the interactions of mutated HBsAg with the nucleocapsid. Two 
methods were employed to evaluate the impact of mutations on binding; 
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(i) immunoprecipitation of the interacting molecules with polyclonal anti-core 
antibodies and, (ii) measurement of relative dissociation constants with a newly 
established equilibrium binding assay in solution. Scatchard and non-linear 
regression analyses of the binding data of L-HBsAg with either fractionated large 
and small, or unfractionated HBcAg particles showed two widely differing 
affinities, suggesting the existence of two components to the binding sites between 
the molecules. In contrast to L-HBsAg, only one affinity was observed for the 
binding of phage bearing specific ligands to these particles, suggesting a different 
mode of interaction between the phage and L-HBsAg with HBcAg, in which the 
later displays a more complex behaviour. The interactions between HBsAg and 
HBcAg are believed to involve a large area which is mediated by two interdependent 
binding domains. Separately, these domains bind with low affinities to their 
respective binding sites on HBcAg, but an intact complex consists of these two 
domains bound to the HBcAg through high- and low-affinitiy interactions. In 
addition, point mutation studies show that the Arg residue at position 92 was 
particularly important for the interaction. 
Elucidation of the regions and amino acids in L-HIB sAg that are required to 
interact efficiently with HBcAg have furnished clues to the structure and function of 
these molecules, especially L-HBsAg, during assembly of the virus. However, 
many questions remain to be answered, particularly the regions on HBcAg that are 
involved with the binding domains in L-HIBsAg. The ultimate goal of study of the 
interaction between the two molecules is to design anti-HBV drugs to inhibit the 
essential contact area. However, progress in this field has been hampered by the 
lack of structural information at high resolution. This goal will certainly occupy the 
experiments of many scientists in the fields of chemistry, biochemistry, molecular 
biology, structural biology and pharmacology who will pursue the problem in the 
next millennium. 
Summary and Conclusion 	 127 
REFERENCES 
References 	 128 
Aota, S.J., Gojobori, T., Ishibashi, F., Maruyama, T. and Ikemura, T. (1988). Codon 
usage tabulated from GeneBank sequence data. Nuci. Acids Res. 16 (suppi): r-315-
r402. 
Argos, P. and Fuller, S.D. (1988). A model for the hapatitis B virus core protein: 
prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J. 
8 19-824. 
Avantaggiati, M.L., Natoli, G., Balsano, C., Chirillo, P., Artini, M., DeMarzio, E., 
Collepardo, D. and Levrero, M. (1993). The hepatitis B virus (HBV) PX 
trasnactivates the C-Fos promoter through multiple cis-acting elements. Onco gene. 
1567-1574. 
Bachmann, B.J. (1972). Pedigrees of some mutant strains of Escherichia coli K-12. 
Bacteriol. Rev. 36: 525-557. 
Balsano,C., Avantaggiati, M.L., Natoli, G., DeMarzio, E., Will, H., Perricaudet, M. 
and Levero, M. (1991). Full-length and truncated versions of the hepatitis B virus 
(HBV) X-protein (PX) transactivate the CMYC protooncogene at the transcriptional 
level. Biochem. Biophys. Res. 176: 985-992. 
Bartenschlager, R. and Schailer, H. (1988). The amino-terminal domain of 
hepanaviral P-gene encodes the terminal protein (genome-linked protein) believed to 
prime reverse transcription. EMBO J. 7: 4185-4192. 
Bass, S.H., Mulkerrin, M.G. and Wells, J.A. (1991). A systematic mutational 
analysis of hormon-binding determinants in the human growth hormone receptor. 
Proc. Nati. Acad. Sci. USA. 88: 4498-4502. 
Bayer, M., Blumberg, B. and Werner, B. (1968). Particles associated with Australia 
antigen in the sera of patients with leukemia, Down's Syndrome and hepatitis. 
Nature. 218: 1057-1059. 
Benn, J. and Schneider, R.J. (1994). Hepatitis B virus HBx protein activates Ras-
GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. 
Proc. Nati. Acad. Sci. USA. 91: 10350-10354. 
Berting, A., Hehnen, J., Kroeger, M. and Gerlich, W.H. (1995). Computer-aided 
studies on the spatial structure of the small hepatitis B surface protein. Intervirol. 38: 
8-15. 
Beyhl, F.E. (1986). Interactions of detergents with microsomal enzymes: effects of 
some ionic and non-ionic detergents on glucose-6-phosphatase. Med. Sci. 14: 417-
418. 
Birnbaum, F. and Nassal, M. (1990). Hepatitis B virus nucleocapsid assembly: 
primary structure requirements in the core protein. J.virol. 64: 3319-3330. 
References 	 129 
Birnboim, H.C. (1983). A rapid alkaline extraction method for the isolation of 
plasmid DNA. Method Enzymol. 100: 243-255. 
Birboim, H.C. and Doly, J. (1979). A rapid alkaline extraction procedure for 
screening recombinant plasmid DNA. Nuci. Acids Res. 7: 15 13-1523. 
Bonekamp, F. and Jensen, K.F. (1988). The AGG codon is translated very slowly in 
E.coli even at very low expression level. Nuci. Acids Res. 16: 30 13-3020. 
Bordbar, A.K., Saboury, A.A. and Moosavi-Movahedi, A.A. (1996). The shapes of 
Scatchrd plots for systems with two sets of binding sites. Biochem. Edu . 24: 172-
175. 
Borisova, G., Arya, B., Dislers, A., Borschukova, 0., Tsibinogin, V., Skrastina, D., 
Eldarov, M.A., Pumpens, P., Skryabin, K.G. and Grens, B. (1993). Hybrid hepatitis 
B virus nucleocapsid bearing an immunodorninant region from hepatitis B virus 
surface antigen. J. Virol. 67: 3696-3701. 
Borisova, G.P., Berzins, I., Pushko, P.M., Pumpen, P., Gren, E.J., Tsibinogin, V.V., 
Loseva, V., Ose, V., Ulrich, R., Siakkou. H. and Rosenthal, H.A. (1989). 
Recombinant core particles of hepatitis B virus exposing foreign antigenic 
determinants on their surface. FEBS Letters. 259: 12 1-124. 
Bottcher, B., Wynne, S.A. and Crowther, R.A. (1997). Determination of the fold of 
the core protein of hepatitis B virus by electron cryomicroscopy. Nature. 386: 88-91. 
Bowie, J.U., Reidhaar-Olsen, J.F., Lim, W.A. and Sauer, R.T. (1990). Deciphering 
the message in protein sequences: tolerence to amino acid substitutions. Science. 
247: 1306-1310. 
Bruss, V. and Ganen, D. (1991a). Mutational analysis of hepatitis B surface antigen 
particle assembly and secretion. J. virol. 65: 3813-3820. 
Bruss, V. and Ganem, D. (1991b). The role of envelope proteins in hepatitis B virus 
assembly. Proc. Nazi. Acad. Sci. USA. 88: 1059-1063. 
Bruss, V., Lu., X., Thomssen, R. and Gerlich, W.H. (1994). Post-translational 
alterations in transmembrane topology of the hepatitis B virus large envelope 
protein. EMBO J. 13: 2273-2279. 
Bruss, V. and Thomssen, R. (1994). Mapping a region of the large envelope protein 
required for hepatitis B virion maturation. J. Virol. 68:1643-1650. 
Bruss, V. and Vieluf, K. (1995). Functions of the internal Pre-S domain of the large 
surface protein in hepatitis B virus particle morphogenesis. J. Virol. 69: 6652-6657. 
Buendia, M.A. (1992). Hepatitis B viruses and hepatocellular carcinoma. Adv. 
Cancer Res. 59: 167-226. 
References 	 130 
Bullock, W.O., Fermamdez, J.M. and Hunter, W.M. (1978). XL1-Blue: a high 
efficiency plasmid transforming recA Escherichia coli strain with -galactosidase 
selection. Biotechniques. 5: 376-378. 
Burrell, C.J., MacKay, P., Greenaway, P.J., Hofshneider, P.H. and Murray K. 
(1979). Expression in Escherichia coli of hepatitis B virus DNA sequences cloned 
in plasmid pBR322. Nature. 279: 43-47. 
Cheng, K., Smith, G.L. and Moss, B. (1986). Hepatitis B virus large surface protein 
is not secreted but is immunogenic when selectively expressed by recombinant 
vaccinia virus. J. Virol. 60: 337-344. 
Cheong, J.H., Yi, M.K., Lin, Y. and Murakami, S. (1995). Human RPB5, a subunit 
shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X 
protein and may play a role in X transactivation. EMBO J. 14: 143-150. 
Chisari, F.V., Flippi, P., McLachlan, A., Millich, D.R., Riggs, M., Lee, S., Palmiter, 
R.D., Pinkert, C.A. and Brinster, R.L. (1986). Expression of hepatitis B virus large 
envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic 
mice. J. Virol. 60: 880-887. 
Chothia, C. (1976). The nature of the accessible and buried surfaces in proteins. J. 
Mol. Biol. 105: 1-12. 
Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Appleyard, G., Syred, A.D., 
Highfueld, P.E., Rowlands, D.J. and Brown , F. (1987). Improved immunogeneicity 
of a peptide epitope after fusion of hepatitis B core protein. Nature. 330: 381-384. 
Cleland, J.K., Jones, A.J.S. and Craik, C.S. (1995). Introduction to protein 
engineering. In Cleland, J.L. and Craik., C.S. (ed.) Protein engineering: principles 
and practicle. New York, USA:John Wiley and Sons, PP. 1-32. 
Cohen, S.N., Chang, A.C.Y. and Hsu, L. (1972). Nonchromosomal antibiotic 
resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. 
Proc. Natl. Acad. Sci. USA. 69: 2110-2114 
Cohen, B.J. and Richmond, J.E. (1982). Electron microscopy of hepatitis B core 
antigen synthesized in Echerichia coli. Nature. 296: 677-678. 
Cornish-Bowder, A. (1995). Fundamentals of Enzyme Kinetics. London, UK: 
Portland Press. 
Creighton, T. E. (1984). Proteins. New York, USA: W.H. Freeman and Company. 
Cross, J.L., Wen, P. and Rutter, W.J. (1993). Transactivation by hepatitis B virus X 
protein is promiscuous and dependent on mitogen-activated cellular serine threonine 
kinase. Proc. NatI. Acad. Sci. USA. 90: 8078-8082. 
References 	 131 
Crowther, R.A., Kiselev, N.A., Bottcher, B., Bemman, J.A., Borisova, G.P., Ose, V. 
and Pumpens, P. (1994). Three-dimensional structure of hepatitis B virus core 
particles determined by electron cryomicroscopy. Cell. 77: 943-950. 
Dalquist, F.W. (1978). The meaning of Scatchard and Hill plots. Method Enzymol. 
48:270-299. 
Dane, D.S., Cameron, C.H. and Briggs, M. (1970). Virus-like particles in serum of 
patients with Australia-antigen-associated hepatitis. Lancet, I: 695-698. 
Darget, M. and Ehrlich, S.D. (1974). Prolonged incubation in calcium chloride 
improves competence of Escherichia coli cells. Gene. 6: 23-28. 
Dimmock, N.J. and Primrose, S.B. (1994). Introduction to Modern Virology. 
Cambridge, Great Britain, University Press. 
Doria, M., Klein, N., Lucito, R. and Schneider, R.J. (1995). The hepatitis B virus 
HIBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator 
of transcription factor. EMBO J. 14: 4747-4757. 
Dudley, F.J., Schever, P.J. and Sherlock, S. (1972). Natural history of hepatitis B 
associated antigen: positive chronic liver disease. Lancet. ii: 1388-1393. 
Dyson, M.R., Germaschewski, V. and Murray, K. (1995). Direct measurement via 
phage titre of the dissociation constants in solution of fusion phage-substrate 
complexes. Nuci. Acids Res. 23: 153 1-1535. 
Dyson, M.R. and Murray, K. (1995). Selection of peptide inhibitors of interactions 
involved in complex protein assemblies: association of the core and surface antigens 
of hepatitis B virus. Proc. Nail. Acad. Sci. USA.. 92: 2 194-2198. 
Eble, B.E., Lingappa, V.R. and Ganem, D. (1986). Hepatitis B surface antigen and 
unusual secreted protein initially synthesized as a transmembrane polypeptide. Mol. 
Cell Biol. 6: 1454-1463. 
Eble, B.E., Lingappa, V.R. and Ganem, D. (1990). The N-terminal (PreS2) domain 
of a hepatitis B virus surface glycoprotein is translocated across membranes by 
downstream signal sequence. J. Virol. 64: 1414-1419. 
Eble, B., Macroe, D., Lingappa, V. and Ganem, D. (1987). Multiple topogenic 
sequences determine the transmembrane orientation of hepatitis B surface antigen. 
Mol. Cell Biol. 7: 359 1-3601. 
Edman, J.C., Hallewell, R.A., Valenzuela, P., Goodman, H.M. and Rutter, W.J. 
(1981). Synthesis of hepatitis B surface and core antigen in Escherichia coli. 
Nature. 291: 503-506. 
References 	 132 
Emilsson, V., Naslund, A.K. and Kurland, C.G. (1993). Growth rate dependent 
accumulation of twelve tRNA species in Escherichia coli. J. Mol. Biol. 230: 483-
491. 
Fallows, D. and Goff. S.P. (1995). Mutations in the epsilon sequences of human 
hepatitis B virus affect both RNA encapcidation and reverse trnscription. J. Virol. 69: 
3067-3073. 
Fernholz, D., Galle, P.R. Stemler, M., Brunetto, M., Bonino, F. and Will, H. (1993). 
Infectious hepatitis B virus variant defective in Pre-S2 protein expression in a 
chronic carrier. Virol. 194: 137-148. 
Friguet, B., Chaffotte, A.F., Djavadi-Ohaniance, L. and Goldberg, M.E. (1985). 
Measurements of the true affinity constant in solution of antigen-antibody complexes 
by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77: 305-319. 
Gallina, A., Bonelli, F., Zentilin, L., Rindi, G., Muttini, M. and Milanesi, G. (1989). 
A recombinant hepatitis B core antigen polypeptide with the protamine-like domain 
deleted self-assembles into capsid particles but fails to bind nucleic acids. J. virol. 
63: 4645-4652. 
Ganem, D. (1991). Assembly of Hepadnaviral virions and subviral particles. Current 
Topics in Microbiol. and Immunol. 168: 6 1-63. 
Ganem, D. and Varmus, H.E. (1987). The molecular biology of the hepatitis B 
viruses. Annu. Rev. Biochem. 56: 651-693. 
Gavilanes, F., Gonzalez-Ros, J.M. and Peterson, D.L. (1982). Structure of hepatitis 
B surface antigen: characterization of the lipid components and their association 
with the viral proteins. J. Biol. Chem. 257: 7770-7777. 
Germ J., Purcell, R., Hoggan, M., Holland, P. and Chanock, R. (1969). Biophysical 
properties of Australia antigen. J. Virol. 4: 763-768. 
Gibbs, C.S. (1995). Structure-functions relationships for protein design. In Cleland, 
J.L. and Craik., C.S. (ed.) Protein engineering: principles and practicle. New York, 
USA:John Wiley and Sons, PP. 317-347. 
Gibson, T.J. (1984). Studies on Epstein Barr virus genome. PhD thesis, Cambridge 
university, U.K. 
Goding, J. W. (1978). Use of staphylococcal protein A as an immunological reagent. 
J. Immunol. Methods. 20: 241-253. 
Gough, N.M. and Murray, K. (1982). Expression of HBV surface, core and e 
antigens by stable rat and mouse cell lines. J. Mol. Biol. 162: 43-67. 
References 	 133 
Hancock, A.A., DeLean, A.L. and Lefkowitz R.J. (1979). Quantitative resolution of 
beta-adrenergic receptor subtypes by selective ligand-binding: application of a 
computerized model fitting technique. Mol. Pharmacol. 16: 1-9. 
Hatton, 1., Zhou, S.L. and Standring, D.N. (1992). RNA-binding and DNA-binding 
activities in hepatitis B virus capsid protein: a model for their roles in viral 
replication. J. Virol. 66: 5232-5241. 
Heermann, K.H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten H. and 
Gerlich, W.H. (1984). Large surface proteins of hepatitis B virus containing the Pre-
S sequence. J. Virol. 52: 396-402. 
Hilditch, C.M., Rogers, L.J. and Bishop, D.H.L. (1990). Physicochemical analysis of 
the hepatitis B virus core antigen produced by a baculovirus expression vector. J. 
Gen. Virol. 71: 2755-2759. 
Hoofnagle, T.H., Dusheiko, G.M., Seeff, L.B., Jones, E.A.Waggoner, J.G. and 
Bales, Z.B. (1981). Seroconversion from hepatitis B e antigen to antibody in chronic 
type B hepatitis. Annu. Inter. Med. 94: 744-748. 
Hu, K.Q., Vierling, J.M. and Siddiqui, A. (1990). Trans-activation of HLA-DR gene 
by hepatitis B virus X gene product. Proc. Nazi. Acad. Sci. USA. 87: 7140-7144. 
Hu, K.Q., Yu, C.H. and Vierling, V.J. (1992). Up-regulation of intercellular-
adhesion-molecule-i transcription by hepatitis B virus X-protein. Proc. Nazi. Acad. 
Sci. USA. 89: 11441-11445. 
Hulme, E.C. and Birdsall N.J.M. (1992). Strategy and tactics in receptor-binding 
studies. In Hulme, E.C. (ed) Receptor-ligand interactions, a pratical approach. 
Oxford: IRL press, pp.  63-176. 
Huovila, A.J., Elder, A.M. and Fuller, S.D. (1992). Hepatitis B virus surface antigen 
assembles in a post-ER, pre-Golgi compartment. J. Cell Biol. 118: 1305-1320. 
Hutchison, C.A., Phillips, S., Edgell, M.H., Gillam, S., Jahnke, P. and Smith, M. 
(1978). Mutagenesis at a specific position in a DNA sequence. J. Biol. Chem. 253: 
6551-6560. 
Ikemura, T. (1982). Correlation between the abtindance of Escherichia coli tRNAs 
and the occurrence of respective codons in its protein genes: a proposal for 
synonomous codon choice that is optimal for the E.coli translating system. J. Mol. 
Biol. 151: 389-409. 
Janin, J. (1979). Surface and inside volumes in globular proteins. Nature. 277: 491-
492. 
Janin, J. and Chothia, C. (1990). The structure of protein-protein recognition sites. 
J. Biol. Chem. 265: 16027-16030. 
References 	 134 
Kenny, J.M., Bonsdorff, C-H., Nassal, M. and Fuller, S.D. (1995). Evolutionary 
conservation in hepatitis B virus core structure: composition of human and duck 
cores. Structure. 3: 1009-1019. 
Kim, C.M., Koike, K., Saito, I., Miyamura, T. and Jay, G. (1991). HBx gene of 
hepatitis B virus induces liver cancer in transgenic mice. Nature. 361: 742-745. 
Khudyakov, Y.E. and Makhov, A.M. (1989). Prediction of terminal protein and 
ribonucleases H domains in the gene P products of hepadnaviruses. FEBS Letters. 
243: 115-118. 
Klotz, K.M. and Hunston, D. (1971). Properties of graphical representations of 
multiple classes of binding sites. Biochem. 10: 3065-3069. 
Knaus, T. and Nassal, M. (1993). The encapsidation signal on the hepatitis B virus-
RNA pregenome forms a stem-loop structure that is critical for its function. Nuci. 
Acids. Res. 21: 3967-3975. 
Kniskern, P.J., Hagopian, A., Montgomery, D.L., Burke, P., Dunn, N.R., Hofmann, 
K.J., Miller, W.J. and Ellis, R.W. (1986). Unusually high expression of a foreign 
gene (hepatitis B virus core antigen) in Saccharomyces cerevisiae. Gene. 46: 135-
141. 
Kunkel, T.A. (1985). Rapid and efficient site-specific mutagenesis without 
phenotypic selection. Proc. Nati. Acad. Sci. U.S.A. 82: 488-492. 
Kunkel, T.A., Roberts, S.D. and Zakour, R.A. (1987). Rapid and efficient site-
specific mutagenesis without phenotypic selection. Method Enzymol. 154: 367-382. 
Kuroki, K., Floreani, M., Mimms, L.T. and Ganem, D. (1990). Epitope Mapping of 
the PreS 1 Domain of the hepatitis B virus large surface protein. Virol. 176: 620-
624. 
Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature. 227: 680-685. 
Lee, T.H., Elledge, S.J. and Butel, J.S. (1995). Hepatitis B virus X protein interacts 
with a probable cellular DNA repair protein. J. Virol. 69: 1107-1114. 
Lien, J.M., Aldrich, C.E. and Mason, W.S. (1986). Evidence that a capped 
oligonucletides is the primer for duck hepatitis B virus plus strand synthesis. J. 
Virol. 57: 229-237. 
Lis, J.T. (1980). Fractionation of DNA fragments by polyethylene glycol induced 
precipitation. Method Enzymol. 65: 347-353. 
Lis, J.T. and Schleif, R. (1975). Size fractionation of double-stranded DNA by 
precipitation with polyethylene glycol. Nuci. Acids Res. 2: 383-389. 
References 	 135 
Liu, C.C., Yansura, D. and Levinson, A. (1982). Direct expression of hepatitis B 
surface antigen in monkey cells from an SV40 vector. DNA. 1: 213-221. 
Loeb, D.D., Hirsch, R.C. and Ganem, D. (1991). Sequence-independent RNA 
cleavages generate the primers for plus strand DNA synthesis in Hepatitis B virus-
implications for other reverse transcribing elements. EMBO J. 10: 3533-3540. 
McAleer, W.J., Buynak, E.B., Maigetter, R.Z., Wampler, D.E., Miller, W.J. and 
Hilleman, M.R. (1984). Human hepatitis B vaccine from recombinant yeast. Nature. 
307: 178-180. 
Machida, A., Kishimoto, S., Ohnuma H., Baba, K., Ito, Y., Miyamoto, H., Funatsu, 
G. and Oda, K. (1984). A polypeptide containing 55 amino acid residues coded by 
the PreS region of hepatitis B virus deoxyribonucleic bears the receptor for 
polymerized human as well as chimpanzee albumins. Gastroenterology, 86: 910-
918. 
Machida, A., Ohnuma, H., Tsuda, F., Yoshikawa, A., Hoshi, Y., Tanaka, T., 
Khishimoto, S., Akahane, Y., Miyakawa, Y. and Mayumi, M. (1991). 
Phosphorylation in the carboxyl terminal domain of the capsid protein of hepatitis B 
virus: evaluation with a monoclonal antibody. J. Virol. 65: 6024-6030. 
Mahe, Y., Mukaida, N., Kuno, K., Akiyama, M., Ikeda, N., Matsushima, K. and 
Murakami, S. (1991). Hepatitis B virus X protein transactivates human interleukin-8 
gene through acting on nuclear factor-icB and CCAAT enhancer binding protein-like 
cis elements. J. Biol. Chem. 266: 13759-13763. 
Matsuda, K., Satoh, S. and Ohori, H. (1988). DNA-binding activity of hepatitis B e 
antigen polypeptide lacking the protamine-like sequence of nucleocapsid protein of 
human hepatitis B virus. J. Virol. 62: 35 17-3521. 
Mazzara, G.P., Plunkett, G. and McClain, W.H. (1981). DNA sequence of the 
transfer-RNA region of bacteriophage T4: implications for transfer-RNA synthesis. 
Proc. Nail. Acad. Sci. USA. 78: 889-892. 
Messing, J., Gronenborn, B., Muller-Hill, B. and Hofschneider, P.H. (1977). 
Filamentous coliphage M13 as a cloning vehicle: insertion of a HindU fragment of 
the lac regulatory region in Ml 3 replicative form in vitro. Proc. Nati. Acad. Sci. 
USA. 74: 3642-3646. 
Mimms L.T., Floreani, M., Tyner, J., Whitters, E., Rosenlof, R., Wray L, Goetze, A., 
Sarin, V. and Eble, K. (1990). Discrimination of hepatitis B virus (HBV) subtypes 
using monoclonal-antibodies to the PreS 1 and PreS2 domains of the viral envelope. 
Virol. 176: 604-619. 
References 	 136 
Misra, R. and Reeves, P. (1995). Intermediates in the synthesis of To1C protein 
include an incomplete peptide stalled at a rare Arg codon. Eur. J. Biochem. 152: 
15 1-155. 
Miyanohara, A., Imamura, T., A.raki, M., Sugawara, K., Ohtomo, N. and Matsubara, 
K. (1986). Expression of hepatitis B virus core antigen gene in Saccharomyces 
cerevisae: synthesis of two polypeptide translated from different initiation codons. J. 
Virol. 59: 176-180. 
Moos, M., Nguyen, N.Y. and Liu, T.Y. (1988). Reproducible, high yield sequencing 
of proteins electrophoretically separated and transferred to an innert support. I Biol. 
Chem. 263: 6005-6008. 
Munson, P.J. and Rodbard, D. (1980). Ligand: a versatile computerized approach for 
characterization of ligand-binding systems. Anal. Biochem. 107: 220-239. 
Murray, K., Bruce, S.A., Wingfield, P., van Eerd, P., de Reus, A. and Schellekens, 
H. (1984). Hepatitis B virus antigen made in microbial cells immunise against viral 
infection. EMBO J. 3: 645-650. 
Nassal, M.(1992). The arginine-rich domain of the hepatitis B virus core protein is 
required for precore encapsidation and productive viral positive-strand DNA 
synthesis but not for virus assembly. J. virol. 66: 4107-4116. 
Nassal, M. and Rieger, A. (1993). An intramolecular disulfide bridge between Cys-
7 and Cys-6 1 determines the structure of the secretory core gene product (e antigen) 
of hepatitis B virus. J. Virol. 67: 4307-4315. 
Nassal, M. and Schaller, H. (1993). Hepatitis B virus replication. Trends in 
Microbiol. 1: 221-228. 
Natoli, G., Avantaggiati, M.L., Chirillo, P., Pun, P.L. lanni, A., Balsano, C. and 
Levrero, M. (1994). Ras- and Raf-dependent activation of C-Jun transcriptional 
activity by the hepatitis B virus transactivator pX. Oncogene. 9: 2837-2843. 
Nelson, R.M. and Long, G.L. (1991). Solution-phase equilibrium binding interaction 
of human protein S with C4b-binding protein. Biochem. 30: 2384-2390. 
Neurath, A.R., Kent, S.B.H., Stnick, N. and Parker, K. (1986). Identification and 
chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 46: 
429-436. 
Neurath, A.R., Stirck, N., Seto, B. and Girard, M. (1989). Peptides from the Pre-Si 
region of the hepatitis B virus envelope protein as components of polyvalent hybrid 
vaccines. In Vaccines (89):modern approaches to new vaccines including prevention 
of AIDS. New York: Cold Spring harbor Laboratory, pp.  473-478. 
References 	 - 	137 
Nisonoff, A. and Pressman, D. (1958). Heterogeneity and average combining 
constants of antibodies from individual rabbits. J. Immunol. 80: 4 17-428. 
Onodera, S., Ohori, H., Yamaki, M. and Ishida, N. (1982). Electron microscopy of 
human hepatitis B virus cores by negative staining-carbon film technique. J. Med. 
Virol. 10: 147-155. 
Oostra, B.A., Harver, R., Ely, B.K., Markham, A.F. and Smith, A.E. (1983). 
Transforming activity of polyoma virus middle T antigen probed by site-directed 
mutagenesis. Nature. 304: 456. 
Ostapchuk, P., Hearing, P. and Ganem, D. (1994). A dramatic shift in the 
transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B 
viral morphogenesis. EMBO J. 13: 1048-1057. 
Ou, J.-H., Laub, 0. and Rutter, W.J. (1986). Hepatitis B virus gene function: the 
precore region targets the core antigen to cellular membranes and causes the 
secretion of the e antigen. Proc. Nail. Acad. Sci. USA. 83: 1578-1582. 
Pasek, M., Goto, T., Gilbert, W., Zink, B., Schaller, H., MacKay, P., Leadbetter, G. 
and Murray, K. (1979). Hepatitis B virus genes and their expression in E.coli. 
Nature. 282: 575-579. 
Patzer, E.J., Nakamura, E.R., Simonsen, C.C., Levinson, A.D. and Brands, R. 
(1986). Intracellular assembly and packaging of hepatitis B surface antigen particles 
occurs in the endoplasmic reticulum. J. Virol. 58: 884-892. 
Patzer, E.J., Nakamura, E.R. and Yaffe, A. (1984). Intracellular transport and 
secretion of hepatitis B surface antigen in mammalian cells. J. Virol. 51: 346-354. 
Persing, D.H., Varmus, H.E. and Ganem, D. (1987). The PreS 1 protein of hepatitis B 
virus is acylated at its amino terminus with myristic acid. J. virol. 61: 1672-1677. 
Petit, M.-A. and Pillot, J. (1985). HBc and HBe antigenicity and DNA-binding 
activity of major core protein P22 in hepatitis B virus core particles isolated from the 
cytoplasm of human liver cells. J. Virol. 53: 543-551. 
Poisson, F., Severac, A., Hourioux, C., Goudeau, A. and Roingeard, P. (1997). Both 
PreS 1 and S domains of hepatitis B virus envelope proteins interact with the core 
particle. Virol. 228: 115-120. 
Pollack, J.R. and Ganem, D. (1993a). An RNA stem-loop structure directs hepatitis 
B virus genomic RNA encapsidation. J. Virol. 67: 3254-3263. 
Pollack, J.R. and Ganem, D. (1993b). Site-specific RNA binding by a hepatitis B 
virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA 
synthesis. J. Virol. 68: 5579-5587. 
References 	 138 
Pontisso, P., Petit, M.A., Bankowski, M.J. and Peeples, M.E. (1989). Human liver 
plasma membrane contain receptor for hepatitis B virus PreS 1 region and, via 
polymerized human serum albumin for the PreS2 region. J. Virol. 63: 198 1-1988. 
Prange, R., Nagel, R. and Streeck, R. (1992). Deletions in the hepatitis B virus small 
envelope protein: effect on assembly and secretion of surface antigen particles. J. 
Virol. 66: 5832-5841. 
Prange, R. and Streeck, R. E. (1995). Novel transmembrane topology of the hepatitis 
B virus envelope proteins. EMBO J. 14: 247-256. 
Prasad, V.R. and Goff, S.P. (1989). Linker insertion mutagenesis of the human 
immunodeficiency virus reverse transcriptase expressed in bacteria: defination of the 
minimal polymerase domain. Proc. Nati. Acad. Sci. USA. 86: 3104-3108. 
Qadri, I., Maguire, H.F. and Siddiqui, A. (1995). Hepatitis B virus transactivator 
protein X interacts with the TATA-binding protein. Proc. Natl. Acad. Sci. USA. 92: 
1003-1007. 
Radziwill, G., Tucker, W. and Schaller, H. (1990). Mutational analysis of the 
hepatitis B virus P gene product domain structure and RNAs H activity. J. Virol. 64: 
613-620. 
Raney, A.K., Milich, D.R. and McLachlam, A. (1989). Characterisation of hepatitis 
B virus major surface antigen gene transcription regulatory elements in differentiated 
hepatoma cell lines. J. Virol. 63: 39 19-3925. 
Redeker, A.G. (1975). Viral hepatitis: clinical aspects. Am J. Med. Sci. 270: 9-16. 
Reich, J.G., Wangermann, G., Faick, M. and Rohde, K. (1972). A general strategy 
for parameter estimation from isosteric and allosterik-kinetic data and binding 
measurements. Eur. J. Biochem. 26: 368-379. 
Reiger, A. and Nassal, M. (1995). Distinct requirements for primary sequence in the 
5'- and 3'- part of a bulge in the hepatitis B virus RNA encapsidation signal 
revealved by a combined in vivo selection/ in vitro amplication system. Nuci. Acids 
Res. 23: 3909-3915. 
Robinson, M., Lilley, R., Little, S., Emtage, J.S., Yarranton, G., Stephens, P., 
Millacan, A., Eaton, M. and Humphreys, G. (1984). Codon usage can affect 
translation rate in Escherichia coli. Nucl. Acids. Res. 12: 6663-6671. 
Robinson, W. S. and Luttwick, L.I. (1976). The virus of hepatitis type B. New Eng. 
J. Med. 295: 1168-1 175. 
Rosenthal, H.E. (1967). A graphic method for the determination and presentation of 
binding parameters in a complex system. Anal. Biochem. 20: 525-532. 
References 	 139 
Rossi, J. and Zoller, M. (1987). Site-specific and regionally directed mutagenesis of 
protein encoding sequences. In Oxender, D.L., and Fox, C.F. (ed.) Protein 
Engineering. New York, USA: Alan R. Liss, INC, pp  5 1-64. 
Rossinck, M.J., Jameel, S., Loukin, S.H. and Siddiui, A. (1986). Expression of 
hepatitis B viral core region in mammalian cells. Mol. Cellular Bio. 6: 1393-1400. 
Rossner, M.T. (1982). Hepatitis B virus X gene product: a promiscuous 
transcriptional activator. J. Med. Virol. 36: 101-117. 
Salfeld, J., Pfaff, E., Noah, M. and Schaller, H. (1989). Antigenic determinants and 
functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 63: 
798-808. 
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989). Molecular cloning: a laboratory 
manual. Cold Spring Harbour, New York. Cold Spring Harbor Laboratory Press. 
Sanger, F. and Coulson, A.R. (1975). A rapid method for determining sequences in 
DNA by primed synthesis with DNA polymerase. J. Mol. Biol. 94: 441-448. 
Sanger, F., Nicklen, S. and Coulson, A.R. (1977). DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74: 5463-5467. 
Saxena, P. and Walker, J.R. (1992). Expression of ArgU: the Escherichia coli gene 
coding for a rare arginine tRNA. J. Bacteriol. 174: 1956-1964. 
Schaller (1993). Molecular biology of Hepatitis B virus. ZMBH 1992-93 report. 
118-130. 
Schaller, H. and Fisher, M. (1991). Transcriptional control of Hepadnavirus gene 
expression. Current Topic in Microbiol. and Immunol. 168: 2 1-39. 
Schoedel., F., Moriaty, A.M., Peterson, D.L., Zheng, J., Hughes, J.L., Will, H., 
Leturcq, D.J., McGee, J.S. and Milich, D.R. (1992). The position of heterologous 
epitopes inserted in hepatitis B virus core particles determines their immunogenicity. 
J. Virol. 66: 106-114. 
Schroder, R., Maassen, A., Lippoldt, A., Bomer, T., Vonbaehr, R. and Dobrowolski, 
P. (1991). Expression of the core antigen gene of hepatitis B virus (HBV) in 
Acetobacter methanolicus using broad host range vectors. Appl. Microb. Biotech. 35: 
63 1-637. 
Scott, J.K. and Smith, G.P. (1990). Searching for peptide ligands with an epitope 
library. Science. 249: 386-390. 
Seeger, C., Summers, J. and Mason, W.S. (1991). Viral DNA synthesis. Current 
Topic in Microbiol. and Immunol. 168: '4 1-59. 
References 	 140 
Seto, E., Benedict, T.S., Peterlin, B.M. and Ou, J. H. (1988). Transactivation of the 
human immunodeficiency virus long terminal repeat by the hepatitis B virus X 
protein. Proc. Nat!. Acad. Sci. USA. 85: 8262-8290. 
Siddiqui, A., Jameel, S. and Mapoles, J. (1987). Expression of the hepatitis B virus 
X gene in mammalian cells. Proc. Nat!. Acad. Sci. USA. 84: 2513-2517. 
Simon, K., Lingappa, V.R. and Ganem, D. (1988). Secreted hepatitis B virus surface 
antigen polypeptides are derived from a transmembrane precursor. J. Cell. Biol. 107: 
2 163-2168. 
Slagle, B.L., Lee, P.-H. and Butel, J.S. (1992). Hepatitis B virus and hepatocellular 
carcinoma. Prog. Med. Virol. 39: 167-203. 
Smith, L.M., Sanders, J.Z., Kaiser, R.J., Hughes, P., Dodd, C., Connell, C.R., 
Heiner, C., Kent, S.B.H. and Hood, L.E. (1986). Fluorescence detection in 
automated DNA-sequence analysis. Nature. 321: 674-678. 
Smith, G.P. and Scott, J.K. (1993). Libraries of peptides and proteins displayed on 
filamentous phage. Method EnzymoL 217: 228-257. 
Sondek, J. and Shortle, D. (1990). Accommodation of single amino acid insertions 
by the native state of staphylococcal nuclease. Proteins. 7: 299-305. 
Sorensen, M.A., Kurland, C. and Pedersen, S. (1989). Codon usage determines 
translation rate in Escherichia coli. J. Mol. Biol. 207: 365-377. 
Spanjaard, R.A. and van Duin, J.E. (1988). Translation of the sequence AGG-AGG 
yields 50% ribosomal frameshift. Proc. Nat!. Acad. Sci. USA. 85: 7967-7971. 
Stahl, S., MacKay, P., Magazin, M., Bruce, S. and Murray, K. (1982). Hepatitis B 
virus core antigen: synthesis in Escherichia coli and application in diagnosis. Proc. 
Nail. Acad. Sci. USA. 79: 1606-1610. 
Stahl, S.J. and Murray, K. (1989). Immunogenicity of peptide fusions to hepatitis 
virus core antigen. Proc. Nat!. Acad. Sci. USA. 86: 6283-6287. 
Stevens, C.E., Toy, P.T., Tong, M.J.,Taylor, P.E., Vyas, G.N. Nair, P.V., Gudavalli, 
M. and Krugman, S. (1985). Perinatal hepatitis B virus transmission in the United 
States. J. American Med. Association. 253: 1740-1745. 
Stewart, F.S. (1993). Mutations that affect the structure and interactions of the core 
antigen of hepatitis B virus. PhD Thesis, University of Edinburgh. 
Stirk, H.J., Thornton, J.M. and Howard, C.R. (1992). A topological model for 
hepatitis B surface antigen. Intervirol. 339: 148-158. 
References 	 141 
Szmuness, W., Stevens, C.E., Harley, E.J. Zhang, A., Olwszko, W.R., William, 
D.C., Sodovsky, R., Morrison, J.M. and Keilner, A. (1980). Hepatitis B vaccine: 
demonstration of efficacy in a controlled clinical trial in a high-risk population in 
the United States. New England J. Med. 303: 833-841. 
Tabor, S. and Richardson, C.C. (1985). A bacteriophage T7 RNA polymerase 
promoter system for controlled exclusive expression of specific genes. Proc. Nati. 
Acad. Sci. USA. 82: 1074-1078. 
Takahashi, K., Kishimoto, S., Ohori, K., Yoshizawa, H., Machida, A., Ohnuma, H., 
Tsuda, F., Munekata, B., Miyakawa, Y. and Mayumi, M. (1991). Molecular 
heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus. J. 
Immunol. 147: 3156-3160. 
Takahashi, K., Machisa, A., Funatsu, G., Nomura, M., Usuda, S., Aoyagi, S., 
Tachibana, K., Miyamoto, H., Imai, M., Makamura, T., Miyakawa, Y. and Mayumi, 
M. (1983). Immunochemical structure of hepatitis B e antigen in the serum. J. 
Immunol. 130: 2903-2907. 
Thomas, H.C. and Scully, L.J. (1985). Antiviral therapy in chronic hepatitis B virus 
infection. British Med. Bulletin. 41: 374-380. 
Toh, H., Hayashida, H. and Miyata, T. (1983). Sequence homology between 
retroviral reverse transcriptase and putative polymerases of hepatitis B virus and 
cauliflower mosaic virus. Nature: 305: 827-829. 
Twu, J.-S, Lai, M.-Y., Chen, D.-S. and Robinson, W.S. (1993). Activation of 
protooncogene C-Jun by the X protein of hepatitis B virus. Virol. 192: 346-350. 
Twu, J.-S and Robinson, W.S. (1989). Hepatitis B virus X gene can transactivate 
heterologous viral sequences. Proc. Natl. Acad. Sci. USA. 86: 2046-2050. 
Twu, J.-S. and Schloemer, R.H. (1987). Transcriptional transactivating function of 
hepatitis B virus. J. Virol. 61: 3448-3453. 
Ueda, K., Tsurimoto, T. and Matsubara, K. (1991). Three envelope proteins of 
hepatitis B virus: large 5, middle S and major S proteins needed for the formation of 
Dane particles. J. Virol. 65: 352 1-3529. 
Ulrich, R., Meisel, H., Soza, A., Kruger, D.H., Ladhoff, A.M., Borisova, G. and 
Pumper, P. (1993). Characterization of chimeric core particles of hepatitis B virus 
containing foreign epitopes. In Vaccine (93): a modern approaches to new vaccines 
including prevention of AIDS. New York: Cold Spring Harbor press, pp.  323-328. 
Uy, A., Bruss, V., Gerlich, W.H., Kochel. H.G. and Thomssen, R. (1986). Precore 
sequence of hepatitis B virus inducing e antigen and membrane-association of the 
viral core protein. Virol. 155: 89-96. 
References 	 - 	 142 
Valenzuela, P., Medina, A., Ruffer, W.J., Ammerer, G. and Hall, B.D. (1982) 
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. 
Nature. 298: 347-350. 
Will, H., Reiser, W., Weimer, T., Pfaff, E., Buscher, M., Sprengel, R., Cattaneo, R. 
and Schaller, H. (1987). Replication strategy of human hepatitis B virus. J. Virol. 
61: 904-911. 
Wingfield, P.T., Stahl, S.J., Williams, R.W. and Steven, A.C. (1995). Hepatitis core 
antigen produced in Escherichia coli: subunit conformational analysis and in vitro 
capsid assembly. Biochem. 34: 4919-4932. 
Wunderlich, G. and Bruss, V. (1996). Characterization of early hepatitis B virus 
surface protein oligomers. Arch. Virol. 141: 1191-1205. 
Yaginuma, K and Koike, K. (1989). Identification of a promoter region for 3.6 
kilobase mRNA of hepatitis B virus and specific cellular binding protein. J. Virol. 
63: 2914-2921. 
Zahn, K. and Landy, A. (1996). Modulation of lambda integrase synthesis by rare 
arginine tRNA. Mol. Microbiol. 21: 69-76. 
Zheng, J., Schödel, F. and Peterson, D.L. (1992). The structure of hepanaviral core 
antigens. J. Rio. Chem. 267: 9422-9428. 
Zhou, D.-X., Taraboulous, A., Ou, J.-H. and Yen, T.S.B. (1990). Activation of class 
I major histocompatibility complex gene expression by hepatitis B virus. J. virol. 64: 
4025-4028. 
Zhou, S.L. and Standring, D.N. (1991). Production of hepatitis B virus nucleocapsid-
like core particles in Xenopus oocytes: assembly occurs mainly in the cytoplasm and 
does not require the nucleus. J. Virol. 65: 5457-5464. 
Zierler, K. (1989). Misuse of nonlinear Scatchard Plots. Trends Biochem. Sci. 14: 
3 14-3 17. 
Zlotnick, A., Cheng, N., Conway, J.F., Steven, A.C., Stahl, S.J. and Wingfield, P.T. 
(1996). Dimorphism of hepatitis B virus capsids is strongly influenced by the C-
terminus of the capsid protein. Biochem. 35: 7412-7421. 
References 	 143 
